<?xml version="1.0" encoding="utf-8"?>
<iati-activities version="2.03" generated-datetime="2026-11-11T15:32:23+00:00">
  <iati-activity last-updated-datetime="2026-11-10T13:42:47+00:00" xml:lang="en" default-currency="USD" humanitarian="0" hierarchy="1">
    <iati-identifier>47045-ZAF-C-NDOH-1</iati-identifier>
    <reporting-org ref="47045" type="30">
      <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
    </reporting-org>
    <title>
      <narrative>Investing for Impact against Tuberculosis and HIV - South Africa (01-Apr-2016-31-Mar-2019)</narrative>
    </title>
    <description type="1">
      <narrative>South Africa, TB/HIV, National Department of Health of the Republic of South Africa</narrative>
    </description>
    <description type="2">
      <narrative>Goals: Ensuring an enabling and accessible legal framework that protects and promotes human rights in order to support implementation of the NSP; Initiating at least 80% of eligible patients on antiretroviral treatment, with 70% alive and on treatment five years after initiation; Reducing new HIV infections by at least 50%, using combination prevention approaches; Reducing self-reported stigma related to HIV and TB by at least 50%; Reducing the number of new TB infections and deaths from TB by 50%. Objectives: Addressing Social and Structural Drivers of HIV and TB Prevention, Care and Impact; Ensuring protection of human rights and improving access to justice; Preventing New HIV, STI and TB Infections; Sustaining Health and Wellness.</narrative>
    </description>
    <participating-org ref="47045" type="30" role="1" crs-channel-code="47045">
      <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
    </participating-org>
    <participating-org type="10" role="2" crs-channel-code="12001">
      <narrative>National Department of Health of the Republic of South Africa</narrative>
    </participating-org>
    <participating-org type="10" role="4" crs-channel-code="12001">
      <narrative>National Department of Health of the Republic of South Africa</narrative>
    </participating-org>
    <other-identifier ref="ZAF-C-NDOHP01" type="A1">
      <owner-org ref="47045">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </owner-org>
    </other-identifier>
    <activity-status code="4" />
    <activity-date type="1" iso-date="2016-04-01" />
    <activity-date type="2" iso-date="2016-04-01" />
    <activity-date type="3" iso-date="2019-03-31" />
    <activity-date type="4" iso-date="2019-03-31" />
    <contact-info type="1">
      <organisation>
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </organisation>
      <department>
        <narrative>Communications</narrative>
      </department>
      <telephone>+41 58 791 1700</telephone>
      <email>website@theglobalfund.org</email>
      <website>https://www.theglobalfund.org</website>
      <mailing-address>
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria, Global Health Campus, Chemin du Pommier 40, 1218 Grand-Saconnex, Geneva, Switzerland</narrative>
      </mailing-address>
    </contact-info>
    <contact-info type="2">
      <organisation>
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </organisation>
      <department>
        <narrative>Grant Management Division</narrative>
      </department>
      <person-name>
        <narrative>John Ochero</narrative>
      </person-name>
      <job-title>
        <narrative>Fund Portfolio Manager</narrative>
      </job-title>
      <telephone>+41 58 791 1700</telephone>
      <email>john.ochero@theglobalfund.org</email>
      <website>https://www.theglobalfund.org</website>
      <mailing-address>
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria, Global Health Campus, Chemin du Pommier 40, 1218 Grand-Saconnex, Geneva, Switzerland</narrative>
      </mailing-address>
    </contact-info>
    <activity-scope code="4" />
    <recipient-country code="ZA" percentage="100">
      <narrative>South Africa</narrative>
    </recipient-country>
    <sector vocabulary="1" code="13040" percentage="50">
      <narrative>TB/HIV</narrative>
    </sector>
    <sector vocabulary="1" code="12263" percentage="50">
      <narrative>TB/HIV</narrative>
    </sector>
    <tag vocabulary="2" code="3">
      <narrative>Ensure healthy lives and promote well-being for all at all ages</narrative>
    </tag>
    <tag vocabulary="3" code="3.3">
      <narrative>End the epidemics of AIDS, tuberculosis, malaria and neglected tropical diseases, and combat hepatitis, water-borne diseases and other communicable diseases</narrative>
    </tag>
    <collaboration-type code="1" />
    <default-flow-type code="10" />
    <default-finance-type code="110" />
    <default-aid-type code="C01" vocabulary="1" />
    <default-tied-status code="5" />
    <transaction ref="8a1c598e-0495-4525-9050-0e7d172ce181">
      <transaction-type code="2" />
      <transaction-date iso-date="2016-07-25" />
      <value currency="USD" value-date="2016-07-25">58900330.00</value>
      <description>
        <narrative>Global Fund commitment to ZAF-C-NDOHP01.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="10">
        <narrative>National Department of Health of the Republic of South Africa</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="13e9d9dc-47bf-4f39-aecc-5ce4e29e1826">
      <transaction-type code="3" />
      <transaction-date iso-date="2016-07-26" />
      <value currency="USD" value-date="2016-07-26">12669796.00</value>
      <description>
        <narrative>Global Fund disbursement to ZAF-C-NDOHP01.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="10">
        <narrative>National Department of Health of the Republic of South Africa</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="506772cc-a7f1-4ba0-bade-2e44d719b324">
      <transaction-type code="3" />
      <transaction-date iso-date="2016-09-06" />
      <value currency="USD" value-date="2016-09-06">8050971.00</value>
      <description>
        <narrative>Global Fund disbursement to ZAF-C-NDOHP01.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="10">
        <narrative>National Department of Health of the Republic of South Africa</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="b445338e-2bec-4602-8b09-313065434e70">
      <transaction-type code="3" />
      <transaction-date iso-date="2016-12-13" />
      <value currency="USD" value-date="2016-12-13">9627301.00</value>
      <description>
        <narrative>Global Fund disbursement to ZAF-C-NDOHP01.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="10">
        <narrative>National Department of Health of the Republic of South Africa</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="c9f91d98-ff6b-4102-baa8-a7da30bd7fd3">
      <transaction-type code="3" />
      <transaction-date iso-date="2017-05-09" />
      <value currency="USD" value-date="2017-05-09">12584310.00</value>
      <description>
        <narrative>Global Fund disbursement to ZAF-C-NDOHP01.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="10">
        <narrative>National Department of Health of the Republic of South Africa</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="b68d5f35-47b0-4cb6-8196-24cd3f94195c">
      <transaction-type code="3" />
      <transaction-date iso-date="2017-07-27" />
      <value currency="USD" value-date="2017-07-27">8350299.00</value>
      <description>
        <narrative>Global Fund disbursement to ZAF-C-NDOHP01.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="10">
        <narrative>National Department of Health of the Republic of South Africa</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="3c25738a-2383-4b4f-a9fa-52d00c7e244d">
      <transaction-type code="3" />
      <transaction-date iso-date="2017-10-05" />
      <value currency="USD" value-date="2017-10-05">75659.44</value>
      <description>
        <narrative>Global Fund disbursement to ZAF-C-NDOHP01.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="10">
        <narrative>National Department of Health of the Republic of South Africa</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="6ab6ac32-254d-4f8f-bf3e-1e4d69c970e0">
      <transaction-type code="3" />
      <transaction-date iso-date="2017-11-07" />
      <value currency="USD" value-date="2017-11-07">7541993.56</value>
      <description>
        <narrative>Global Fund disbursement to ZAF-C-NDOHP01.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="10">
        <narrative>National Department of Health of the Republic of South Africa</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="9d24bc87-c608-4814-b1d3-3fe826620b6b">
      <transaction-type code="2" />
      <transaction-date iso-date="2017-12-15" />
      <value currency="USD" value-date="2017-12-15">50000.00</value>
      <description>
        <narrative>Global Fund commitment to ZAF-C-NDOHP01.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="10">
        <narrative>National Department of Health of the Republic of South Africa</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="872b0097-3756-4603-8f7b-aebe18331558">
      <transaction-type code="2" />
      <transaction-date iso-date="2017-12-18" />
      <value currency="USD" value-date="2017-12-18">18319748.13</value>
      <description>
        <narrative>Global Fund commitment to ZAF-C-NDOHP01.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="10">
        <narrative>National Department of Health of the Republic of South Africa</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="f89ec1a6-bc09-409e-89f1-ca5a9d6497a2">
      <transaction-type code="3" />
      <transaction-date iso-date="2018-01-16" />
      <value currency="USD" value-date="2018-01-16">7527394.13</value>
      <description>
        <narrative>Global Fund disbursement to ZAF-C-NDOHP01.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="10">
        <narrative>National Department of Health of the Republic of South Africa</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="373f371e-0f96-4153-bcb3-be4b4c934521">
      <transaction-type code="2" />
      <transaction-date iso-date="2018-04-20" />
      <value currency="USD" value-date="2018-04-20">-50000.00</value>
      <description>
        <narrative>Global Fund commitment to ZAF-C-NDOHP01.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="10">
        <narrative>National Department of Health of the Republic of South Africa</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="a024bdbe-6c75-4f63-aa2a-6a2735a39dde">
      <transaction-type code="2" />
      <transaction-date iso-date="2018-04-20" />
      <value currency="USD" value-date="2018-04-20">100000.00</value>
      <description>
        <narrative>Global Fund commitment to ZAF-C-NDOHP01.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="10">
        <narrative>National Department of Health of the Republic of South Africa</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="7727f43c-9239-4c2f-aa9e-b855a9cb4629">
      <transaction-type code="3" />
      <transaction-date iso-date="2018-05-08" />
      <value currency="USD" value-date="2018-05-08">10792354.00</value>
      <description>
        <narrative>Global Fund disbursement to ZAF-C-NDOHP01.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="10">
        <narrative>National Department of Health of the Republic of South Africa</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="45873439-7325-4b47-8747-4964a086bc05">
      <transaction-type code="2" />
      <transaction-date iso-date="2018-08-17" />
      <value currency="USD" value-date="2018-08-17">13890744.00</value>
      <description>
        <narrative>Global Fund commitment to ZAF-C-NDOHP01.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="10">
        <narrative>National Department of Health of the Republic of South Africa</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="541615d0-d9d9-4219-9fe0-e99f5b2da2dc">
      <transaction-type code="3" />
      <transaction-date iso-date="2018-08-21" />
      <value currency="USD" value-date="2018-08-21">13890744.00</value>
      <description>
        <narrative>Global Fund disbursement to ZAF-C-NDOHP01.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="10">
        <narrative>National Department of Health of the Republic of South Africa</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="353f03b8-dc8b-46ae-9dfe-b25a1e34c830">
      <transaction-type code="2" />
      <transaction-date iso-date="2018-12-17" />
      <value currency="USD" value-date="2018-12-17">35343914.40</value>
      <description>
        <narrative>Global Fund commitment to ZAF-C-NDOHP01.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="10">
        <narrative>National Department of Health of the Republic of South Africa</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="3dc4040b-96bd-4fef-9bee-371a561c3f32">
      <transaction-type code="3" />
      <transaction-date iso-date="2018-12-18" />
      <value currency="USD" value-date="2018-12-18">17193281.00</value>
      <description>
        <narrative>Global Fund disbursement to ZAF-C-NDOHP01.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="10">
        <narrative>National Department of Health of the Republic of South Africa</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="9d6587a9-1604-4d4c-b666-d34e9b45ef27">
      <transaction-type code="3" />
      <transaction-date iso-date="2018-12-31" />
      <value currency="USD" value-date="2018-12-31">50000.00</value>
      <description>
        <narrative>Global Fund disbursement to ZAF-C-NDOHP01.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="10">
        <narrative>National Department of Health of the Republic of South Africa</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="ecbb812d-185f-4f74-8a35-3ec161594428">
      <transaction-type code="3" />
      <transaction-date iso-date="2019-03-21" />
      <value currency="USD" value-date="2019-03-21">10117626.00</value>
      <description>
        <narrative>Global Fund disbursement to ZAF-C-NDOHP01.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="10">
        <narrative>National Department of Health of the Republic of South Africa</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="52130a0d-655c-49b7-a068-49f916d082e4">
      <transaction-type code="2" />
      <transaction-date iso-date="2020-05-04" />
      <value currency="USD" value-date="2020-05-04">-8033007.40</value>
      <description>
        <narrative>Global Fund commitment to ZAF-C-NDOHP01.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="10">
        <narrative>National Department of Health of the Republic of South Africa</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="56f014e0-e9bf-4e8e-95f9-7b16a7e2714f">
      <transaction-type code="2" />
      <transaction-date iso-date="2020-05-04" />
      <value currency="USD" value-date="2020-05-04">-50000.00</value>
      <description>
        <narrative>Global Fund commitment to ZAF-C-NDOHP01.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="10">
        <narrative>National Department of Health of the Republic of South Africa</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="a9bf0dbe-3f48-41dd-906a-d6e5dd753d7d">
      <transaction-type code="7" />
      <transaction-date iso-date="2020-07-10" />
      <value currency="USD" value-date="2020-07-10">92939.90</value>
      <description>
        <narrative>Funds returned to the Global Fund from ZAF-C-NDOHP01.</narrative>
      </description>
      <provider-org type="10">
        <narrative>National Department of Health of the Republic of South Africa</narrative>
      </provider-org>
      <receiver-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="a5c25511-855c-468f-beca-442931834ff4">
      <transaction-type code="2" />
      <transaction-date iso-date="2020-07-17" />
      <value currency="USD" value-date="2020-07-17">-92939.90</value>
      <description>
        <narrative>Global Fund commitment to ZAF-C-NDOHP01.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="10">
        <narrative>National Department of Health of the Republic of South Africa</narrative>
      </receiver-org>
    </transaction>
    <document-link url="https://data.theglobalfund.org/grant/ZAF-C-NDOH" format="text/html">
      <title>
        <narrative>Grant page on the data explorer of the Global Fund.</narrative>
      </title>
      <description>
        <narrative>An overview of a grant over its lifetime.</narrative>
      </description>
      <category code="A12" />
      <category code="A01" />
      <category code="A02" />
      <category code="A05" />
      <category code="A07" />
      <category code="A08" />
      <language code="en" />
      <document-date iso-date="2026-11-11" />
    </document-link>
    <document-link url="https://www.theglobalfund.org/media/13342/core_grantregulationsversiontwo_regulations_en.pdf" format="application/pdf">
      <title>
        <narrative>Grant terms and conditions.</narrative>
      </title>
      <description>
        <narrative>General terms and conditions which apply to Global Fund grants.</narrative>
      </description>
      <category code="A04" />
      <language code="en" />
    </document-link>
    <result type="1" aggregation-status="0">
      <title>
        <narrative>Number of cases with RR-TB and/or MDR-TB that began second-line treatment</narrative>
      </title>
      <description>
        <narrative>Module: MDR-TB.</narrative>
      </description>
      <indicator measure="5" aggregation-status="0">
        <title>
          <narrative>Number of cases with RR-TB and/or MDR-TB that began second-line treatment</narrative>
        </title>
        <description>
          <narrative>Geographic coverage: National. Aggregation: Cumulative annually.</narrative>
        </description>
        <baseline year="2015" iso-date="2015-12-31">
          <comment>
            <narrative>Numerator: 11538; Denominator: 18734; Percentage: 61.6%.</narrative>
          </comment>
        </baseline>
        <period>
          <period-start iso-date="2016-04-01" />
          <period-end iso-date="2016-09-30" />
          <target>
            <comment>
              <narrative>Numerator: 5218; Denominator: 7089; Percentage: 73.6%.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 5779; Denominator: 5644; Percentage: 102.4%.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2016-10-01" />
          <period-end iso-date="2017-03-31" />
          <target>
            <comment>
              <narrative>Numerator: 10436; Denominator: 14177; Percentage: 73.6%.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 11617; Denominator: 14177; Percentage: 81.9%.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2017-04-01" />
          <period-end iso-date="2017-09-30" />
          <target>
            <comment>
              <narrative>Numerator: 6675.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 4833.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2017-10-01" />
          <period-end iso-date="2018-03-31" />
          <target>
            <comment>
              <narrative>Numerator: 13350.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 10208.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2018-04-01" />
          <period-end iso-date="2018-09-30" />
          <target>
            <comment>
              <narrative>Numerator: 8544.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 4709.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2018-10-01" />
          <period-end iso-date="2019-03-31" />
          <target>
            <comment>
              <narrative>Numerator: 17087.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 9476.</narrative>
            </comment>
          </actual>
        </period>
      </indicator>
    </result>
    <result type="1" aggregation-status="0">
      <title>
        <narrative>Percentage of HIV-positive registered TB patients given anti-retroviral therapy during TB treatment</narrative>
      </title>
      <description>
        <narrative>Module: TB/HIV.</narrative>
      </description>
      <indicator measure="2" aggregation-status="0">
        <title>
          <narrative>Percentage of HIV-positive registered TB patients given anti-retroviral therapy during TB treatment</narrative>
        </title>
        <description>
          <narrative>Geographic coverage: National. Aggregation: Cumulative annually.</narrative>
        </description>
        <baseline year="2014" iso-date="2014-12-31" value="78.9" />
        <period>
          <period-start iso-date="2016-04-01" />
          <period-end iso-date="2016-09-30" />
          <target value="80">
            <comment>
              <narrative>Numerator: 71903; Denominator: 89878.</narrative>
            </comment>
          </target>
          <actual value="79.7">
            <comment>
              <narrative>Numerator: 51760; Denominator: 64904.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2016-10-01" />
          <period-end iso-date="2017-03-31" />
          <target value="80">
            <comment>
              <narrative>Numerator: 143805; Denominator: 179756.</narrative>
            </comment>
          </target>
          <actual value="88.2">
            <comment>
              <narrative>Numerator: 128631; Denominator: 145755.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2017-04-01" />
          <period-end iso-date="2017-09-30" />
          <target value="85">
            <comment>
              <narrative>Numerator: 76397; Denominator: 89878.</narrative>
            </comment>
          </target>
          <actual value="82.4">
            <comment>
              <narrative>Numerator: 24272; Denominator: 29456.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2017-10-01" />
          <period-end iso-date="2018-03-31" />
          <target value="85">
            <comment>
              <narrative>Numerator: 152793; Denominator: 179756.</narrative>
            </comment>
          </target>
          <actual value="83.9">
            <comment>
              <narrative>Numerator: 98818; Denominator: 117724.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2018-04-01" />
          <period-end iso-date="2018-09-30" />
          <target value="90">
            <comment>
              <narrative>Numerator: 80890; Denominator: 89878.</narrative>
            </comment>
          </target>
          <actual value="86.9">
            <comment>
              <narrative>Numerator: 26020; Denominator: 29932.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2018-10-01" />
          <period-end iso-date="2019-03-31" />
          <target value="90">
            <comment>
              <narrative>Numerator: 161780; Denominator: 179758.</narrative>
            </comment>
          </target>
          <actual value="85.2">
            <comment>
              <narrative>Numerator: 73279; Denominator: 86038.</narrative>
            </comment>
          </actual>
        </period>
      </indicator>
    </result>
    <result type="1" aggregation-status="0">
      <title>
        <narrative>Percentage of people living with HIV currently receiving antiretroviral therapy</narrative>
      </title>
      <description>
        <narrative>Module: Treatment, care and support.</narrative>
      </description>
      <indicator measure="2" aggregation-status="0">
        <title>
          <narrative>Percentage of people living with HIV currently receiving antiretroviral therapy</narrative>
        </title>
        <description>
          <narrative>Geographic coverage: National. Aggregation: Non cumulative - other.</narrative>
        </description>
        <baseline year="2015" iso-date="2015-12-31" value="76">
          <comment>
            <narrative>Numerator: 3125977; Denominator: 4113977.</narrative>
          </comment>
        </baseline>
        <period>
          <period-start iso-date="2016-04-01" />
          <period-end iso-date="2016-09-30" />
          <target value="56.6">
            <comment>
              <narrative>Numerator: 3603902; Denominator: 6363000.</narrative>
            </comment>
          </target>
          <actual value="54.9">
            <comment>
              <narrative>Numerator: 3494260; Denominator: 6363000.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2016-10-01" />
          <period-end iso-date="2017-03-31" />
          <target value="75.4">
            <comment>
              <narrative>Numerator: 4800000; Denominator: 6363000.</narrative>
            </comment>
          </target>
          <actual value="60.1">
            <comment>
              <narrative>Numerator: 3826622; Denominator: 6363000.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2017-04-01" />
          <period-end iso-date="2017-09-30" />
          <target value="86.6">
            <comment>
              <narrative>Numerator: 5500000; Denominator: 6350000.</narrative>
            </comment>
          </target>
          <actual value="62.3">
            <comment>
              <narrative>Numerator: 3955185; Denominator: 6350000.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2017-10-01" />
          <period-end iso-date="2018-03-31" />
          <target value="59.6">
            <comment>
              <narrative>Numerator: 4200000; Denominator: 7046301.</narrative>
            </comment>
          </target>
          <actual value="59.5">
            <comment>
              <narrative>Numerator: 4189070; Denominator: 7046301.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2018-04-01" />
          <period-end iso-date="2018-09-30" />
          <target value="64.6">
            <comment>
              <narrative>Numerator: 4600000; Denominator: 7121759.</narrative>
            </comment>
          </target>
          <actual value="61.1">
            <comment>
              <narrative>Numerator: 4354123; Denominator: 7121759.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2018-10-01" />
          <period-end iso-date="2019-03-31" />
          <target value="70.2">
            <comment>
              <narrative>Numerator: 5000000; Denominator: 7121759.</narrative>
            </comment>
          </target>
          <actual value="65">
            <comment>
              <narrative>Numerator: 4629831; Denominator: 7121759.</narrative>
            </comment>
          </actual>
        </period>
      </indicator>
    </result>
  </iati-activity>
  <iati-activity last-updated-datetime="2026-11-11T15:32:23+00:00" xml:lang="en" default-currency="USD" humanitarian="0" hierarchy="1">
    <iati-identifier>47045-ZAF-C-NDOH-2</iati-identifier>
    <reporting-org ref="47045" type="30">
      <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
    </reporting-org>
    <title>
      <narrative>Investing for impact against Tuberculosis and HIV - South Africa (01-Apr-2019-31-Mar-2022)</narrative>
    </title>
    <description type="1">
      <narrative>South Africa, TB/HIV, National Department of Health of the Republic of South Africa</narrative>
    </description>
    <description type="2">
      <narrative>Goals: Accelerate prevention to reduce new HIV and TB infections and STIs; Reduce morbidity and mortality by providing treatment, care and adherence support for all; Reach all key and vulnerable populations with customised and targeted interventions; Address the social and structural drivers of HIV, TB and STIs, and lin these effort to the National Development Plan; Ground the response to HIV, TB and STIs in human rights principles and approaches; Promote leadership and shared accountability for sustainable response to HIV, TB and STIs; Mobilise resources and maximise efficiencies to support the achievment of NSP goals and ensure a sustainable approach; Strengthen strategic information to drive progress towards achievement of NSP goals. Objectives: 1.1 Reduce new HIV infections to less than 100,000 by 2022 through combination prevention interventions; 2.1 Implement the 90-90-90 strategy for HIV; 2.2 Implement the 90-90-90 Strategy for TB; 3.1 Increase engagment, collaboration and advocacy of key and vulnerable populations in the development and implementation of social and health support activities; 3.2 To provide an enabling environment to increase access to health services by key and vulnerable populations; 4.1 Implement social and behaviour change programmes to address key drivers of the epidemic and build social cohesion; 4.4 Implement and scale up a package of harm reduction interventions for harmful use of alcohol and drugs in all districts; 4.5 Implement economic strengthening programmes with a focus on youth in priority focus districts; 5.3 Promote an environment that enables and protects human and legal rights and prevents stigma and discrimination; 6.1 Strengthen AIDS Councils to provide effective co-ordination and leadership of all stakeholders for shared accountability in the implementation of the NSP; 7.1 Improve efficiency and mobilise sufficient resources to achieve the goals, objective and targets of the NSP; 8.1 Optimise routinely collected strategic health information for data utilisation in decision making.</narrative>
    </description>
    <participating-org ref="47045" type="30" role="1" crs-channel-code="47045">
      <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
    </participating-org>
    <participating-org type="10" role="2" crs-channel-code="12001">
      <narrative>National Department of Health of the Republic of South Africa</narrative>
    </participating-org>
    <participating-org type="10" role="4" crs-channel-code="12001">
      <narrative>National Department of Health of the Republic of South Africa</narrative>
    </participating-org>
    <other-identifier ref="ZAF-C-NDOHP02" type="A1">
      <owner-org ref="47045">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </owner-org>
    </other-identifier>
    <activity-status code="4" />
    <activity-date type="1" iso-date="2019-04-01" />
    <activity-date type="2" iso-date="2019-04-01" />
    <activity-date type="3" iso-date="2022-03-31" />
    <activity-date type="4" iso-date="2022-03-31" />
    <contact-info type="1">
      <organisation>
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </organisation>
      <department>
        <narrative>Communications</narrative>
      </department>
      <telephone>+41 58 791 1700</telephone>
      <email>website@theglobalfund.org</email>
      <website>https://www.theglobalfund.org</website>
      <mailing-address>
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria, Global Health Campus, Chemin du Pommier 40, 1218 Grand-Saconnex, Geneva, Switzerland</narrative>
      </mailing-address>
    </contact-info>
    <contact-info type="2">
      <organisation>
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </organisation>
      <department>
        <narrative>Grant Management Division</narrative>
      </department>
      <person-name>
        <narrative>John Ochero</narrative>
      </person-name>
      <job-title>
        <narrative>Fund Portfolio Manager</narrative>
      </job-title>
      <telephone>+41 58 791 1700</telephone>
      <email>john.ochero@theglobalfund.org</email>
      <website>https://www.theglobalfund.org</website>
      <mailing-address>
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria, Global Health Campus, Chemin du Pommier 40, 1218 Grand-Saconnex, Geneva, Switzerland</narrative>
      </mailing-address>
    </contact-info>
    <activity-scope code="4" />
    <recipient-country code="ZA" percentage="100">
      <narrative>South Africa</narrative>
    </recipient-country>
    <sector vocabulary="1" code="12263" percentage="47.52">
      <narrative>Tuberculosis</narrative>
    </sector>
    <sector vocabulary="1" code="13040" percentage="29.01">
      <narrative>HIV</narrative>
    </sector>
    <sector vocabulary="1" code="12110" percentage="23.47">
      <narrative>Multicomponent, RSSH</narrative>
    </sector>
    <tag vocabulary="2" code="3">
      <narrative>Ensure healthy lives and promote well-being for all at all ages</narrative>
    </tag>
    <tag vocabulary="3" code="3.3">
      <narrative>End the epidemics of AIDS, tuberculosis, malaria and neglected tropical diseases, and combat hepatitis, water-borne diseases and other communicable diseases</narrative>
    </tag>
    <tag vocabulary="3" code="3.8">
      <narrative>Achieve universal health coverage</narrative>
    </tag>
    <country-budget-items vocabulary="4">
      <budget-item code="01b3eb9e-75bd-47fc-833d-1b5266368425" percentage="1.64">
        <description>
          <narrative>HIV -&gt; Prevention programs for adolescents and youth, in and out of school -&gt; HIV testing services for adolescents and youth, in and out of school</narrative>
        </description>
      </budget-item>
      <budget-item code="557c641d-d721-482b-a47f-096caa882957" percentage="0.1">
        <description>
          <narrative>HIV -&gt; Reducing human rights-related barriers to HIV/TB services -&gt; Human rights and medical ethics related to HIV and HIV/TB for health care providers</narrative>
        </description>
      </budget-item>
      <budget-item code="d3f0ee90-71c1-4dad-ad46-19e91d25c002" percentage="27.26">
        <description>
          <narrative>HIV -&gt; Treatment, care and support -&gt; HIV care</narrative>
        </description>
      </budget-item>
      <budget-item code="955f4722-71fb-4b46-8bd2-2d741fdad76b" percentage="0.09">
        <description>
          <narrative>Multicomponent -&gt; Program management -&gt; Coordination and management of national disease control programs</narrative>
        </description>
      </budget-item>
      <budget-item code="e07bbbe4-54fa-4084-a6fe-7f1c9c3b77b6" percentage="5.99">
        <description>
          <narrative>Multicomponent -&gt; Program management -&gt; Grant management</narrative>
        </description>
      </budget-item>
      <budget-item code="3e9642ae-693f-47d9-95b3-3cf2c3e2e170" percentage="1.21">
        <description>
          <narrative>RSSH -&gt; RSSH: Community systems strengthening -&gt; Other community responses and systems intervention(s)</narrative>
        </description>
      </budget-item>
      <budget-item code="a5a90010-4e5c-42a4-a6f3-569620e48a90" percentage="0.04">
        <description>
          <narrative>RSSH -&gt; RSSH: Financial management systems -&gt; Other financial management intervention(s)</narrative>
        </description>
      </budget-item>
      <budget-item code="b0b850b8-142b-4100-bd18-2da244fde07f" percentage="0.16">
        <description>
          <narrative>RSSH -&gt; RSSH: Financial management systems -&gt; Public financial management (country or donor harmonized) systems</narrative>
        </description>
      </budget-item>
      <budget-item code="79f56a06-e483-471f-ad35-812bf3014339" percentage="0.07">
        <description>
          <narrative>RSSH -&gt; RSSH: Health management information systems and M&amp;E -&gt; Administrative and finance data sources</narrative>
        </description>
      </budget-item>
      <budget-item code="004842a6-d6eb-49a2-a763-882fd356689a" percentage="0.55">
        <description>
          <narrative>RSSH -&gt; RSSH: Health management information systems and M&amp;E -&gt; Program and data quality</narrative>
        </description>
      </budget-item>
      <budget-item code="5221e091-6641-4eee-b68d-9b5879a96a78" percentage="3.97">
        <description>
          <narrative>RSSH -&gt; RSSH: Health management information systems and M&amp;E -&gt; Routine reporting</narrative>
        </description>
      </budget-item>
      <budget-item code="ad843466-bf87-44ef-9b83-217a8cfb22d0" percentage="8.89">
        <description>
          <narrative>RSSH -&gt; RSSH: Health products management systems -&gt; National costed supply chain master plan, and implementation</narrative>
        </description>
      </budget-item>
      <budget-item code="a1d59f86-a576-4ed5-bc14-b2d9fc2c3967" percentage="1.78">
        <description>
          <narrative>RSSH -&gt; RSSH: Health products management systems -&gt; National product selection, registration and quality monitoring</narrative>
        </description>
      </budget-item>
      <budget-item code="7319638f-aa8e-41bc-b90c-e0eb35b6797c" percentage="0.73">
        <description>
          <narrative>RSSH -&gt; RSSH: Health products management systems -&gt; Other procurement supply chain management intervention(s)</narrative>
        </description>
      </budget-item>
      <budget-item code="5e616c4b-3854-4008-8caa-4cb786ae6fe1" percentage="0.39">
        <description>
          <narrative>Tuberculosis -&gt; MDR-TB -&gt; Engaging all care providers (MDR-TB)</narrative>
        </description>
      </budget-item>
      <budget-item code="3637a37c-6acc-4a5b-b7e4-00640fd7e2ec" percentage="5.28">
        <description>
          <narrative>Tuberculosis -&gt; MDR-TB -&gt; Treatment (MDR-TB)</narrative>
        </description>
      </budget-item>
      <budget-item code="f7014493-22e9-4c03-96d0-144fbb3a254f" percentage="30.01">
        <description>
          <narrative>Tuberculosis -&gt; TB care and prevention -&gt; Case detection and diagnosis (TB care and prevention)</narrative>
        </description>
      </budget-item>
      <budget-item code="e6d6284e-9e23-498f-91ee-4393f4aa49a1" percentage="0.02">
        <description>
          <narrative>Tuberculosis -&gt; TB care and prevention -&gt; Collaborative activities with other programs and sectors (TB care and prevention)</narrative>
        </description>
      </budget-item>
      <budget-item code="a0ec8795-341f-4d7b-9bdd-618cfc782127" percentage="1.06">
        <description>
          <narrative>Tuberculosis -&gt; TB care and prevention -&gt; Community TB care delivery</narrative>
        </description>
      </budget-item>
      <budget-item code="accfbf9b-023f-4bd8-b952-bf1cb13e8e9b" percentage="0.15">
        <description>
          <narrative>Tuberculosis -&gt; TB care and prevention -&gt; Prevention (TB care and prevention)</narrative>
        </description>
      </budget-item>
      <budget-item code="edbef7da-ca99-4741-8ce0-ea3ba6cd3d3b" percentage="0.07">
        <description>
          <narrative>Tuberculosis -&gt; TB care and prevention -&gt; Treatment (TB care and prevention)</narrative>
        </description>
      </budget-item>
      <budget-item code="03642497-8d31-43e6-9dc7-a1d83d6bad5e" percentage="0.27">
        <description>
          <narrative>Tuberculosis -&gt; TB/HIV -&gt; Engaging all care providers (TB/HIV)</narrative>
        </description>
      </budget-item>
      <budget-item code="92e11022-488c-4948-abb3-b61f3d9ca4f6" percentage="10.27">
        <description>
          <narrative>Tuberculosis -&gt; TB/HIV -&gt; TB/HIV - Collaborative interventions</narrative>
        </description>
      </budget-item>
    </country-budget-items>
    <collaboration-type code="1" />
    <default-flow-type code="10" />
    <default-finance-type code="110" />
    <default-aid-type code="C01" vocabulary="1" />
    <default-tied-status code="5" />
    <budget type="2" status="2">
      <period-start iso-date="2019-01-01" />
      <period-end iso-date="2019-12-31" />
      <value currency="USD" value-date="2019-01-01">6986681.23</value>
    </budget>
    <budget type="2" status="2">
      <period-start iso-date="2020-01-01" />
      <period-end iso-date="2020-12-31" />
      <value currency="USD" value-date="2020-01-01">36444654.67</value>
    </budget>
    <budget type="2" status="2">
      <period-start iso-date="2021-01-01" />
      <period-end iso-date="2021-12-31" />
      <value currency="USD" value-date="2021-01-01">142491245.89</value>
    </budget>
    <budget type="2" status="2">
      <period-start iso-date="2022-01-01" />
      <period-end iso-date="2022-12-31" />
      <value currency="USD" value-date="2022-01-01">78676982.71</value>
    </budget>
    <capital-spend percentage="3.65" />
    <transaction ref="206b4022-b578-4e79-b710-9f81657bace3">
      <transaction-type code="2" />
      <transaction-date iso-date="2019-06-26" />
      <value currency="USD" value-date="2019-06-26">91747794.95</value>
      <description>
        <narrative>Global Fund commitment to ZAF-C-NDOHP02.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="10">
        <narrative>National Department of Health of the Republic of South Africa</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="fcce04da-f6c8-4a2d-91b3-e8098bbcbef4">
      <transaction-type code="3" />
      <transaction-date iso-date="2019-06-27" />
      <value currency="USD" value-date="2019-06-27">10013833.35</value>
      <description>
        <narrative>Global Fund disbursement to ZAF-C-NDOHP02 (Government).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="10">
        <narrative>National Department of Health of the Republic of South Africa</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="29467c51-1a06-40db-9e06-3f3cb748cd3a">
      <transaction-type code="2" />
      <transaction-date iso-date="2019-08-07" />
      <value currency="USD" value-date="2019-08-07">50000.00</value>
      <description>
        <narrative>Global Fund commitment to ZAF-C-NDOHP02.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="10">
        <narrative>National Department of Health of the Republic of South Africa</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="c3c64e32-60b9-47ef-9628-01e41480d0e5">
      <transaction-type code="3" />
      <transaction-date iso-date="2019-11-12" />
      <value currency="USD" value-date="2019-11-12">9110243.00</value>
      <description>
        <narrative>Global Fund disbursement to ZAF-C-NDOHP02 (Government).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="10">
        <narrative>National Department of Health of the Republic of South Africa</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="c163ec85-9525-44df-9ca6-23af0b6f2e7b">
      <transaction-type code="3" />
      <transaction-date iso-date="2020-02-11" />
      <value currency="USD" value-date="2020-02-11">13703383.88</value>
      <description>
        <narrative>Global Fund disbursement to ZAF-C-NDOHP02 (Government).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="10">
        <narrative>National Department of Health of the Republic of South Africa</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="099b5b39-0c27-4c91-a750-2fde17a458dd">
      <transaction-type code="3" />
      <transaction-date iso-date="2020-02-18" />
      <value currency="USD" value-date="2020-02-18">50000.00</value>
      <description>
        <narrative>Global Fund disbursement to ZAF-C-NDOHP02 (Other 3rd Party).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="10">
        <narrative>National Department of Health of the Republic of South Africa</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="6eab3f81-a0c6-419a-95f9-f5d1140b8a73">
      <transaction-type code="3" />
      <transaction-date iso-date="2020-05-13" />
      <value currency="USD" value-date="2020-05-13">12191426.36</value>
      <description>
        <narrative>Global Fund disbursement to ZAF-C-NDOHP02 (Government).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="10">
        <narrative>National Department of Health of the Republic of South Africa</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="c2bcc355-de2c-4de0-8803-939e3f64acc8">
      <transaction-type code="2" />
      <transaction-date iso-date="2020-06-26" />
      <value currency="USD" value-date="2020-06-26">50000.00</value>
      <description>
        <narrative>Global Fund commitment to ZAF-C-NDOHP02.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="10">
        <narrative>National Department of Health of the Republic of South Africa</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="365cfe4f-d636-4454-992e-7c8f3dd4ae92">
      <transaction-type code="3" />
      <transaction-date iso-date="2020-07-29" />
      <value currency="USD" value-date="2020-07-29">11208339.36</value>
      <description>
        <narrative>Global Fund disbursement to ZAF-C-NDOHP02 (Government).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="10">
        <narrative>National Department of Health of the Republic of South Africa</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="2db3b620-8a98-4bbe-821a-bc1fade070a1">
      <transaction-type code="2" />
      <transaction-date iso-date="2020-11-05" />
      <value currency="USD" value-date="2020-11-05">2671829.55</value>
      <description>
        <narrative>Global Fund commitment to ZAF-C-NDOHP02.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="10">
        <narrative>National Department of Health of the Republic of South Africa</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="a0f2a5c5-4514-496d-a6be-51417e07199c">
      <transaction-type code="3" />
      <transaction-date iso-date="2020-12-09" />
      <value currency="USD" value-date="2020-12-09">6735572.83</value>
      <description>
        <narrative>Global Fund disbursement to ZAF-C-NDOHP02 (Government).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="10">
        <narrative>National Department of Health of the Republic of South Africa</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="a3265067-2f7d-484d-9670-68bb826b6e8a">
      <transaction-type code="3" />
      <transaction-date iso-date="2020-12-09" />
      <value currency="USD" value-date="2020-12-09">10688462.81</value>
      <description>
        <narrative>Global Fund disbursement to ZAF-C-NDOHP02 (Government).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="10">
        <narrative>National Department of Health of the Republic of South Africa</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="bf01703c-70cd-4e1b-a008-5bae9d4cba4e">
      <transaction-type code="3" />
      <transaction-date iso-date="2020-12-09" />
      <value currency="USD" value-date="2020-12-09">2559146.84</value>
      <description>
        <narrative>Global Fund disbursement to ZAF-C-NDOHP02 (Government).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="10">
        <narrative>National Department of Health of the Republic of South Africa</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="c3403d4e-3073-4f96-9067-f2f00cb2a300">
      <transaction-type code="3" />
      <transaction-date iso-date="2020-12-09" />
      <value currency="USD" value-date="2020-12-09">6997749.39</value>
      <description>
        <narrative>Global Fund disbursement to ZAF-C-NDOHP02 (Government).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="10">
        <narrative>National Department of Health of the Republic of South Africa</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="2199b437-b375-4ad5-9522-650b2b02e7a0">
      <transaction-type code="2" />
      <transaction-date iso-date="2021-02-03" />
      <value currency="USD" value-date="2021-02-03">-8539637.13</value>
      <description>
        <narrative>Global Fund commitment to ZAF-C-NDOHP02.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="10">
        <narrative>National Department of Health of the Republic of South Africa</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="d7fa54a5-654b-458d-872d-df8da6d473ff">
      <transaction-type code="2" />
      <transaction-date iso-date="2021-02-03" />
      <value currency="USD" value-date="2021-02-03">51701657.34</value>
      <description>
        <narrative>Global Fund commitment to ZAF-C-NDOHP02.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="10">
        <narrative>National Department of Health of the Republic of South Africa</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="25968f3e-a5f2-44ac-8148-6d217509b0cd">
      <transaction-type code="3" />
      <transaction-date iso-date="2021-02-05" />
      <value currency="USD" value-date="2021-02-05">4126697.12</value>
      <description>
        <narrative>Global Fund disbursement to ZAF-C-NDOHP02 (Government).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="10">
        <narrative>National Department of Health of the Republic of South Africa</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="7d7bcdd6-092b-46ff-93b8-25b16b1e7752">
      <transaction-type code="3" />
      <transaction-date iso-date="2021-02-05" />
      <value currency="USD" value-date="2021-02-05">6542951.88</value>
      <description>
        <narrative>Global Fund disbursement to ZAF-C-NDOHP02 (Government).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="10">
        <narrative>National Department of Health of the Republic of South Africa</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="8ece9ab7-d96f-4ffd-98b8-6a0563a93518">
      <transaction-type code="3" />
      <transaction-date iso-date="2021-02-05" />
      <value currency="USD" value-date="2021-02-05">5711761.29</value>
      <description>
        <narrative>Global Fund disbursement to ZAF-C-NDOHP02 (Government).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="10">
        <narrative>National Department of Health of the Republic of South Africa</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="49b9e8b6-f861-4db6-9fc0-5bea90d528e5">
      <transaction-type code="2" />
      <transaction-date iso-date="2021-03-12" />
      <value currency="USD" value-date="2021-03-12">15879436.94</value>
      <description>
        <narrative>Global Fund commitment to ZAF-C-NDOHP02.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="10">
        <narrative>National Department of Health of the Republic of South Africa</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="f2abf78f-054b-484d-8795-eb9dae62ee68">
      <transaction-type code="2" />
      <transaction-date iso-date="2021-03-12" />
      <value currency="USD" value-date="2021-03-12">-2671829.55</value>
      <description>
        <narrative>Global Fund commitment to ZAF-C-NDOHP02.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="10">
        <narrative>National Department of Health of the Republic of South Africa</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="d54f4440-5acd-4f27-90f5-cb1c87210c4d">
      <transaction-type code="3" />
      <transaction-date iso-date="2021-03-26" />
      <value currency="USD" value-date="2021-03-26">8381062.73</value>
      <description>
        <narrative>Global Fund disbursement to ZAF-C-NDOHP02 (Pooled Procurement Mechanism).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="10">
        <narrative>National Department of Health of the Republic of South Africa</narrative>
      </receiver-org>
      <disbursement-channel code="3" />
    </transaction>
    <transaction ref="9bd2524f-3993-49c5-afa6-5b634dfbabf9">
      <transaction-type code="3" />
      <transaction-date iso-date="2021-04-01" />
      <value currency="USD" value-date="2021-04-01">50000.00</value>
      <description>
        <narrative>Global Fund disbursement to ZAF-C-NDOHP02 (Other 3rd Party).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="10">
        <narrative>National Department of Health of the Republic of South Africa</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="9a442208-9af5-47ad-9ad6-af385637b871">
      <transaction-type code="3" />
      <transaction-date iso-date="2021-04-06" />
      <value currency="USD" value-date="2021-04-06">1096587.07</value>
      <description>
        <narrative>Global Fund disbursement to ZAF-C-NDOHP02 (Pooled Procurement Mechanism).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="10">
        <narrative>National Department of Health of the Republic of South Africa</narrative>
      </receiver-org>
      <disbursement-channel code="3" />
    </transaction>
    <transaction ref="84d33648-88aa-4282-941f-2be53900ebd0">
      <transaction-type code="2" />
      <transaction-date iso-date="2021-04-09" />
      <value currency="USD" value-date="2021-04-09">5988461.31</value>
      <description>
        <narrative>Global Fund commitment to ZAF-C-NDOHP02.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="10">
        <narrative>National Department of Health of the Republic of South Africa</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="3de2c8f8-deef-4bc2-9909-1a9565d35a0a">
      <transaction-type code="3" />
      <transaction-date iso-date="2021-04-09" />
      <value currency="USD" value-date="2021-04-09">593739.90</value>
      <description>
        <narrative>Global Fund disbursement to ZAF-C-NDOHP02 (Pooled Procurement Mechanism).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="10">
        <narrative>National Department of Health of the Republic of South Africa</narrative>
      </receiver-org>
      <disbursement-channel code="3" />
    </transaction>
    <transaction ref="8d15fc01-0ddb-400a-8b0c-839f75f08a18">
      <transaction-type code="3" />
      <transaction-date iso-date="2021-04-09" />
      <value currency="USD" value-date="2021-04-09">593739.90</value>
      <description>
        <narrative>Global Fund disbursement to ZAF-C-NDOHP02 (Pooled Procurement Mechanism).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="10">
        <narrative>National Department of Health of the Republic of South Africa</narrative>
      </receiver-org>
      <disbursement-channel code="3" />
    </transaction>
    <transaction ref="a3ca6f44-7317-412c-a74c-2bc0b51e5801">
      <transaction-type code="3" />
      <transaction-date iso-date="2021-04-09" />
      <value currency="USD" value-date="2021-04-09">593739.90</value>
      <description>
        <narrative>Global Fund disbursement to ZAF-C-NDOHP02 (Pooled Procurement Mechanism).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="10">
        <narrative>National Department of Health of the Republic of South Africa</narrative>
      </receiver-org>
      <disbursement-channel code="3" />
    </transaction>
    <transaction ref="ac2f95d9-88f6-4feb-9be5-2c6179454ec4">
      <transaction-type code="3" />
      <transaction-date iso-date="2021-04-09" />
      <value currency="USD" value-date="2021-04-09">890609.85</value>
      <description>
        <narrative>Global Fund disbursement to ZAF-C-NDOHP02 (Pooled Procurement Mechanism).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="10">
        <narrative>National Department of Health of the Republic of South Africa</narrative>
      </receiver-org>
      <disbursement-channel code="3" />
    </transaction>
    <transaction ref="8aa78dc7-8101-40dd-acc6-b8cb2e95b43f">
      <transaction-type code="3" />
      <transaction-date iso-date="2021-05-07" />
      <value currency="USD" value-date="2021-05-07">34070144.83</value>
      <description>
        <narrative>Global Fund disbursement to ZAF-C-NDOHP02 (Government).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="10">
        <narrative>National Department of Health of the Republic of South Africa</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="1980a991-b3b4-4df9-a655-4138bfc381ba">
      <transaction-type code="2" />
      <transaction-date iso-date="2021-06-10" />
      <value currency="USD" value-date="2021-06-10">6650887.92</value>
      <description>
        <narrative>Global Fund commitment to ZAF-C-NDOHP02.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="10">
        <narrative>National Department of Health of the Republic of South Africa</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="8a3e0996-669e-48a6-89e5-3d313608e879">
      <transaction-type code="2" />
      <transaction-date iso-date="2021-06-10" />
      <value currency="USD" value-date="2021-06-10">-5988461.31</value>
      <description>
        <narrative>Global Fund commitment to ZAF-C-NDOHP02.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="10">
        <narrative>National Department of Health of the Republic of South Africa</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="6cfe03ca-8464-486b-832d-4613ebaeb1c1">
      <transaction-type code="2" />
      <transaction-date iso-date="2021-06-23" />
      <value currency="USD" value-date="2021-06-23">-6650887.92</value>
      <description>
        <narrative>Global Fund commitment to ZAF-C-NDOHP02.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="10">
        <narrative>National Department of Health of the Republic of South Africa</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="f0b1b68f-2e6a-44fe-9948-af23749b199c">
      <transaction-type code="2" />
      <transaction-date iso-date="2021-06-23" />
      <value currency="USD" value-date="2021-06-23">6650887.92</value>
      <description>
        <narrative>Global Fund commitment to ZAF-C-NDOHP02.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="10">
        <narrative>National Department of Health of the Republic of South Africa</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="35bb2c84-ccc9-46dd-9745-c95c65146076">
      <transaction-type code="3" />
      <transaction-date iso-date="2021-06-28" />
      <value currency="USD" value-date="2021-06-28">49059.99</value>
      <description>
        <narrative>Global Fund disbursement to ZAF-C-NDOHP02 (Pooled Procurement Mechanism).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="10">
        <narrative>National Department of Health of the Republic of South Africa</narrative>
      </receiver-org>
      <disbursement-channel code="3" />
    </transaction>
    <transaction ref="84f1a532-0e3a-49d5-aaab-88a718ec4e78">
      <transaction-type code="3" />
      <transaction-date iso-date="2021-06-28" />
      <value currency="USD" value-date="2021-06-28">57987.28</value>
      <description>
        <narrative>Global Fund disbursement to ZAF-C-NDOHP02 (Pooled Procurement Mechanism).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="10">
        <narrative>National Department of Health of the Republic of South Africa</narrative>
      </receiver-org>
      <disbursement-channel code="3" />
    </transaction>
    <transaction ref="9f213335-d80d-4297-900b-ac158dc1eadb">
      <transaction-type code="3" />
      <transaction-date iso-date="2021-06-28" />
      <value currency="USD" value-date="2021-06-28">6553.69</value>
      <description>
        <narrative>Global Fund disbursement to ZAF-C-NDOHP02 (Pooled Procurement Mechanism).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="10">
        <narrative>National Department of Health of the Republic of South Africa</narrative>
      </receiver-org>
      <disbursement-channel code="3" />
    </transaction>
    <transaction ref="66c49b3f-d403-4e58-95c6-ce54312373f6">
      <transaction-type code="2" />
      <transaction-date iso-date="2021-07-13" />
      <value currency="USD" value-date="2021-07-13">50000.00</value>
      <description>
        <narrative>Global Fund commitment to ZAF-C-NDOHP02.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="10">
        <narrative>National Department of Health of the Republic of South Africa</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="0381b4ce-64d2-496a-91a3-01fac65ac8d5">
      <transaction-type code="2" />
      <transaction-date iso-date="2021-07-20" />
      <value currency="USD" value-date="2021-07-20">22072334.78</value>
      <description>
        <narrative>Global Fund commitment to ZAF-C-NDOHP02.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="10">
        <narrative>National Department of Health of the Republic of South Africa</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="48072b57-89b6-4046-ab96-09a477b06a7f">
      <transaction-type code="2" />
      <transaction-date iso-date="2021-07-20" />
      <value currency="USD" value-date="2021-07-20">-1250102.22</value>
      <description>
        <narrative>Global Fund commitment to ZAF-C-NDOHP02.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="10">
        <narrative>National Department of Health of the Republic of South Africa</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="8078a54b-e2aa-4d6d-9403-33787ce29533">
      <transaction-type code="3" />
      <transaction-date iso-date="2021-07-22" />
      <value currency="USD" value-date="2021-07-22">7583661.64</value>
      <description>
        <narrative>Global Fund disbursement to ZAF-C-NDOHP02 (Government).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="10">
        <narrative>National Department of Health of the Republic of South Africa</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="8b9947b0-a259-4dec-802c-34d88499e8ed">
      <transaction-type code="3" />
      <transaction-date iso-date="2021-07-22" />
      <value currency="USD" value-date="2021-07-22">4585549.79</value>
      <description>
        <narrative>Global Fund disbursement to ZAF-C-NDOHP02 (Government).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="10">
        <narrative>National Department of Health of the Republic of South Africa</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="bd1a9d41-0090-449a-9109-5249b6a399d1">
      <transaction-type code="3" />
      <transaction-date iso-date="2021-07-22" />
      <value currency="USD" value-date="2021-07-22">4627215.33</value>
      <description>
        <narrative>Global Fund disbursement to ZAF-C-NDOHP02 (Government).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="10">
        <narrative>National Department of Health of the Republic of South Africa</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="f46a1304-3961-4338-919d-baaabc76ff01">
      <transaction-type code="3" />
      <transaction-date iso-date="2021-07-22" />
      <value currency="USD" value-date="2021-07-22">5275908.02</value>
      <description>
        <narrative>Global Fund disbursement to ZAF-C-NDOHP02 (Government).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="10">
        <narrative>National Department of Health of the Republic of South Africa</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="ea8f2bab-c7d3-4cf9-a25e-da799af699fc">
      <transaction-type code="3" />
      <transaction-date iso-date="2021-07-28" />
      <value currency="USD" value-date="2021-07-28">3211180.76</value>
      <description>
        <narrative>Global Fund disbursement to ZAF-C-NDOHP02 (Pooled Procurement Mechanism).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="10">
        <narrative>National Department of Health of the Republic of South Africa</narrative>
      </receiver-org>
      <disbursement-channel code="3" />
    </transaction>
    <transaction ref="69d1d4ac-5a73-494b-8a71-cfacb6576269">
      <transaction-type code="3" />
      <transaction-date iso-date="2021-08-30" />
      <value currency="USD" value-date="2021-08-30">37804.85</value>
      <description>
        <narrative>Global Fund disbursement to ZAF-C-NDOHP02 (Pooled Procurement Mechanism).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="10">
        <narrative>National Department of Health of the Republic of South Africa</narrative>
      </receiver-org>
      <disbursement-channel code="3" />
    </transaction>
    <transaction ref="2f23fa9c-9891-4c38-8791-8fde0837a819">
      <transaction-type code="3" />
      <transaction-date iso-date="2021-09-17" />
      <value currency="USD" value-date="2021-09-17">41610.18</value>
      <description>
        <narrative>Global Fund disbursement to ZAF-C-NDOHP02 (Pooled Procurement Mechanism).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="10">
        <narrative>National Department of Health of the Republic of South Africa</narrative>
      </receiver-org>
      <disbursement-channel code="3" />
    </transaction>
    <transaction ref="8083b646-59d5-423d-88b2-2f6d3d496346">
      <transaction-type code="3" />
      <transaction-date iso-date="2021-09-17" />
      <value currency="USD" value-date="2021-09-17">2663843.35</value>
      <description>
        <narrative>Global Fund disbursement to ZAF-C-NDOHP02 (Pooled Procurement Mechanism).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="10">
        <narrative>National Department of Health of the Republic of South Africa</narrative>
      </receiver-org>
      <disbursement-channel code="3" />
    </transaction>
    <transaction ref="c08b8176-432f-4d11-a512-fb76cfa3cd94">
      <transaction-type code="3" />
      <transaction-date iso-date="2021-09-17" />
      <value currency="USD" value-date="2021-09-17">37804.86</value>
      <description>
        <narrative>Global Fund disbursement to ZAF-C-NDOHP02 (Pooled Procurement Mechanism).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="10">
        <narrative>National Department of Health of the Republic of South Africa</narrative>
      </receiver-org>
      <disbursement-channel code="3" />
    </transaction>
    <transaction ref="7594ad74-f818-4040-8337-dae3339d4c2e">
      <transaction-type code="2" />
      <transaction-date iso-date="2021-10-08" />
      <value currency="USD" value-date="2021-10-08">-775863.81</value>
      <description>
        <narrative>Global Fund commitment to ZAF-C-NDOHP02.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="10">
        <narrative>National Department of Health of the Republic of South Africa</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="7c5b0618-52eb-48c5-9a50-d73bb3339df5">
      <transaction-type code="2" />
      <transaction-date iso-date="2021-10-08" />
      <value currency="USD" value-date="2021-10-08">113437.20</value>
      <description>
        <narrative>Global Fund commitment to ZAF-C-NDOHP02.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="10">
        <narrative>National Department of Health of the Republic of South Africa</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="36d64451-2a65-4510-a28e-ba1c37d49aa0">
      <transaction-type code="2" />
      <transaction-date iso-date="2021-10-08" />
      <value currency="USD" value-date="2021-10-08">662426.61</value>
      <description>
        <narrative>Global Fund commitment to ZAF-C-NDOHP02.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="10">
        <narrative>National Department of Health of the Republic of South Africa</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="6d359923-36e5-4ce4-abce-a29a97b2a4db">
      <transaction-type code="2" />
      <transaction-date iso-date="2021-10-12" />
      <value currency="USD" value-date="2021-10-12">26394580.00</value>
      <description>
        <narrative>Global Fund commitment to ZAF-C-NDOHP02.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="10">
        <narrative>National Department of Health of the Republic of South Africa</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="3faf0d5f-5a98-44f3-9aa3-d469f613dd78">
      <transaction-type code="2" />
      <transaction-date iso-date="2021-10-12" />
      <value currency="USD" value-date="2021-10-12">-37804.85</value>
      <description>
        <narrative>Global Fund commitment to ZAF-C-NDOHP02.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="10">
        <narrative>National Department of Health of the Republic of South Africa</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="c387f164-ec5b-4c64-8ba6-511033739a65">
      <transaction-type code="2" />
      <transaction-date iso-date="2021-10-12" />
      <value currency="USD" value-date="2021-10-12">-3499136.74</value>
      <description>
        <narrative>Global Fund commitment to ZAF-C-NDOHP02.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="10">
        <narrative>National Department of Health of the Republic of South Africa</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="cd328472-19d6-4972-be10-0d86d7cfbc15">
      <transaction-type code="2" />
      <transaction-date iso-date="2021-10-12" />
      <value currency="USD" value-date="2021-10-12">3536941.59</value>
      <description>
        <narrative>Global Fund commitment to ZAF-C-NDOHP02.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="10">
        <narrative>National Department of Health of the Republic of South Africa</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="03bbfb74-2817-4774-bfa3-4313bd151ce7">
      <transaction-type code="2" />
      <transaction-date iso-date="2021-10-13" />
      <value currency="USD" value-date="2021-10-13">3574746.45</value>
      <description>
        <narrative>Global Fund commitment to ZAF-C-NDOHP02.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="10">
        <narrative>National Department of Health of the Republic of South Africa</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="7a63d107-b4ed-4a29-84ea-e2af0287b980">
      <transaction-type code="2" />
      <transaction-date iso-date="2021-10-13" />
      <value currency="USD" value-date="2021-10-13">-37804.86</value>
      <description>
        <narrative>Global Fund commitment to ZAF-C-NDOHP02.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="10">
        <narrative>National Department of Health of the Republic of South Africa</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="ce17dedd-2180-4806-9ef7-6ca23a79dc8f">
      <transaction-type code="2" />
      <transaction-date iso-date="2021-10-13" />
      <value currency="USD" value-date="2021-10-13">-3536941.59</value>
      <description>
        <narrative>Global Fund commitment to ZAF-C-NDOHP02.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="10">
        <narrative>National Department of Health of the Republic of South Africa</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="0d81a2c3-795d-470a-9ee1-e1f5f12b8034">
      <transaction-type code="3" />
      <transaction-date iso-date="2021-10-14" />
      <value currency="USD" value-date="2021-10-14">15010.00</value>
      <description>
        <narrative>Global Fund disbursement to ZAF-C-NDOHP02 (Government).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="10">
        <narrative>National Department of Health of the Republic of South Africa</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="28731f95-71e5-408a-8402-7cfa1b7e561a">
      <transaction-type code="3" />
      <transaction-date iso-date="2021-10-14" />
      <value currency="USD" value-date="2021-10-14">1994045.00</value>
      <description>
        <narrative>Global Fund disbursement to ZAF-C-NDOHP02 (Government).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="10">
        <narrative>National Department of Health of the Republic of South Africa</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="5681bc93-4ef4-4f16-9482-e8f76f7d7e9a">
      <transaction-type code="3" />
      <transaction-date iso-date="2021-10-14" />
      <value currency="USD" value-date="2021-10-14">2045205.00</value>
      <description>
        <narrative>Global Fund disbursement to ZAF-C-NDOHP02 (Government).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="10">
        <narrative>National Department of Health of the Republic of South Africa</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="6a51a9e1-31e1-44b1-ac93-2c9036ad0d18">
      <transaction-type code="3" />
      <transaction-date iso-date="2021-10-14" />
      <value currency="USD" value-date="2021-10-14">1415466.00</value>
      <description>
        <narrative>Global Fund disbursement to ZAF-C-NDOHP02 (Government).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="10">
        <narrative>National Department of Health of the Republic of South Africa</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="8b7172e7-4ffc-4cb5-8259-8a87aeaf46a8">
      <transaction-type code="3" />
      <transaction-date iso-date="2021-10-14" />
      <value currency="USD" value-date="2021-10-14">1047720.00</value>
      <description>
        <narrative>Global Fund disbursement to ZAF-C-NDOHP02 (Government).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="10">
        <narrative>National Department of Health of the Republic of South Africa</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="8e4100e8-9b7a-44a1-83d7-908b0ac328aa">
      <transaction-type code="3" />
      <transaction-date iso-date="2021-10-14" />
      <value currency="USD" value-date="2021-10-14">1132240.00</value>
      <description>
        <narrative>Global Fund disbursement to ZAF-C-NDOHP02 (Government).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="10">
        <narrative>National Department of Health of the Republic of South Africa</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="a2670600-b035-4f82-b4d5-d47624a3b24e">
      <transaction-type code="3" />
      <transaction-date iso-date="2021-10-14" />
      <value currency="USD" value-date="2021-10-14">1492183.00</value>
      <description>
        <narrative>Global Fund disbursement to ZAF-C-NDOHP02 (Government).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="10">
        <narrative>National Department of Health of the Republic of South Africa</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="add4cc5c-1bb4-4100-8dc0-003a9bee785c">
      <transaction-type code="3" />
      <transaction-date iso-date="2021-10-14" />
      <value currency="USD" value-date="2021-10-14">17252711.00</value>
      <description>
        <narrative>Global Fund disbursement to ZAF-C-NDOHP02 (Government).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="10">
        <narrative>National Department of Health of the Republic of South Africa</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="ed691b30-6833-471c-a4d0-12025e04f724">
      <transaction-type code="7" />
      <transaction-date iso-date="2021-10-18" />
      <value currency="USD" value-date="2021-10-18">37804.86</value>
      <description>
        <narrative>Funds returned to the Global Fund from ZAF-C-NDOHP02 (Pooled Procurement Mechanism).</narrative>
      </description>
      <provider-org type="10">
        <narrative>National Department of Health of the Republic of South Africa</narrative>
      </provider-org>
      <receiver-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="f702175e-952c-4116-9acd-8d375fc11157">
      <transaction-type code="7" />
      <transaction-date iso-date="2021-10-18" />
      <value currency="USD" value-date="2021-10-18">37804.85</value>
      <description>
        <narrative>Funds returned to the Global Fund from ZAF-C-NDOHP02 (Pooled Procurement Mechanism).</narrative>
      </description>
      <provider-org type="10">
        <narrative>National Department of Health of the Republic of South Africa</narrative>
      </provider-org>
      <receiver-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="a8b67889-9a1c-4f51-8ad3-a199a7f23a36">
      <transaction-type code="2" />
      <transaction-date iso-date="2021-10-19" />
      <value currency="USD" value-date="2021-10-19">-662426.61</value>
      <description>
        <narrative>Global Fund commitment to ZAF-C-NDOHP02.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="10">
        <narrative>National Department of Health of the Republic of South Africa</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="bee5f924-1f21-49cd-bcc7-b8c21efda2f4">
      <transaction-type code="3" />
      <transaction-date iso-date="2021-10-22" />
      <value currency="USD" value-date="2021-10-22">50000.00</value>
      <description>
        <narrative>Global Fund disbursement to ZAF-C-NDOHP02 (Other 3rd Party).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="10">
        <narrative>National Department of Health of the Republic of South Africa</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="387f2219-b5e4-4328-86b1-ce9923c6925a">
      <transaction-type code="2" />
      <transaction-date iso-date="2021-10-23" />
      <value currency="USD" value-date="2021-10-23">-76170.91</value>
      <description>
        <narrative>Global Fund commitment to ZAF-C-NDOHP02.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="10">
        <narrative>National Department of Health of the Republic of South Africa</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="41e19e7d-8eec-42ca-ae65-4b927b391824">
      <transaction-type code="2" />
      <transaction-date iso-date="2021-10-23" />
      <value currency="USD" value-date="2021-10-23">189608.11</value>
      <description>
        <narrative>Global Fund commitment to ZAF-C-NDOHP02.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="10">
        <narrative>National Department of Health of the Republic of South Africa</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="7e578f6c-1a6a-419a-9e25-6407a07b5210">
      <transaction-type code="2" />
      <transaction-date iso-date="2021-10-23" />
      <value currency="USD" value-date="2021-10-23">-113437.20</value>
      <description>
        <narrative>Global Fund commitment to ZAF-C-NDOHP02.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="10">
        <narrative>National Department of Health of the Republic of South Africa</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="c86cf32a-0416-4242-aa6c-d905f528b24a">
      <transaction-type code="7" />
      <transaction-date iso-date="2021-10-25" />
      <value currency="USD" value-date="2021-10-25">76170.91</value>
      <description>
        <narrative>Funds returned to the Global Fund from ZAF-C-NDOHP02 (Pooled Procurement Mechanism).</narrative>
      </description>
      <provider-org type="10">
        <narrative>National Department of Health of the Republic of South Africa</narrative>
      </provider-org>
      <receiver-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="04730d86-3ed9-45d9-8352-e20f3ea6b375">
      <transaction-type code="3" />
      <transaction-date iso-date="2021-11-04" />
      <value currency="USD" value-date="2021-11-04">15394.01</value>
      <description>
        <narrative>Global Fund disbursement to ZAF-C-NDOHP02 (Pooled Procurement Mechanism).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="10">
        <narrative>National Department of Health of the Republic of South Africa</narrative>
      </receiver-org>
      <disbursement-channel code="3" />
    </transaction>
    <transaction ref="9ac2250e-c767-425d-ad65-ddab87412fdd">
      <transaction-type code="2" />
      <transaction-date iso-date="2021-11-27" />
      <value currency="USD" value-date="2021-11-27">-189608.11</value>
      <description>
        <narrative>Global Fund commitment to ZAF-C-NDOHP02.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="10">
        <narrative>National Department of Health of the Republic of South Africa</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="d0a8a5a8-021c-4e01-a54b-73bc847f9518">
      <transaction-type code="2" />
      <transaction-date iso-date="2021-12-07" />
      <value currency="USD" value-date="2021-12-07">52730199.50</value>
      <description>
        <narrative>Global Fund commitment to ZAF-C-NDOHP02.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="10">
        <narrative>National Department of Health of the Republic of South Africa</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="0068e261-5951-453b-be0e-7d8565bdf905">
      <transaction-type code="3" />
      <transaction-date iso-date="2021-12-09" />
      <value currency="USD" value-date="2021-12-09">1943821.61</value>
      <description>
        <narrative>Global Fund disbursement to ZAF-C-NDOHP02 (Government).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="10">
        <narrative>National Department of Health of the Republic of South Africa</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="2ce7a75b-429f-4214-9969-a1a97d044d91">
      <transaction-type code="3" />
      <transaction-date iso-date="2021-12-09" />
      <value currency="USD" value-date="2021-12-09">1077545.17</value>
      <description>
        <narrative>Global Fund disbursement to ZAF-C-NDOHP02 (Government).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="10">
        <narrative>National Department of Health of the Republic of South Africa</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="471d7a41-bd75-4f21-80c1-2fb1c61ea516">
      <transaction-type code="3" />
      <transaction-date iso-date="2021-12-09" />
      <value currency="USD" value-date="2021-12-09">16397475.62</value>
      <description>
        <narrative>Global Fund disbursement to ZAF-C-NDOHP02 (Government).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="10">
        <narrative>National Department of Health of the Republic of South Africa</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="764f7860-f32b-4516-bd0a-7b6e01f87626">
      <transaction-type code="3" />
      <transaction-date iso-date="2021-12-09" />
      <value currency="USD" value-date="2021-12-09">14266.10</value>
      <description>
        <narrative>Global Fund disbursement to ZAF-C-NDOHP02 (Government).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="10">
        <narrative>National Department of Health of the Republic of South Africa</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="7bbd23da-3197-4720-a9ee-c94c6bc8dbc5">
      <transaction-type code="3" />
      <transaction-date iso-date="2021-12-09" />
      <value currency="USD" value-date="2021-12-09">1418213.80</value>
      <description>
        <narrative>Global Fund disbursement to ZAF-C-NDOHP02 (Government).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="10">
        <narrative>National Department of Health of the Republic of South Africa</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="8dfbfaf8-6868-40be-ac66-38198bb67178">
      <transaction-type code="3" />
      <transaction-date iso-date="2021-12-09" />
      <value currency="USD" value-date="2021-12-09">995783.71</value>
      <description>
        <narrative>Global Fund disbursement to ZAF-C-NDOHP02 (Government).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="10">
        <narrative>National Department of Health of the Republic of South Africa</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="bba7a91c-fbf4-4100-8cde-30c9a504b4f2">
      <transaction-type code="3" />
      <transaction-date iso-date="2021-12-09" />
      <value currency="USD" value-date="2021-12-09">1895197.95</value>
      <description>
        <narrative>Global Fund disbursement to ZAF-C-NDOHP02 (Government).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="10">
        <narrative>National Department of Health of the Republic of South Africa</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="c64b182f-3903-464b-855a-a2ffc5ffc321">
      <transaction-type code="3" />
      <transaction-date iso-date="2021-12-09" />
      <value currency="USD" value-date="2021-12-09">1345299.45</value>
      <description>
        <narrative>Global Fund disbursement to ZAF-C-NDOHP02 (Government).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="10">
        <narrative>National Department of Health of the Republic of South Africa</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="e1c0c8e0-1e0c-4f13-8580-914ffd2a8817">
      <transaction-type code="2" />
      <transaction-date iso-date="2021-12-14" />
      <value currency="USD" value-date="2021-12-14">-3559352.44</value>
      <description>
        <narrative>Global Fund commitment to ZAF-C-NDOHP02.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="10">
        <narrative>National Department of Health of the Republic of South Africa</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="00fd9d5c-268a-4d4d-baf9-035f1f371499">
      <transaction-type code="3" />
      <transaction-date iso-date="2022-03-03" />
      <value currency="USD" value-date="2022-03-03">1349819.04</value>
      <description>
        <narrative>Global Fund disbursement to ZAF-C-NDOHP02 (Government).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="10">
        <narrative>National Department of Health of the Republic of South Africa</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="2d3525bf-0bb7-4cd6-b30c-a79219380d7f">
      <transaction-type code="3" />
      <transaction-date iso-date="2022-03-03" />
      <value currency="USD" value-date="2022-03-03">3562733.71</value>
      <description>
        <narrative>Global Fund disbursement to ZAF-C-NDOHP02 (Government).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="10">
        <narrative>National Department of Health of the Republic of South Africa</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="4688591e-26f5-4ffc-99df-35ef5088fde4">
      <transaction-type code="3" />
      <transaction-date iso-date="2022-03-03" />
      <value currency="USD" value-date="2022-03-03">633448.36</value>
      <description>
        <narrative>Global Fund disbursement to ZAF-C-NDOHP02 (Government).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="10">
        <narrative>National Department of Health of the Republic of South Africa</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="640ab520-fba9-4a43-842c-76f780a9ed71">
      <transaction-type code="3" />
      <transaction-date iso-date="2022-03-03" />
      <value currency="USD" value-date="2022-03-03">304343.08</value>
      <description>
        <narrative>Global Fund disbursement to ZAF-C-NDOHP02 (Government).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="10">
        <narrative>National Department of Health of the Republic of South Africa</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="b3e51c87-fd93-4e5c-9c1d-fcd16fd649c4">
      <transaction-type code="3" />
      <transaction-date iso-date="2022-03-03" />
      <value currency="USD" value-date="2022-03-03">1575180.68</value>
      <description>
        <narrative>Global Fund disbursement to ZAF-C-NDOHP02 (Government).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="10">
        <narrative>National Department of Health of the Republic of South Africa</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="dec9436d-5d37-4787-8ceb-89c9d44deb93">
      <transaction-type code="3" />
      <transaction-date iso-date="2022-03-03" />
      <value currency="USD" value-date="2022-03-03">58618.28</value>
      <description>
        <narrative>Global Fund disbursement to ZAF-C-NDOHP02 (Government).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="10">
        <narrative>National Department of Health of the Republic of South Africa</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="fd69fc18-5041-4c79-9d63-eae25f68c36d">
      <transaction-type code="3" />
      <transaction-date iso-date="2022-03-03" />
      <value currency="USD" value-date="2022-03-03">2336310.56</value>
      <description>
        <narrative>Global Fund disbursement to ZAF-C-NDOHP02 (Government).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="10">
        <narrative>National Department of Health of the Republic of South Africa</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="08b98af7-3161-4070-96c4-a4afd67e6cf8">
      <transaction-type code="3" />
      <transaction-date iso-date="2022-05-19" />
      <value currency="USD" value-date="2022-05-19">1504558.00</value>
      <description>
        <narrative>Global Fund disbursement to ZAF-C-NDOHP02 (Government).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="10">
        <narrative>National Department of Health of the Republic of South Africa</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="4a53f14c-c967-417a-aa2d-a9f9874a6dc0">
      <transaction-type code="3" />
      <transaction-date iso-date="2022-05-19" />
      <value currency="USD" value-date="2022-05-19">153333.00</value>
      <description>
        <narrative>Global Fund disbursement to ZAF-C-NDOHP02 (Government).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="10">
        <narrative>National Department of Health of the Republic of South Africa</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="4e9c0b0b-9b8f-4740-9e0f-301cea718856">
      <transaction-type code="3" />
      <transaction-date iso-date="2022-05-19" />
      <value currency="USD" value-date="2022-05-19">5813333.00</value>
      <description>
        <narrative>Global Fund disbursement to ZAF-C-NDOHP02 (Government).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="10">
        <narrative>National Department of Health of the Republic of South Africa</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="c706d30f-d058-424b-96a2-d64021fec328">
      <transaction-type code="3" />
      <transaction-date iso-date="2022-05-19" />
      <value currency="USD" value-date="2022-05-19">1383765.00</value>
      <description>
        <narrative>Global Fund disbursement to ZAF-C-NDOHP02 (Government).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="10">
        <narrative>National Department of Health of the Republic of South Africa</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="daea3ba7-7d41-41ab-b6e8-4a36c6d43028">
      <transaction-type code="3" />
      <transaction-date iso-date="2022-05-19" />
      <value currency="USD" value-date="2022-05-19">779297.00</value>
      <description>
        <narrative>Global Fund disbursement to ZAF-C-NDOHP02 (Government).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="10">
        <narrative>National Department of Health of the Republic of South Africa</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="e62072dc-ea20-4ee0-a4f0-dcfa806297ab">
      <transaction-type code="3" />
      <transaction-date iso-date="2022-05-19" />
      <value currency="USD" value-date="2022-05-19">366667.00</value>
      <description>
        <narrative>Global Fund disbursement to ZAF-C-NDOHP02 (Government).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="10">
        <narrative>National Department of Health of the Republic of South Africa</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="63a81099-dc14-42d1-923f-3aab428254d0">
      <transaction-type code="2" />
      <transaction-date iso-date="2023-02-24" />
      <value currency="USD" value-date="2023-02-24">3068822.72</value>
      <description>
        <narrative>Global Fund commitment to ZAF-C-NDOHP02.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="10">
        <narrative>National Department of Health of the Republic of South Africa</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="f5870806-2a11-4329-a694-31ad9033117c">
      <transaction-type code="2" />
      <transaction-date iso-date="2023-02-24" />
      <value currency="USD" value-date="2023-02-24">-7821189.38</value>
      <description>
        <narrative>Global Fund commitment to ZAF-C-NDOHP02.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="10">
        <narrative>National Department of Health of the Republic of South Africa</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="abd303f6-7f96-4f9e-aa9d-fd10d83849f2">
      <transaction-type code="2" />
      <transaction-date iso-date="2024-03-11" />
      <value currency="USD" value-date="2024-03-11">-3068822.72</value>
      <description>
        <narrative>Global Fund commitment to ZAF-C-NDOHP02.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="10">
        <narrative>National Department of Health of the Republic of South Africa</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="14ab754d-d509-4daf-9ad7-356440ba76c4">
      <transaction-type code="7" />
      <transaction-date iso-date="2024-04-01" />
      <value currency="USD" value-date="2024-04-01">94214.43</value>
      <description>
        <narrative>Funds returned to the Global Fund from ZAF-C-NDOHP02 (Other 3rd Party).</narrative>
      </description>
      <provider-org type="10">
        <narrative>National Department of Health of the Republic of South Africa</narrative>
      </provider-org>
      <receiver-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="0a02d81e-9ed7-48da-9dca-200a08e6b7f5">
      <transaction-type code="7" />
      <transaction-date iso-date="2024-04-03" />
      <value currency="USD" value-date="2024-04-03">236654.03</value>
      <description>
        <narrative>Funds returned to the Global Fund from ZAF-C-NDOHP02 (Other 3rd Party).</narrative>
      </description>
      <provider-org type="10">
        <narrative>National Department of Health of the Republic of South Africa</narrative>
      </provider-org>
      <receiver-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="d7b57ccc-1199-42fe-b8c5-106b6e6330c3">
      <transaction-type code="2" />
      <transaction-date iso-date="2024-04-05" />
      <value currency="USD" value-date="2024-04-05">-236654.03</value>
      <description>
        <narrative>Global Fund commitment to ZAF-C-NDOHP02.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="10">
        <narrative>National Department of Health of the Republic of South Africa</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="2058636f-d5a5-4927-aa9c-2086b1c05ad4">
      <transaction-type code="2" />
      <transaction-date iso-date="2024-04-05" />
      <value currency="USD" value-date="2024-04-05">-94214.43</value>
      <description>
        <narrative>Global Fund commitment to ZAF-C-NDOHP02.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="10">
        <narrative>National Department of Health of the Republic of South Africa</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="82536eee-5c84-471f-89b6-f35981c41428">
      <transaction-type code="7" />
      <transaction-date iso-date="2024-05-24" />
      <value currency="USD" value-date="2024-05-24">130722.09</value>
      <description>
        <narrative>Funds returned to the Global Fund from ZAF-C-NDOHP02 (Other 3rd Party).</narrative>
      </description>
      <provider-org type="10">
        <narrative>National Department of Health of the Republic of South Africa</narrative>
      </provider-org>
      <receiver-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="ba9d1ec4-469d-477d-8b7d-2cf336a287cf">
      <transaction-type code="2" />
      <transaction-date iso-date="2024-05-29" />
      <value currency="USD" value-date="2024-05-29">-130722.09</value>
      <description>
        <narrative>Global Fund commitment to ZAF-C-NDOHP02.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="10">
        <narrative>National Department of Health of the Republic of South Africa</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="63d5aed2-fa61-4c7e-a887-a3d88661e496">
      <transaction-type code="7" />
      <transaction-date iso-date="2025-08-04" />
      <value currency="USD" value-date="2025-08-04">2690383.58</value>
      <description>
        <narrative>Funds returned to the Global Fund from ZAF-C-NDOHP02 (Government).</narrative>
      </description>
      <provider-org type="10">
        <narrative>National Department of Health of the Republic of South Africa</narrative>
      </provider-org>
      <receiver-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="2f975399-92f3-4b5e-9e59-b08d5965016b">
      <transaction-type code="2" />
      <transaction-date iso-date="2025-08-07" />
      <value currency="USD" value-date="2025-08-07">-2690383.58</value>
      <description>
        <narrative>Global Fund commitment to ZAF-C-NDOHP02.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="10">
        <narrative>National Department of Health of the Republic of South Africa</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="de6d3e56-b157-4942-874d-d63260aa5fb1">
      <transaction-type code="7" />
      <transaction-date iso-date="2025-09-16" />
      <value currency="USD" value-date="2025-09-16">3834.33</value>
      <description>
        <narrative>Funds returned to the Global Fund from ZAF-C-NDOHP02 (Government).</narrative>
      </description>
      <provider-org type="10">
        <narrative>National Department of Health of the Republic of South Africa</narrative>
      </provider-org>
      <receiver-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="e7f84221-965e-4e0f-8252-1259f8861ca9">
      <transaction-type code="2" />
      <transaction-date iso-date="2025-09-22" />
      <value currency="USD" value-date="2025-09-22">-3834.33</value>
      <description>
        <narrative>Global Fund commitment to ZAF-C-NDOHP02.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="10">
        <narrative>National Department of Health of the Republic of South Africa</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="ZAF-C-NDOHP02-EXP-20200331">
      <transaction-type code="4" />
      <transaction-date iso-date="2020-03-31" />
      <value currency="USD" value-date="2020-03-31">20354805.00</value>
      <description>
        <narrative>Expenditure reported by National Department of Health of the Republic of South Africa for ZAF-C-NDOHP02, Apr 2019 to Mar 2020.</narrative>
      </description>
      <provider-org type="10">
        <narrative>National Department of Health of the Republic of South Africa</narrative>
      </provider-org>
    </transaction>
    <transaction ref="ZAF-C-NDOHP02-EXP-20210331">
      <transaction-type code="4" />
      <transaction-date iso-date="2021-03-31" />
      <value currency="USD" value-date="2021-03-31">72467129.39</value>
      <description>
        <narrative>Expenditure reported by National Department of Health of the Republic of South Africa for ZAF-C-NDOHP02, Apr 2020 to Mar 2021.</narrative>
      </description>
      <provider-org type="10">
        <narrative>National Department of Health of the Republic of South Africa</narrative>
      </provider-org>
    </transaction>
    <transaction ref="ZAF-C-NDOHP02-EXP-20220331">
      <transaction-type code="4" />
      <transaction-date iso-date="2022-03-31" />
      <value currency="USD" value-date="2022-03-31">128279357.37</value>
      <description>
        <narrative>Expenditure reported by National Department of Health of the Republic of South Africa for ZAF-C-NDOHP02, Apr 2021 to Mar 2022.</narrative>
      </description>
      <provider-org type="10">
        <narrative>National Department of Health of the Republic of South Africa</narrative>
      </provider-org>
    </transaction>
    <transaction ref="ZAF-C-NDOHP02-EXP-20220930">
      <transaction-type code="4" />
      <transaction-date iso-date="2022-09-30" />
      <value currency="USD" value-date="2022-09-30">-7554134.45</value>
      <description>
        <narrative>Expenditure reported by National Department of Health of the Republic of South Africa for ZAF-C-NDOHP02, Apr 2022 to Sep 2022.</narrative>
      </description>
      <provider-org type="10">
        <narrative>National Department of Health of the Republic of South Africa</narrative>
      </provider-org>
    </transaction>
    <document-link url="https://data.theglobalfund.org/grant/ZAF-C-NDOH" format="text/html">
      <title>
        <narrative>Grant page on the data explorer of the Global Fund.</narrative>
      </title>
      <description>
        <narrative>An overview of a grant over its lifetime.</narrative>
      </description>
      <category code="A12" />
      <category code="A01" />
      <category code="A02" />
      <category code="A05" />
      <category code="A07" />
      <category code="A08" />
      <language code="en" />
      <document-date iso-date="2026-11-11" />
    </document-link>
    <document-link url="https://www.theglobalfund.org/media/13342/core_grantregulationsversiontwo_regulations_en.pdf" format="application/pdf">
      <title>
        <narrative>Grant terms and conditions.</narrative>
      </title>
      <description>
        <narrative>General terms and conditions which apply to Global Fund grants.</narrative>
      </description>
      <category code="A04" />
      <language code="en" />
    </document-link>
    <result type="1" aggregation-status="0">
      <title>
        <narrative>Number of TB cases with RR-TB and/or MDR-TB notified</narrative>
      </title>
      <description>
        <narrative>Module: MDR-TB.</narrative>
      </description>
      <indicator measure="1" aggregation-status="0">
        <title>
          <narrative>Number of TB cases with RR-TB and/or MDR-TB notified</narrative>
        </title>
        <description>
          <narrative>Geographic coverage: Subnational. Aggregation: Non cumulative.</narrative>
        </description>
        <baseline year="2017" iso-date="2017-12-31" value="5394" />
        <period>
          <period-start iso-date="2019-04-01" />
          <period-end iso-date="2019-09-30" />
          <target value="3042" />
          <actual value="2859" />
        </period>
        <period>
          <period-start iso-date="2019-10-01" />
          <period-end iso-date="2020-03-31" />
          <target value="3042" />
          <actual value="2827" />
        </period>
        <period>
          <period-start iso-date="2020-04-01" />
          <period-end iso-date="2020-09-30" />
          <target value="3147" />
          <actual value="2216" />
        </period>
        <period>
          <period-start iso-date="2020-10-01" />
          <period-end iso-date="2021-03-31" />
          <target value="3147" />
          <actual value="1958" />
        </period>
        <period>
          <period-start iso-date="2021-04-01" />
          <period-end iso-date="2022-03-31" />
          <target value="7990" />
          <actual value="4193" />
        </period>
        <period>
          <period-start iso-date="2021-04-01" />
          <period-end iso-date="2021-09-30" />
          <target value="3628" />
          <actual value="2049" />
        </period>
        <period>
          <period-start iso-date="2021-10-01" />
          <period-end iso-date="2022-03-31" />
          <target value="4362" />
          <actual value="2144" />
        </period>
      </indicator>
    </result>
    <result type="1" aggregation-status="0">
      <title>
        <narrative>Number of cases with RR-TB and/or MDR-TB that began second-line treatment</narrative>
      </title>
      <description>
        <narrative>Module: MDR-TB.</narrative>
      </description>
      <indicator measure="1" aggregation-status="0">
        <title>
          <narrative>Number of cases with RR-TB and/or MDR-TB that began second-line treatment</narrative>
        </title>
        <description>
          <narrative>Geographic coverage: Subnational. Aggregation: Non cumulative.</narrative>
        </description>
        <baseline year="2017" iso-date="2017-12-31" value="5133" />
        <period>
          <period-start iso-date="2019-04-01" />
          <period-end iso-date="2019-09-30" />
          <target value="2737" />
          <actual value="1711" />
        </period>
        <period>
          <period-start iso-date="2019-10-01" />
          <period-end iso-date="2020-03-31" />
          <target value="2737" />
          <actual value="2054" />
        </period>
        <period>
          <period-start iso-date="2020-04-01" />
          <period-end iso-date="2020-09-30" />
          <target value="2832" />
          <actual value="1721" />
        </period>
        <period>
          <period-start iso-date="2020-10-01" />
          <period-end iso-date="2021-03-31" />
          <target value="2832" />
          <actual value="1391" />
        </period>
        <period>
          <period-start iso-date="2021-04-01" />
          <period-end iso-date="2021-09-30" />
          <target value="3265" />
          <actual value="1591" />
        </period>
        <period>
          <period-start iso-date="2021-04-01" />
          <period-end iso-date="2022-03-31" />
          <target value="7189" />
          <actual value="3160" />
        </period>
        <period>
          <period-start iso-date="2021-10-01" />
          <period-end iso-date="2022-03-31" />
          <target value="3924" />
          <actual value="1569" />
        </period>
      </indicator>
    </result>
    <result type="1" aggregation-status="0">
      <title>
        <narrative>Percentage of HMIS or other routine reporting units submitting timely reports according to national guidelines</narrative>
      </title>
      <description>
        <narrative>Module: RSSH: Health management information systems and M&amp;E.</narrative>
      </description>
      <indicator measure="2" aggregation-status="0">
        <title>
          <narrative>Percentage of HMIS or other routine reporting units submitting timely reports according to national guidelines</narrative>
        </title>
        <description>
          <narrative>Geographic coverage: National. Aggregation: Non cumulative.</narrative>
        </description>
        <baseline year="2018" iso-date="2018-12-31" value="99.12">
          <comment>
            <narrative>Numerator: 4819; Denominator: 4862.</narrative>
          </comment>
        </baseline>
        <period>
          <period-start iso-date="2019-04-01" />
          <period-end iso-date="2019-09-30" />
          <target value="99">
            <comment>
              <narrative>Numerator: 4170; Denominator: 4212.</narrative>
            </comment>
          </target>
          <actual value="99.6">
            <comment>
              <narrative>Numerator: 4253; Denominator: 4271.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2019-10-01" />
          <period-end iso-date="2020-03-31" />
          <target value="99.37">
            <comment>
              <narrative>Numerator: 4890; Denominator: 4921.</narrative>
            </comment>
          </target>
          <actual value="98.8">
            <comment>
              <narrative>Numerator: 4881; Denominator: 4941.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2020-04-01" />
          <period-end iso-date="2020-09-30" />
          <target value="99.37">
            <comment>
              <narrative>Numerator: 4890; Denominator: 4921.</narrative>
            </comment>
          </target>
          <actual value="96.7">
            <comment>
              <narrative>Numerator: 4655; Denominator: 4815.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2020-10-01" />
          <period-end iso-date="2021-03-31" />
          <target value="99.37">
            <comment>
              <narrative>Numerator: 4890; Denominator: 4921.</narrative>
            </comment>
          </target>
          <actual value="99.1">
            <comment>
              <narrative>Numerator: 4730; Denominator: 4774.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2021-04-01" />
          <period-end iso-date="2022-03-31" />
          <target value="99.4">
            <comment>
              <narrative>Numerator: 9780; Denominator: 9842.</narrative>
            </comment>
          </target>
          <actual value="99">
            <comment>
              <narrative>Numerator: 9477; Denominator: 9574.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2021-04-01" />
          <period-end iso-date="2021-09-30" />
          <target value="99.4">
            <comment>
              <narrative>Numerator: 4890; Denominator: 4921.</narrative>
            </comment>
          </target>
          <actual value="99.1">
            <comment>
              <narrative>Numerator: 4743; Denominator: 4785.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2021-10-01" />
          <period-end iso-date="2022-03-31" />
          <target value="99.4">
            <comment>
              <narrative>Numerator: 4890; Denominator: 4921.</narrative>
            </comment>
          </target>
          <actual value="98.9">
            <comment>
              <narrative>Numerator: 4734; Denominator: 4789.</narrative>
            </comment>
          </actual>
        </period>
      </indicator>
    </result>
    <result type="1" aggregation-status="0">
      <title>
        <narrative>Number of children &lt;5 in contact with TB patients who began isonizide preventive therapy</narrative>
      </title>
      <description>
        <narrative>Module: TB care and prevention.</narrative>
      </description>
      <indicator measure="1" aggregation-status="0">
        <title>
          <narrative>Number of children &lt;5 in contact with TB patients who began isonizide preventive therapy</narrative>
        </title>
        <description>
          <narrative>Geographic coverage: Subnational. Aggregation: Non cumulative.</narrative>
        </description>
        <baseline year="2017" iso-date="2017-12-31" value="12883" />
        <period>
          <period-start iso-date="2019-04-01" />
          <period-end iso-date="2019-09-30" />
          <target value="7730" />
          <actual value="5173" />
        </period>
        <period>
          <period-start iso-date="2019-10-01" />
          <period-end iso-date="2020-03-31" />
          <target value="7730" />
          <actual value="4855" />
        </period>
        <period>
          <period-start iso-date="2020-04-01" />
          <period-end iso-date="2020-09-30" />
          <target value="9018" />
          <actual value="2335" />
        </period>
        <period>
          <period-start iso-date="2020-10-01" />
          <period-end iso-date="2021-03-31" />
          <target value="9018" />
          <actual value="3568" />
        </period>
        <period>
          <period-start iso-date="2021-04-01" />
          <period-end iso-date="2021-09-30" />
          <target value="11464" />
          <actual value="5891" />
        </period>
        <period>
          <period-start iso-date="2021-04-01" />
          <period-end iso-date="2022-03-31" />
          <target value="25242" />
          <actual value="12116" />
        </period>
        <period>
          <period-start iso-date="2021-10-01" />
          <period-end iso-date="2022-03-31" />
          <target value="13778" />
          <actual value="6225" />
        </period>
      </indicator>
    </result>
    <result type="1" aggregation-status="0">
      <title>
        <narrative>Number of notified cases of all forms of TB (i.e. bacteriologically confirmed + clinically diagnosed), new and relapse cases</narrative>
      </title>
      <description>
        <narrative>Module: TB care and prevention.</narrative>
      </description>
      <indicator measure="1" aggregation-status="0">
        <title>
          <narrative>Number of notified cases of all forms of TB (i.e. bacteriologically confirmed + clinically diagnosed), new and relapse cases</narrative>
        </title>
        <description>
          <narrative>Geographic coverage: Subnational. Aggregation: Non cumulative.</narrative>
        </description>
        <baseline year="2017" iso-date="2017-12-31" value="83699" />
        <period>
          <period-start iso-date="2019-04-01" />
          <period-end iso-date="2019-09-30" />
          <target value="39063" />
          <actual value="32485" />
        </period>
        <period>
          <period-start iso-date="2019-10-01" />
          <period-end iso-date="2020-03-31" />
          <target value="61036" />
          <actual value="47616" />
        </period>
        <period>
          <period-start iso-date="2020-04-01" />
          <period-end iso-date="2020-09-30" />
          <target value="52550" />
          <actual value="31441" />
        </period>
        <period>
          <period-start iso-date="2020-10-01" />
          <period-end iso-date="2021-03-31" />
          <target value="52550" />
          <actual value="36398" />
        </period>
        <period>
          <period-start iso-date="2021-04-01" />
          <period-end iso-date="2022-03-31" />
          <target value="135029" />
          <actual value="87817" />
        </period>
        <period>
          <period-start iso-date="2021-04-01" />
          <period-end iso-date="2021-09-30" />
          <target value="61326" />
          <actual value="41319" />
        </period>
        <period>
          <period-start iso-date="2021-10-01" />
          <period-end iso-date="2022-03-31" />
          <target value="73703" />
          <actual value="46498" />
        </period>
      </indicator>
    </result>
    <result type="1" aggregation-status="0">
      <title>
        <narrative>Treatment success rate- all forms: Percentage of TB cases, all forms, bacteriologically confirmed plus clinically diagnosed, successfully treated (cured plus treatment completed) among all TB cases registered for treatment during a specified period, new and relapse cases</narrative>
      </title>
      <description>
        <narrative>Module: TB care and prevention.</narrative>
      </description>
      <indicator measure="2" aggregation-status="0">
        <title>
          <narrative>Treatment success rate- all forms: Percentage of TB cases, all forms, bacteriologically confirmed plus clinically diagnosed, successfully treated (cured plus treatment completed) among all TB cases registered for treatment during a specified period, new and relapse cases</narrative>
        </title>
        <description>
          <narrative>Geographic coverage: Subnational. Aggregation: Non cumulative.</narrative>
        </description>
        <baseline year="2017" iso-date="2017-12-31" value="83.4">
          <comment>
            <narrative>Numerator: 79142; Denominator: 94896.</narrative>
          </comment>
        </baseline>
        <period>
          <period-start iso-date="2020-04-01" />
          <period-end iso-date="2020-09-30" />
          <target value="90">
            <comment>
              <narrative>Numerator: 35157; Denominator: 39063.</narrative>
            </comment>
          </target>
          <actual value="79.3">
            <comment>
              <narrative>Numerator: 30274; Denominator: 38161.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2020-10-01" />
          <period-end iso-date="2021-03-31" />
          <target value="90">
            <comment>
              <narrative>Numerator: 54932; Denominator: 61035.</narrative>
            </comment>
          </target>
          <actual value="79.4">
            <comment>
              <narrative>Numerator: 35711; Denominator: 44994.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2021-04-01" />
          <period-end iso-date="2021-09-30" />
          <target value="90">
            <comment>
              <narrative>Numerator: 47295; Denominator: 52549.</narrative>
            </comment>
          </target>
          <actual value="79">
            <comment>
              <narrative>Numerator: 28341; Denominator: 35880.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2021-04-01" />
          <period-end iso-date="2022-03-31" />
          <target value="90">
            <comment>
              <narrative>Numerator: 94590; Denominator: 105098.</narrative>
            </comment>
          </target>
          <actual value="78.9">
            <comment>
              <narrative>Numerator: 54498; Denominator: 69031.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2021-10-01" />
          <period-end iso-date="2022-03-31" />
          <target value="90">
            <comment>
              <narrative>Numerator: 47295; Denominator: 52549.</narrative>
            </comment>
          </target>
          <actual value="78.9">
            <comment>
              <narrative>Numerator: 26157; Denominator: 33151.</narrative>
            </comment>
          </actual>
        </period>
      </indicator>
    </result>
    <result type="1" aggregation-status="0">
      <title>
        <narrative>Percentage of HIV-positive new and relapse TB patients on ART during TB treatment</narrative>
      </title>
      <description>
        <narrative>Module: TB/HIV.</narrative>
      </description>
      <indicator measure="2" aggregation-status="0">
        <title>
          <narrative>Percentage of HIV-positive new and relapse TB patients on ART during TB treatment</narrative>
        </title>
        <description>
          <narrative>Geographic coverage: Subnational. Aggregation: Non cumulative.</narrative>
        </description>
        <baseline year="2017" iso-date="2017-12-31" value="87.03">
          <comment>
            <narrative>Numerator: 41302; Denominator: 47457.</narrative>
          </comment>
        </baseline>
        <period>
          <period-start iso-date="2019-04-01" />
          <period-end iso-date="2019-09-30" />
          <target value="90">
            <comment>
              <narrative>Numerator: 19934; Denominator: 22148.</narrative>
            </comment>
          </target>
          <actual value="62.6">
            <comment>
              <narrative>Numerator: 13133; Denominator: 20993.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2019-10-01" />
          <period-end iso-date="2020-03-31" />
          <target value="90">
            <comment>
              <narrative>Numerator: 31146; Denominator: 34607.</narrative>
            </comment>
          </target>
          <actual value="84.5">
            <comment>
              <narrative>Numerator: 22692; Denominator: 26859.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2020-04-01" />
          <period-end iso-date="2020-09-30" />
          <target value="90">
            <comment>
              <narrative>Numerator: 26816; Denominator: 29795.</narrative>
            </comment>
          </target>
          <actual value="84">
            <comment>
              <narrative>Numerator: 16457; Denominator: 19583.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2020-10-01" />
          <period-end iso-date="2021-03-31" />
          <target value="90">
            <comment>
              <narrative>Numerator: 26816; Denominator: 29795.</narrative>
            </comment>
          </target>
          <actual value="85">
            <comment>
              <narrative>Numerator: 15623; Denominator: 18376.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2021-04-01" />
          <period-end iso-date="2022-03-31" />
          <target value="90">
            <comment>
              <narrative>Numerator: 72916; Denominator: 81018.</narrative>
            </comment>
          </target>
          <actual value="89.1">
            <comment>
              <narrative>Numerator: 39368; Denominator: 44177.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2021-04-01" />
          <period-end iso-date="2021-09-30" />
          <target value="90">
            <comment>
              <narrative>Numerator: 33116; Denominator: 36796.</narrative>
            </comment>
          </target>
          <actual value="88.5">
            <comment>
              <narrative>Numerator: 18611; Denominator: 21033.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2021-10-01" />
          <period-end iso-date="2022-03-31" />
          <target value="90">
            <comment>
              <narrative>Numerator: 39800; Denominator: 44222.</narrative>
            </comment>
          </target>
          <actual value="89.7">
            <comment>
              <narrative>Numerator: 20757; Denominator: 23144.</narrative>
            </comment>
          </actual>
        </period>
      </indicator>
    </result>
    <result type="1" aggregation-status="0">
      <title>
        <narrative>Percentage of people living with HIV newly enrolled in HIV care started on TB preventive therapy</narrative>
      </title>
      <description>
        <narrative>Module: TB/HIV.</narrative>
      </description>
      <indicator measure="2" aggregation-status="0">
        <title>
          <narrative>Percentage of people living with HIV newly enrolled in HIV care started on TB preventive therapy</narrative>
        </title>
        <description>
          <narrative>Geographic coverage: Subnational. Aggregation: Non cumulative.</narrative>
        </description>
        <baseline year="2017" iso-date="2017-12-31" value="56.27">
          <comment>
            <narrative>Numerator: 177742; Denominator: 315890.</narrative>
          </comment>
        </baseline>
        <period>
          <period-start iso-date="2019-04-01" />
          <period-end iso-date="2019-09-30" />
          <target value="66.82">
            <comment>
              <narrative>Numerator: 150535; Denominator: 225296.</narrative>
            </comment>
          </target>
          <actual value="90.2">
            <comment>
              <narrative>Numerator: 128419; Denominator: 142332.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2019-10-01" />
          <period-end iso-date="2020-03-31" />
          <target value="66.82">
            <comment>
              <narrative>Numerator: 150535; Denominator: 225296.</narrative>
            </comment>
          </target>
          <actual value="92.1">
            <comment>
              <narrative>Numerator: 121304; Denominator: 131707.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2020-04-01" />
          <period-end iso-date="2020-09-30" />
          <target value="78">
            <comment>
              <narrative>Numerator: 175731; Denominator: 225296.</narrative>
            </comment>
          </target>
          <actual value="93.6">
            <comment>
              <narrative>Numerator: 71975; Denominator: 76905.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2020-10-01" />
          <period-end iso-date="2021-03-31" />
          <target value="78">
            <comment>
              <narrative>Numerator: 175731; Denominator: 225296.</narrative>
            </comment>
          </target>
          <actual value="93.9">
            <comment>
              <narrative>Numerator: 82087; Denominator: 87403.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2021-04-01" />
          <period-end iso-date="2022-03-31" />
          <target value="90">
            <comment>
              <narrative>Numerator: 405532; Denominator: 450592.</narrative>
            </comment>
          </target>
          <actual value="92.4">
            <comment>
              <narrative>Numerator: 143306; Denominator: 155045.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2021-04-01" />
          <period-end iso-date="2021-09-30" />
          <target value="90">
            <comment>
              <narrative>Numerator: 202766; Denominator: 225296.</narrative>
            </comment>
          </target>
          <actual value="94.3">
            <comment>
              <narrative>Numerator: 77406; Denominator: 82077.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2021-10-01" />
          <period-end iso-date="2022-03-31" />
          <target value="90">
            <comment>
              <narrative>Numerator: 202766; Denominator: 225296.</narrative>
            </comment>
          </target>
          <actual value="90.3">
            <comment>
              <narrative>Numerator: 65900; Denominator: 72968.</narrative>
            </comment>
          </actual>
        </period>
      </indicator>
    </result>
    <result type="1" aggregation-status="0">
      <title>
        <narrative>Percentage of registered new and relapse TB patients with documented HIV status</narrative>
      </title>
      <description>
        <narrative>Module: TB/HIV.</narrative>
      </description>
      <indicator measure="2" aggregation-status="0">
        <title>
          <narrative>Percentage of registered new and relapse TB patients with documented HIV status</narrative>
        </title>
        <description>
          <narrative>Geographic coverage: Subnational. Aggregation: Non cumulative.</narrative>
        </description>
        <baseline year="2017" iso-date="2017-12-31" value="94.79">
          <comment>
            <narrative>Numerator: 79342; Denominator: 83699.</narrative>
          </comment>
        </baseline>
        <period>
          <period-start iso-date="2019-04-01" />
          <period-end iso-date="2019-09-30" />
          <target value="100">
            <comment>
              <narrative>Numerator: 39063; Denominator: 39063.</narrative>
            </comment>
          </target>
          <actual value="49.3">
            <comment>
              <narrative>Numerator: 20993; Denominator: 42612.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2019-10-01" />
          <period-end iso-date="2020-03-31" />
          <target value="100">
            <comment>
              <narrative>Numerator: 61036; Denominator: 61035.</narrative>
            </comment>
          </target>
          <actual value="87.8">
            <comment>
              <narrative>Numerator: 41581; Denominator: 47345.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2020-04-01" />
          <period-end iso-date="2020-09-30" />
          <target value="100">
            <comment>
              <narrative>Numerator: 52550; Denominator: 52549.</narrative>
            </comment>
          </target>
          <actual value="79.4">
            <comment>
              <narrative>Numerator: 30130; Denominator: 37939.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2020-10-01" />
          <period-end iso-date="2021-03-31" />
          <target value="100">
            <comment>
              <narrative>Numerator: 52550; Denominator: 52549.</narrative>
            </comment>
          </target>
          <actual value="76.8">
            <comment>
              <narrative>Numerator: 28672; Denominator: 37355.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2021-04-01" />
          <period-end iso-date="2022-03-31" />
          <target value="100">
            <comment>
              <narrative>Numerator: 135029; Denominator: 135029.</narrative>
            </comment>
          </target>
          <actual value="88.4">
            <comment>
              <narrative>Numerator: 75631; Denominator: 85585.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2021-04-01" />
          <period-end iso-date="2021-09-30" />
          <target value="100">
            <comment>
              <narrative>Numerator: 61326; Denominator: 61326.</narrative>
            </comment>
          </target>
          <actual value="87.3">
            <comment>
              <narrative>Numerator: 34501; Denominator: 39530.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2021-10-01" />
          <period-end iso-date="2022-03-31" />
          <target value="100">
            <comment>
              <narrative>Numerator: 73703; Denominator: 73703.</narrative>
            </comment>
          </target>
          <actual value="89.3">
            <comment>
              <narrative>Numerator: 41130; Denominator: 46055.</narrative>
            </comment>
          </actual>
        </period>
      </indicator>
    </result>
    <result type="1" aggregation-status="0">
      <title>
        <narrative>Percentage of people living with HIV currently receiving antiretroviral therapy</narrative>
      </title>
      <description>
        <narrative>Module: Treatment, care and support.</narrative>
      </description>
      <indicator measure="2" aggregation-status="0">
        <title>
          <narrative>Percentage of people living with HIV currently receiving antiretroviral therapy</narrative>
        </title>
        <description>
          <narrative>Geographic coverage: National. Aggregation: Non cumulative - other.</narrative>
        </description>
        <baseline year="2017" iso-date="2017-12-31" value="59.45">
          <comment>
            <narrative>Numerator: 4189070; Denominator: 7046301.</narrative>
          </comment>
        </baseline>
        <baseline year="2017" iso-date="2017-12-31" value="58">
          <dimension name="Age" value="15+" />
        </baseline>
        <baseline year="2017" iso-date="2017-12-31" value="58">
          <dimension name="Age" value="15+" />
        </baseline>
        <baseline year="2017" iso-date="2017-12-31" value="58">
          <dimension name="Age" value="15+" />
        </baseline>
        <baseline year="2017" iso-date="2017-12-31" value="58">
          <dimension name="Age" value="15+" />
        </baseline>
        <baseline year="2017" iso-date="2017-12-31" value="58">
          <dimension name="Age" value="15+" />
        </baseline>
        <baseline year="2017" iso-date="2017-12-31" value="60">
          <dimension name="Age" value="&lt;15" />
        </baseline>
        <baseline year="2017" iso-date="2017-12-31" value="60">
          <dimension name="Age" value="&lt;15" />
        </baseline>
        <baseline year="2017" iso-date="2017-12-31" value="60">
          <dimension name="Age" value="&lt;15" />
        </baseline>
        <baseline year="2017" iso-date="2017-12-31" value="60">
          <dimension name="Age" value="&lt;15" />
        </baseline>
        <baseline year="2017" iso-date="2017-12-31" value="60">
          <dimension name="Age" value="&lt;15" />
        </baseline>
        <period>
          <period-start iso-date="2019-04-01" />
          <period-end iso-date="2019-09-30" />
          <target value="70.52">
            <comment>
              <narrative>Numerator: 5400000; Denominator: 7656920.</narrative>
            </comment>
          </target>
          <actual value="63.4">
            <comment>
              <narrative>Numerator: 4855841; Denominator: 7656920.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2019-10-01" />
          <period-end iso-date="2020-03-31" />
          <target value="75.75">
            <comment>
              <narrative>Numerator: 5800000; Denominator: 7656920.</narrative>
            </comment>
          </target>
          <actual value="65.5">
            <comment>
              <narrative>Numerator: 5015476; Denominator: 7656920.</narrative>
            </comment>
          </actual>
          <actual value="66.8">
            <dimension name="Age" value="15+" />
            <comment>
              <narrative>Numerator: 4866991; Denominator: 7280359.</narrative>
            </comment>
          </actual>
          <actual value="46.6">
            <dimension name="Age" value="&lt;15" />
            <comment>
              <narrative>Numerator: 148485; Denominator: 318856.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2020-04-01" />
          <period-end iso-date="2020-09-30" />
          <target value="76.45">
            <comment>
              <narrative>Numerator: 5950000; Denominator: 7782830.</narrative>
            </comment>
          </target>
          <actual value="63.6">
            <comment>
              <narrative>Numerator: 4948925; Denominator: 7782830.</narrative>
            </comment>
          </actual>
          <actual value="61.8">
            <dimension name="Age" value="15+" />
            <comment>
              <narrative>Numerator: 4806662; Denominator: 7782830.</narrative>
            </comment>
          </actual>
          <actual value="1.8">
            <dimension name="Age" value="&lt;15" />
            <comment>
              <narrative>Numerator: 142263; Denominator: 7782830.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2020-10-01" />
          <period-end iso-date="2021-03-31" />
          <target value="78.38">
            <comment>
              <narrative>Numerator: 6100000; Denominator: 7782830.</narrative>
            </comment>
          </target>
          <actual value="65.7">
            <comment>
              <narrative>Numerator: 5115943; Denominator: 7782830.</narrative>
            </comment>
          </actual>
          <actual value="64">
            <dimension name="Age" value="15+" />
            <comment>
              <narrative>Numerator: 4979284; Denominator: 7782830.</narrative>
            </comment>
          </actual>
          <actual value="1.8">
            <dimension name="Age" value="&lt;15" />
            <comment>
              <narrative>Numerator: 136659; Denominator: 7782830.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2021-04-01" />
          <period-end iso-date="2021-09-30" />
          <target value="78.5">
            <comment>
              <narrative>Numerator: 6200000; Denominator: 7899150.</narrative>
            </comment>
          </target>
          <actual value="66.1">
            <comment>
              <narrative>Numerator: 5222838; Denominator: 7899150.</narrative>
            </comment>
          </actual>
          <actual value="64.25">
            <dimension name="Age" value="15+" />
            <comment>
              <narrative>Numerator: 5075226; Denominator: 7899150.</narrative>
            </comment>
          </actual>
          <actual value="1.66">
            <dimension name="Age" value="&lt;15" />
            <comment>
              <narrative>Numerator: 130876; Denominator: 7899150.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2021-04-01" />
          <period-end iso-date="2022-03-31" />
          <target value="79.8">
            <comment>
              <narrative>Numerator: 6300000; Denominator: 7899150.</narrative>
            </comment>
          </target>
          <actual value="66.7">
            <comment>
              <narrative>Numerator: 5271837; Denominator: 7899150.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2021-10-01" />
          <period-end iso-date="2022-03-31" />
          <target value="79.8">
            <comment>
              <narrative>Numerator: 6300000; Denominator: 7899150.</narrative>
            </comment>
          </target>
          <actual value="66.7">
            <comment>
              <narrative>Numerator: 5271837; Denominator: 7899150.</narrative>
            </comment>
          </actual>
          <actual value="72.95">
            <dimension name="Age" value="15+" />
            <comment>
              <narrative>Numerator: 5148698; Denominator: 7058030.</narrative>
            </comment>
          </actual>
          <actual value="51.69">
            <dimension name="Age" value="&lt;15" />
            <comment>
              <narrative>Numerator: 123139; Denominator: 238244.</narrative>
            </comment>
          </actual>
        </period>
      </indicator>
    </result>
  </iati-activity>
  <iati-activity last-updated-datetime="2026-11-11T15:32:23+00:00" xml:lang="en" default-currency="USD" humanitarian="0" hierarchy="1">
    <iati-identifier>47045-ZAF-C-NDOH-3</iati-identifier>
    <reporting-org ref="47045" type="30">
      <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
    </reporting-org>
    <title>
      <narrative>Investing for impact against Tuberculosis and HIV - South Africa (01-Apr-2022-30-Sep-2025)</narrative>
    </title>
    <description type="1">
      <narrative>South Africa, TB/HIV, National Department of Health of the Republic of South Africa</narrative>
    </description>
    <description type="2">
      <narrative>Goals: Accelerate prevention to reduce new HIV and TB infections and STIs; Reduce morbidity and mortality by providing treatment, care and adherence support for all; Ground the response to HIV, TB and STIs in human rights principles and approaches; Promote leadership and shared accountability for sustainable response to HIV, TB and STIs; Mobilise resources and maximise efficiencies to support the achievment of NSP goals and ensure a sustainable approach; Strengthen strategic information to drive progress towards achievement of NSP goals. Objectives: To strengthen infrastructure and implementation of  surveillance systems for pandemic preparedness; To ensure adequate supplies and monitoring of medical oxygen; To strengthen procurement system's safe practices in waste management; Promote an environment that enables and protects human and legal rights and prevents stigma and discrimination; Strengthen AIDS Councils to provide effective co-ordination and leadership of all stakeholders for shared accountability in the implementation of the NSP; Improve efficiency and mobilise sufficient resources to achieve the goals, objective and targets of the NSP; Optimise routinely collected strategic health information for data utilisation in decision making.</narrative>
    </description>
    <participating-org ref="47045" type="30" role="1" crs-channel-code="47045">
      <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
    </participating-org>
    <participating-org type="10" role="2" crs-channel-code="12001">
      <narrative>National Department of Health of the Republic of South Africa</narrative>
    </participating-org>
    <participating-org type="10" role="4" crs-channel-code="12001">
      <narrative>National Department of Health of the Republic of South Africa</narrative>
    </participating-org>
    <other-identifier ref="ZAF-C-NDOHP03" type="A1">
      <owner-org ref="47045">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </owner-org>
    </other-identifier>
    <activity-status code="3" />
    <activity-date type="1" iso-date="2022-04-01" />
    <activity-date type="2" iso-date="2022-04-01" />
    <activity-date type="3" iso-date="2025-09-30" />
    <activity-date type="4" iso-date="2025-09-30" />
    <contact-info type="1">
      <organisation>
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </organisation>
      <department>
        <narrative>Communications</narrative>
      </department>
      <telephone>+41 58 791 1700</telephone>
      <email>website@theglobalfund.org</email>
      <website>https://www.theglobalfund.org</website>
      <mailing-address>
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria, Global Health Campus, Chemin du Pommier 40, 1218 Grand-Saconnex, Geneva, Switzerland</narrative>
      </mailing-address>
    </contact-info>
    <contact-info type="2">
      <organisation>
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </organisation>
      <department>
        <narrative>Grant Management Division</narrative>
      </department>
      <person-name>
        <narrative>John Ochero</narrative>
      </person-name>
      <job-title>
        <narrative>Fund Portfolio Manager</narrative>
      </job-title>
      <telephone>+41 58 791 1700</telephone>
      <email>john.ochero@theglobalfund.org</email>
      <website>https://www.theglobalfund.org</website>
      <mailing-address>
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria, Global Health Campus, Chemin du Pommier 40, 1218 Grand-Saconnex, Geneva, Switzerland</narrative>
      </mailing-address>
    </contact-info>
    <activity-scope code="4" />
    <recipient-country code="ZA" percentage="100">
      <narrative>South Africa</narrative>
    </recipient-country>
    <sector vocabulary="1" code="12263" percentage="45.59">
      <narrative>Tuberculosis</narrative>
    </sector>
    <sector vocabulary="1" code="13040" percentage="36.18">
      <narrative>HIV</narrative>
    </sector>
    <sector vocabulary="1" code="12110" percentage="18.23">
      <narrative>Multicomponent, RSSH</narrative>
    </sector>
    <tag vocabulary="2" code="3">
      <narrative>Ensure healthy lives and promote well-being for all at all ages</narrative>
    </tag>
    <tag vocabulary="3" code="3.3">
      <narrative>End the epidemics of AIDS, tuberculosis, malaria and neglected tropical diseases, and combat hepatitis, water-borne diseases and other communicable diseases</narrative>
    </tag>
    <tag vocabulary="3" code="3.8">
      <narrative>Achieve universal health coverage</narrative>
    </tag>
    <country-budget-items vocabulary="4">
      <budget-item code="67b7abf2-42e5-4cc4-b75d-4eb6ea4f22b4" percentage="1.01">
        <description>
          <narrative>HIV -&gt; Differentiated HIV Testing Services -&gt; Self-testing</narrative>
        </description>
      </budget-item>
      <budget-item code="56595a18-f1ed-4f39-8c05-d687d5911e6b" percentage="0.93">
        <description>
          <narrative>HIV -&gt; Reducing human rights-related barriers to HIV/TB services -&gt; Human rights and medical ethics related to HIV and HIV/TB for health care providers</narrative>
        </description>
      </budget-item>
      <budget-item code="336e2f1a-7395-4d59-b42e-5e9916975074" percentage="0.01">
        <description>
          <narrative>HIV -&gt; Treatment, care and support -&gt; Counseling and psycho-social support</narrative>
        </description>
      </budget-item>
      <budget-item code="b0eb178f-7923-4f1d-a0dc-04aed075b79a" percentage="34.23">
        <description>
          <narrative>HIV -&gt; Treatment, care and support -&gt; Differentiated ART service delivery and HIV care</narrative>
        </description>
      </budget-item>
      <budget-item code="31a8e187-9648-42f5-a520-92e7e53d4ac6" percentage="12.05">
        <description>
          <narrative>Multicomponent -&gt; Program management -&gt; Grant management</narrative>
        </description>
      </budget-item>
      <budget-item code="a459608e-6d6a-4392-8e91-a6ce763883ca" percentage="0.63">
        <description>
          <narrative>RSSH -&gt; RSSH: Community systems strengthening -&gt; Community-based monitoring</narrative>
        </description>
      </budget-item>
      <budget-item code="ea41b061-34f4-4f5f-b2d7-d7e7838c9c59" percentage="0.18">
        <description>
          <narrative>RSSH -&gt; RSSH: Financial management systems -&gt; Routine grant financial management</narrative>
        </description>
      </budget-item>
      <budget-item code="c9e8bc4a-398e-4c4b-afbb-cf98965f552e" percentage="0.01">
        <description>
          <narrative>RSSH -&gt; RSSH: Health management information systems and M&amp;E -&gt; Analysis, evaluations, reviews and transparency</narrative>
        </description>
      </budget-item>
      <budget-item code="7d2483ee-e340-40e2-8f81-88b761c385aa" percentage="2.15">
        <description>
          <narrative>RSSH -&gt; RSSH: Health management information systems and M&amp;E -&gt; Routine reporting</narrative>
        </description>
      </budget-item>
      <budget-item code="cc2a3288-298b-4e87-9cd4-3b8c1601d54c" percentage="0.15">
        <description>
          <narrative>RSSH -&gt; RSSH: Health products management systems -&gt; Policy, strategy, governance</narrative>
        </description>
      </budget-item>
      <budget-item code="45f58950-e70b-425c-a83d-28115a57a936" percentage="1.76">
        <description>
          <narrative>RSSH -&gt; RSSH: Health products management systems -&gt; Regulatory/quality assurance support</narrative>
        </description>
      </budget-item>
      <budget-item code="73afa0ce-d818-4bb2-adeb-c13f28c03a1f" percentage="0.25">
        <description>
          <narrative>RSSH -&gt; RSSH: Health products management systems -&gt; Storage and distribution capacity</narrative>
        </description>
      </budget-item>
      <budget-item code="4078713e-8351-4887-be1a-1617bf48ccd5" percentage="0.06">
        <description>
          <narrative>RSSH -&gt; RSSH: Health sector governance and planning -&gt; National health sector strategies and financing</narrative>
        </description>
      </budget-item>
      <budget-item code="2c422db1-945a-4222-b6eb-8ea39fbf434f" percentage="0.27">
        <description>
          <narrative>RSSH -&gt; RSSH: Laboratory systems -&gt; Information systems and integrated specimen transport networks</narrative>
        </description>
      </budget-item>
      <budget-item code="ca59d83d-94c4-4f56-93fe-88d1caf39c5a" percentage="0.37">
        <description>
          <narrative>RSSH -&gt; RSSH: Laboratory systems -&gt; Infrastructure and equipment management systems</narrative>
        </description>
      </budget-item>
      <budget-item code="0651e028-d13e-4937-8777-a97183a5b108" percentage="0.05">
        <description>
          <narrative>RSSH -&gt; RSSH: Laboratory systems -&gt; Laboratory supply chain systems</narrative>
        </description>
      </budget-item>
      <budget-item code="951569a8-a591-40fc-9492-c7eb2322279f" percentage="0.3">
        <description>
          <narrative>RSSH -&gt; RSSH: Laboratory systems -&gt; National laboratory governance and management structures</narrative>
        </description>
      </budget-item>
      <budget-item code="9a89bb7c-0497-4574-b9d1-dd46b1823c81" percentage="0.09">
        <description>
          <narrative>Tuberculosis -&gt; MDR-TB -&gt; Engaging all care providers (MDR-TB)</narrative>
        </description>
      </budget-item>
      <budget-item code="8194063f-1bf8-4be2-9ebd-2823d5ac44a3" percentage="5.05">
        <description>
          <narrative>Tuberculosis -&gt; MDR-TB -&gt; Treatment (MDR-TB)</narrative>
        </description>
      </budget-item>
      <budget-item code="b108d9bd-d341-43a6-a473-1be4efabc458" percentage="0.49">
        <description>
          <narrative>Tuberculosis -&gt; Removing human rights and gender related barriers to TB services -&gt; Stigma and discrimination reduction (TB)</narrative>
        </description>
      </budget-item>
      <budget-item code="a93b0a8f-4b2d-4b43-806e-06b2f2240144" percentage="25.46">
        <description>
          <narrative>Tuberculosis -&gt; TB care and prevention -&gt; Case detection and diagnosis (TB care and prevention)</narrative>
        </description>
      </budget-item>
      <budget-item code="2695e028-456c-4ded-83a4-ded520ff9d79" percentage="0.07">
        <description>
          <narrative>Tuberculosis -&gt; TB care and prevention -&gt; Community TB care delivery</narrative>
        </description>
      </budget-item>
      <budget-item code="e5d69248-af9e-44de-a99d-c2557c675f55" percentage="0.25">
        <description>
          <narrative>Tuberculosis -&gt; TB care and prevention -&gt; Engaging all care providers (TB care and prevention)</narrative>
        </description>
      </budget-item>
      <budget-item code="3ec9daf3-963a-4853-8e5f-65867d3e7630" percentage="0.48">
        <description>
          <narrative>Tuberculosis -&gt; TB care and prevention -&gt; Prevention (TB care and prevention)</narrative>
        </description>
      </budget-item>
      <budget-item code="2b47e4dd-6430-4bc5-829c-127bb93a72a8" percentage="0">
        <description>
          <narrative>Tuberculosis -&gt; TB care and prevention -&gt; Treatment (TB care and prevention)</narrative>
        </description>
      </budget-item>
      <budget-item code="3844a48b-ee6f-484c-866d-4d19de42ce72" percentage="12.72">
        <description>
          <narrative>Tuberculosis -&gt; TB/HIV -&gt; Community TB/HIV care delivery</narrative>
        </description>
      </budget-item>
      <budget-item code="f9ff8a94-1fc1-4acf-863f-a191df107ee9" percentage="0.14">
        <description>
          <narrative>Tuberculosis -&gt; TB/HIV -&gt; Engaging all care providers (TB/HIV)</narrative>
        </description>
      </budget-item>
      <budget-item code="d5851297-913c-4ce3-a373-c0915334727a" percentage="0.43">
        <description>
          <narrative>Tuberculosis -&gt; TB/HIV -&gt; TB/HIV - Prevention</narrative>
        </description>
      </budget-item>
      <budget-item code="31f7c6af-8b6f-4289-90f3-c6f20f232eb7" percentage="0.41">
        <description>
          <narrative>Tuberculosis -&gt; TB/HIV -&gt; TB/HIV - Screening, testing and diagnosis</narrative>
        </description>
      </budget-item>
    </country-budget-items>
    <collaboration-type code="1" />
    <default-flow-type code="10" />
    <default-finance-type code="110" />
    <default-aid-type code="C01" vocabulary="1" />
    <default-tied-status code="5" />
    <budget type="2" status="2">
      <period-start iso-date="2022-01-01" />
      <period-end iso-date="2022-12-31" />
      <value currency="USD" value-date="2022-01-01">27369090.42</value>
    </budget>
    <budget type="2" status="2">
      <period-start iso-date="2023-01-01" />
      <period-end iso-date="2023-12-31" />
      <value currency="USD" value-date="2023-01-01">80764824.59</value>
    </budget>
    <budget type="2" status="2">
      <period-start iso-date="2024-01-01" />
      <period-end iso-date="2024-12-31" />
      <value currency="USD" value-date="2024-01-01">177676544.98</value>
    </budget>
    <budget type="2" status="2">
      <period-start iso-date="2025-01-01" />
      <period-end iso-date="2025-12-31" />
      <value currency="USD" value-date="2025-01-01">99197719.66</value>
    </budget>
    <capital-spend percentage="12.64" />
    <transaction ref="39dc4de7-d4e5-46a8-b2c8-55deef2050ab">
      <transaction-type code="2" />
      <transaction-date iso-date="2022-07-11" />
      <value currency="USD" value-date="2022-07-11">119390576.00</value>
      <description>
        <narrative>Global Fund commitment to ZAF-C-NDOHP03.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="10">
        <narrative>National Department of Health of the Republic of South Africa</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="67a120c3-9155-47be-b16c-e579e77f48a5">
      <transaction-type code="3" />
      <transaction-date iso-date="2022-07-14" />
      <value currency="USD" value-date="2022-07-14">3341293.00</value>
      <description>
        <narrative>Global Fund disbursement to ZAF-C-NDOHP03 (Government).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="10">
        <narrative>National Department of Health of the Republic of South Africa</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="3e51f6c6-1f86-4301-9267-7cfca107da3b">
      <transaction-type code="3" />
      <transaction-date iso-date="2022-08-25" />
      <value currency="USD" value-date="2022-08-25">2787881.00</value>
      <description>
        <narrative>Global Fund disbursement to ZAF-C-NDOHP03 (Government).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="10">
        <narrative>National Department of Health of the Republic of South Africa</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="5e3a45ab-a0cc-400a-a7b7-88c7902398fb">
      <transaction-type code="3" />
      <transaction-date iso-date="2022-08-25" />
      <value currency="USD" value-date="2022-08-25">1494778.00</value>
      <description>
        <narrative>Global Fund disbursement to ZAF-C-NDOHP03 (Government).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="10">
        <narrative>National Department of Health of the Republic of South Africa</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="c4e02ed4-b465-4521-80c6-13a0e2288f0f">
      <transaction-type code="3" />
      <transaction-date iso-date="2022-08-25" />
      <value currency="USD" value-date="2022-08-25">987226.00</value>
      <description>
        <narrative>Global Fund disbursement to ZAF-C-NDOHP03 (Government).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="10">
        <narrative>National Department of Health of the Republic of South Africa</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="c4a3a7e0-f76f-4965-8687-f9d4b64d1777">
      <transaction-type code="3" />
      <transaction-date iso-date="2022-09-22" />
      <value currency="USD" value-date="2022-09-22">354235.00</value>
      <description>
        <narrative>Global Fund disbursement to ZAF-C-NDOHP03 (Government).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="10">
        <narrative>National Department of Health of the Republic of South Africa</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="757c1cc8-7ef7-4d15-9ce5-b39ae66333d8">
      <transaction-type code="2" />
      <transaction-date iso-date="2022-09-24" />
      <value currency="USD" value-date="2022-09-24">2151479.20</value>
      <description>
        <narrative>Global Fund commitment to ZAF-C-NDOHP03.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="10">
        <narrative>National Department of Health of the Republic of South Africa</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="17a685da-2b5c-4e63-a863-e73c72b67c3e">
      <transaction-type code="3" />
      <transaction-date iso-date="2022-12-01" />
      <value currency="USD" value-date="2022-12-01">1253961.12</value>
      <description>
        <narrative>Global Fund disbursement to ZAF-C-NDOHP03 (Government).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="10">
        <narrative>National Department of Health of the Republic of South Africa</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="24ea466e-bdc1-48d9-8ba3-613a3e1ef70e">
      <transaction-type code="3" />
      <transaction-date iso-date="2022-12-01" />
      <value currency="USD" value-date="2022-12-01">10258154.38</value>
      <description>
        <narrative>Global Fund disbursement to ZAF-C-NDOHP03 (Government).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="10">
        <narrative>National Department of Health of the Republic of South Africa</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="64d45418-37a5-4d64-afd3-6b9833e9733c">
      <transaction-type code="3" />
      <transaction-date iso-date="2022-12-01" />
      <value currency="USD" value-date="2022-12-01">32013.32</value>
      <description>
        <narrative>Global Fund disbursement to ZAF-C-NDOHP03 (Government).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="10">
        <narrative>National Department of Health of the Republic of South Africa</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="80e77f5f-83db-4cc1-b713-0db578d62b72">
      <transaction-type code="3" />
      <transaction-date iso-date="2022-12-01" />
      <value currency="USD" value-date="2022-12-01">2086986.29</value>
      <description>
        <narrative>Global Fund disbursement to ZAF-C-NDOHP03 (Pooled Procurement Mechanism).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="10">
        <narrative>National Department of Health of the Republic of South Africa</narrative>
      </receiver-org>
      <disbursement-channel code="3" />
    </transaction>
    <transaction ref="82652e39-fe22-4fea-bae0-95fb1514d066">
      <transaction-type code="3" />
      <transaction-date iso-date="2022-12-01" />
      <value currency="USD" value-date="2022-12-01">47383.44</value>
      <description>
        <narrative>Global Fund disbursement to ZAF-C-NDOHP03 (Government).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="10">
        <narrative>National Department of Health of the Republic of South Africa</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="d4189b19-eb9a-4a02-b489-6c973ba17676">
      <transaction-type code="3" />
      <transaction-date iso-date="2022-12-01" />
      <value currency="USD" value-date="2022-12-01">12989222.17</value>
      <description>
        <narrative>Global Fund disbursement to ZAF-C-NDOHP03 (Government).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="10">
        <narrative>National Department of Health of the Republic of South Africa</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="a9dd711f-8a91-495a-8a5b-15d1da69294c">
      <transaction-type code="3" />
      <transaction-date iso-date="2022-12-20" />
      <value currency="USD" value-date="2022-12-20">2440804.84</value>
      <description>
        <narrative>Global Fund disbursement to ZAF-C-NDOHP03 (Government).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="10">
        <narrative>National Department of Health of the Republic of South Africa</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="9d8f032a-e991-4d9b-9999-8c4da6d8200e">
      <transaction-type code="2" />
      <transaction-date iso-date="2023-02-01" />
      <value currency="USD" value-date="2023-02-01">-64492.91</value>
      <description>
        <narrative>Global Fund commitment to ZAF-C-NDOHP03.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="10">
        <narrative>National Department of Health of the Republic of South Africa</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="0dd8077a-2684-4c59-b7f5-b860f4a0a7e5">
      <transaction-type code="3" />
      <transaction-date iso-date="2023-04-20" />
      <value currency="USD" value-date="2023-04-20">9064633.02</value>
      <description>
        <narrative>Global Fund disbursement to ZAF-C-NDOHP03 (Government).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="10">
        <narrative>National Department of Health of the Republic of South Africa</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="557c2c9a-92e4-416a-8756-c051d17b224c">
      <transaction-type code="3" />
      <transaction-date iso-date="2023-04-20" />
      <value currency="USD" value-date="2023-04-20">36166653.37</value>
      <description>
        <narrative>Global Fund disbursement to ZAF-C-NDOHP03 (Government).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="10">
        <narrative>National Department of Health of the Republic of South Africa</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="6fb7e532-c194-4cbf-94fe-fbb6ea1ad45e">
      <transaction-type code="3" />
      <transaction-date iso-date="2023-10-26" />
      <value currency="USD" value-date="2023-10-26">5627797.99</value>
      <description>
        <narrative>Global Fund disbursement to ZAF-C-NDOHP03 (Government).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="10">
        <narrative>National Department of Health of the Republic of South Africa</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="fdf72cd2-dcbf-46a6-81f4-75f18befeaef">
      <transaction-type code="3" />
      <transaction-date iso-date="2023-10-26" />
      <value currency="USD" value-date="2023-10-26">32544539.35</value>
      <description>
        <narrative>Global Fund disbursement to ZAF-C-NDOHP03 (Government).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="10">
        <narrative>National Department of Health of the Republic of South Africa</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="06c815de-60e0-4a03-af8e-4f37ecf30c87">
      <transaction-type code="2" />
      <transaction-date iso-date="2024-03-21" />
      <value currency="USD" value-date="2024-03-21">50000.00</value>
      <description>
        <narrative>Global Fund commitment to ZAF-C-NDOHP03.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="10">
        <narrative>National Department of Health of the Republic of South Africa</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="94daefee-2c35-486c-bed0-1ece170babda">
      <transaction-type code="3" />
      <transaction-date iso-date="2024-04-11" />
      <value currency="USD" value-date="2024-04-11">50000.00</value>
      <description>
        <narrative>Global Fund disbursement to ZAF-C-NDOHP03 (Other 3rd Party).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="10">
        <narrative>National Department of Health of the Republic of South Africa</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="bc655b28-3f6d-4975-9e33-73b2a9edeec3">
      <transaction-type code="2" />
      <transaction-date iso-date="2024-06-06" />
      <value currency="USD" value-date="2024-06-06">178757615.98</value>
      <description>
        <narrative>Global Fund commitment to ZAF-C-NDOHP03.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="10">
        <narrative>National Department of Health of the Republic of South Africa</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="2438494a-bb16-4d8a-a499-19dec11bf6a9">
      <transaction-type code="3" />
      <transaction-date iso-date="2024-06-11" />
      <value currency="USD" value-date="2024-06-11">29755298.60</value>
      <description>
        <narrative>Global Fund disbursement to ZAF-C-NDOHP03 (Government).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="10">
        <narrative>National Department of Health of the Republic of South Africa</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="2602493f-3315-427e-af20-0f6ad9b2c597">
      <transaction-type code="3" />
      <transaction-date iso-date="2024-09-17" />
      <value currency="USD" value-date="2024-09-17">22629798.35</value>
      <description>
        <narrative>Global Fund disbursement to ZAF-C-NDOHP03 (Government).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="10">
        <narrative>National Department of Health of the Republic of South Africa</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="a6364576-715b-462b-a84a-54a4b5f40153">
      <transaction-type code="3" />
      <transaction-date iso-date="2024-12-31" />
      <value currency="USD" value-date="2024-12-31">9512036.36</value>
      <description>
        <narrative>Global Fund disbursement to ZAF-C-NDOHP03 (Government).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="10">
        <narrative>National Department of Health of the Republic of South Africa</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="ce6d139b-abeb-4f36-8413-b9f983dd773d">
      <transaction-type code="3" />
      <transaction-date iso-date="2024-12-31" />
      <value currency="USD" value-date="2024-12-31">17466735.00</value>
      <description>
        <narrative>Global Fund disbursement to ZAF-C-NDOHP03 (Government).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="10">
        <narrative>National Department of Health of the Republic of South Africa</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="aaebb661-0010-4625-b3bb-07a0b67d1395">
      <transaction-type code="7" />
      <transaction-date iso-date="2025-05-01" />
      <value currency="USD" value-date="2025-05-01">147331.70</value>
      <description>
        <narrative>Funds returned to the Global Fund from ZAF-C-NDOHP03 (Government).</narrative>
      </description>
      <provider-org type="10">
        <narrative>National Department of Health of the Republic of South Africa</narrative>
      </provider-org>
      <receiver-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="6130cc54-7bd7-4a39-923e-5668d99e2408">
      <transaction-type code="2" />
      <transaction-date iso-date="2025-05-02" />
      <value currency="USD" value-date="2025-05-02">-147331.70</value>
      <description>
        <narrative>Global Fund commitment to ZAF-C-NDOHP03.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="10">
        <narrative>National Department of Health of the Republic of South Africa</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="2a9f9cbc-c565-4ad2-ae9c-76752792f334">
      <transaction-type code="2" />
      <transaction-date iso-date="2025-10-03" />
      <value currency="USD" value-date="2025-10-03">88194390.00</value>
      <description>
        <narrative>Global Fund commitment to ZAF-C-NDOHP03.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="10">
        <narrative>National Department of Health of the Republic of South Africa</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="5fdc0e35-3797-4148-858c-9e07c7af9573">
      <transaction-type code="2" />
      <transaction-date iso-date="2025-10-03" />
      <value currency="USD" value-date="2025-10-03">-56705855.45</value>
      <description>
        <narrative>Global Fund commitment to ZAF-C-NDOHP03.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="10">
        <narrative>National Department of Health of the Republic of South Africa</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="53bda657-7228-4f62-9d53-2ffa4a4d4d10">
      <transaction-type code="3" />
      <transaction-date iso-date="2025-10-07" />
      <value currency="USD" value-date="2025-10-07">34356358.96</value>
      <description>
        <narrative>Global Fund disbursement to ZAF-C-NDOHP03 (Government).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="10">
        <narrative>National Department of Health of the Republic of South Africa</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="1c0f167a-c072-409d-bf59-034d668a0210">
      <transaction-type code="3" />
      <transaction-date iso-date="2025-12-01" />
      <value currency="USD" value-date="2025-12-01">1013953.22</value>
      <description>
        <narrative>Global Fund disbursement to ZAF-C-NDOHP03 (Government).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="10">
        <narrative>National Department of Health of the Republic of South Africa</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="4c4b8ec3-bfdb-4b21-903a-b048596085a9">
      <transaction-type code="3" />
      <transaction-date iso-date="2025-12-01" />
      <value currency="USD" value-date="2025-12-01">18822912.55</value>
      <description>
        <narrative>Global Fund disbursement to ZAF-C-NDOHP03 (Government).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="10">
        <narrative>National Department of Health of the Republic of South Africa</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="8a715fac-a1a4-4320-8200-9765b303e1bf">
      <transaction-type code="3" />
      <transaction-date iso-date="2025-12-01" />
      <value currency="USD" value-date="2025-12-01">22851026.45</value>
      <description>
        <narrative>Global Fund disbursement to ZAF-C-NDOHP03 (Government).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="10">
        <narrative>National Department of Health of the Republic of South Africa</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="118a4734-cfeb-4309-a7cb-a3a8b196792c">
      <transaction-type code="7" />
      <transaction-date iso-date="2026-04-17" />
      <value currency="USD" value-date="2026-04-17">2294878.75</value>
      <description>
        <narrative>Funds returned to the Global Fund from ZAF-C-NDOHP03 (Government).</narrative>
      </description>
      <provider-org type="10">
        <narrative>National Department of Health of the Republic of South Africa</narrative>
      </provider-org>
      <receiver-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="4333222c-20c7-48e7-97e4-482ff22d302c">
      <transaction-type code="2" />
      <transaction-date iso-date="2026-04-24" />
      <value currency="USD" value-date="2026-04-24">-2294878.75</value>
      <description>
        <narrative>Global Fund commitment to ZAF-C-NDOHP03.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="10">
        <narrative>National Department of Health of the Republic of South Africa</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="53428341-7ee3-48f0-ba4d-0b5f1c9ee461">
      <transaction-type code="7" />
      <transaction-date iso-date="2026-07-10" />
      <value currency="USD" value-date="2026-07-10">121772.43</value>
      <description>
        <narrative>Funds returned to the Global Fund from ZAF-C-NDOHP03 (Government).</narrative>
      </description>
      <provider-org type="10">
        <narrative>National Department of Health of the Republic of South Africa</narrative>
      </provider-org>
      <receiver-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="4e8dde4a-3784-4a36-886a-2ecfd5e2d56d">
      <transaction-type code="2" />
      <transaction-date iso-date="2026-07-15" />
      <value currency="USD" value-date="2026-07-15">-121772.43</value>
      <description>
        <narrative>Global Fund commitment to ZAF-C-NDOHP03.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="10">
        <narrative>National Department of Health of the Republic of South Africa</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="aaffa4fa-1a78-4924-89eb-08afe87b0909">
      <transaction-type code="2" />
      <transaction-date iso-date="2026-09-23" />
      <value currency="USD" value-date="2026-09-23">10842684.68</value>
      <description>
        <narrative>Global Fund commitment to ZAF-C-NDOHP03.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="10">
        <narrative>National Department of Health of the Republic of South Africa</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="d76f4c8c-b94f-408f-ba13-8280929b4a82">
      <transaction-type code="2" />
      <transaction-date iso-date="2026-09-23" />
      <value currency="USD" value-date="2026-09-23">-53838031.04</value>
      <description>
        <narrative>Global Fund commitment to ZAF-C-NDOHP03.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="10">
        <narrative>National Department of Health of the Republic of South Africa</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="8434f638-c4c1-4459-bc57-d6ef444e09ed">
      <transaction-type code="3" />
      <transaction-date iso-date="2026-09-29" />
      <value currency="USD" value-date="2026-09-29">10842684.68</value>
      <description>
        <narrative>Global Fund disbursement to ZAF-C-NDOHP03 (Government).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="10">
        <narrative>National Department of Health of the Republic of South Africa</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="1389beeb-7b80-429d-b182-8c315128603c">
      <transaction-type code="7" />
      <transaction-date iso-date="2026-11-01" />
      <value currency="USD" value-date="2026-11-01">297451.16</value>
      <description>
        <narrative>Funds returned to the Global Fund from ZAF-C-NDOHP03 (Government).</narrative>
      </description>
      <provider-org type="10">
        <narrative>National Department of Health of the Republic of South Africa</narrative>
      </provider-org>
      <receiver-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="683f5d9d-28c1-48df-9701-830f0b6050f1">
      <transaction-type code="2" />
      <transaction-date iso-date="2026-11-06" />
      <value currency="USD" value-date="2026-11-06">-297451.16</value>
      <description>
        <narrative>Global Fund commitment to ZAF-C-NDOHP03.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="10">
        <narrative>National Department of Health of the Republic of South Africa</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="ZAF-C-NDOHP03-EXP-20230331">
      <transaction-type code="4" />
      <transaction-date iso-date="2023-03-31" />
      <value currency="USD" value-date="2023-03-31">59526742.92</value>
      <description>
        <narrative>Expenditure reported by National Department of Health of the Republic of South Africa for ZAF-C-NDOHP03, Apr 2022 to Mar 2023.</narrative>
      </description>
      <provider-org type="10">
        <narrative>National Department of Health of the Republic of South Africa</narrative>
      </provider-org>
    </transaction>
    <transaction ref="ZAF-C-NDOHP03-EXP-20240331">
      <transaction-type code="4" />
      <transaction-date iso-date="2024-03-31" />
      <value currency="USD" value-date="2024-03-31">74126910.64</value>
      <description>
        <narrative>Expenditure reported by National Department of Health of the Republic of South Africa for ZAF-C-NDOHP03, Apr 2023 to Mar 2024.</narrative>
      </description>
      <provider-org type="10">
        <narrative>National Department of Health of the Republic of South Africa</narrative>
      </provider-org>
    </transaction>
    <document-link url="https://data.theglobalfund.org/grant/ZAF-C-NDOH" format="text/html">
      <title>
        <narrative>Grant page on the data explorer of the Global Fund.</narrative>
      </title>
      <description>
        <narrative>An overview of a grant over its lifetime.</narrative>
      </description>
      <category code="A12" />
      <category code="A01" />
      <category code="A02" />
      <category code="A05" />
      <category code="A07" />
      <category code="A08" />
      <language code="en" />
      <document-date iso-date="2026-11-11" />
    </document-link>
    <document-link url="https://www.theglobalfund.org/media/13342/core_grantregulationsversiontwo_regulations_en.pdf" format="application/pdf">
      <title>
        <narrative>Grant terms and conditions.</narrative>
      </title>
      <description>
        <narrative>General terms and conditions which apply to Global Fund grants.</narrative>
      </description>
      <category code="A04" />
      <language code="en" />
    </document-link>
    <document-link url="https://docs.theglobalfund.org/files/Applications/Funding Requests/ZAF/2021/TB_HIV/en/ZAF-C_FundingRequest_1_en.zip" format="application/zip">
      <title>
        <narrative>2021 - Funding Request - Window 6 - TB/HIV - South Africa - English</narrative>
      </title>
      <description>
        <narrative>Funding Request of funding request FR1042-ZAF-C.</narrative>
      </description>
      <category code="A01" />
      <category code="A02" />
      <category code="A08" />
      <language code="en" />
      <document-date iso-date="2021-09-10" />
    </document-link>
    <result type="1" aggregation-status="0">
      <title>
        <narrative>Number of PSA plants installed with Global Fund investments and functional</narrative>
      </title>
      <indicator measure="5" aggregation-status="0">
        <title>
          <narrative>Number of PSA plants installed with Global Fund investments and functional</narrative>
        </title>
        <description>
          <narrative>Geographic coverage: National. Aggregation: Non cumulative - other.</narrative>
        </description>
        <baseline year="2023" iso-date="2023-12-31">
          <comment>
            <narrative>Numerator: 0; Denominator: 0; Percentage: 0%.</narrative>
          </comment>
        </baseline>
        <period>
          <period-start iso-date="2025-04-01" />
          <period-end iso-date="2025-12-31" />
          <target>
            <comment>
              <narrative>Numerator: 62.</narrative>
            </comment>
          </target>
        </period>
        <period>
          <period-start iso-date="2025-10-01" />
          <period-end iso-date="2025-12-31" />
          <actual>
            <comment>
              <narrative>Numerator: 0.</narrative>
            </comment>
          </actual>
        </period>
      </indicator>
    </result>
    <result type="1" aggregation-status="0">
      <title>
        <narrative>Percentage of service delivery reports from community health units integrated/interoperable with the national HMIS</narrative>
      </title>
      <indicator measure="2" aggregation-status="0">
        <title>
          <narrative>Percentage of service delivery reports from community health units integrated/interoperable with the national HMIS</narrative>
        </title>
        <description>
          <narrative>Geographic coverage: National. Aggregation: Non cumulative.</narrative>
        </description>
        <baseline year="2023" iso-date="2023-12-31" value="100">
          <comment>
            <narrative>Numerator: 42; Denominator: 42.</narrative>
          </comment>
        </baseline>
        <period>
          <period-start iso-date="2023-07-01" />
          <period-end iso-date="2024-03-31" />
          <target value="100">
            <comment>
              <narrative>Numerator: 71; Denominator: 71.</narrative>
            </comment>
          </target>
        </period>
        <period>
          <period-start iso-date="2024-04-01" />
          <period-end iso-date="2024-09-30" />
          <target value="100">
            <comment>
              <narrative>Numerator: 71; Denominator: 71.</narrative>
            </comment>
          </target>
        </period>
        <period>
          <period-start iso-date="2024-10-01" />
          <period-end iso-date="2025-03-31" />
          <target value="100">
            <comment>
              <narrative>Numerator: 42; Denominator: 42.</narrative>
            </comment>
          </target>
          <actual value="97.62">
            <comment>
              <narrative>Numerator: 41; Denominator: 42.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2025-04-01" />
          <period-end iso-date="2025-12-31" />
          <target value="100">
            <comment>
              <narrative>Numerator: 46; Denominator: 46.</narrative>
            </comment>
          </target>
        </period>
        <period>
          <period-start iso-date="2025-10-01" />
          <period-end iso-date="2025-12-31" />
          <actual value="97.62">
            <comment>
              <narrative>Numerator: 41; Denominator: 42.</narrative>
            </comment>
          </actual>
        </period>
      </indicator>
    </result>
    <result type="1" aggregation-status="0">
      <title>
        <narrative>Number of TB cases with RR-TB and/or MDR-TB notified</narrative>
      </title>
      <description>
        <narrative>Module: MDR-TB.</narrative>
      </description>
      <indicator measure="1" aggregation-status="0">
        <title>
          <narrative>Number of TB cases with RR-TB and/or MDR-TB notified</narrative>
        </title>
        <description>
          <narrative>Geographic coverage: Subnational, less than 100% national program target. Aggregation: Non cumulative.</narrative>
        </description>
        <baseline year="2020" iso-date="2020-12-31" value="4647" />
        <period>
          <period-start iso-date="2022-04-01" />
          <period-end iso-date="2022-09-30" />
          <target value="2334" />
          <actual value="2238" />
        </period>
        <period>
          <period-start iso-date="2022-04-01" />
          <period-end iso-date="2023-03-31" />
          <target value="4669" />
          <actual value="4104" />
        </period>
        <period>
          <period-start iso-date="2022-10-01" />
          <period-end iso-date="2023-03-31" />
          <target value="2335" />
          <actual value="1866" />
        </period>
        <period>
          <period-start iso-date="2023-04-01" />
          <period-end iso-date="2023-09-30" />
          <target value="2401" />
          <actual value="1729" />
        </period>
        <period>
          <period-start iso-date="2023-04-01" />
          <period-end iso-date="2024-03-31" />
          <target value="4802" />
          <actual value="3942" />
        </period>
        <period>
          <period-start iso-date="2023-10-01" />
          <period-end iso-date="2024-03-31" />
          <target value="2401" />
          <actual value="2213" />
        </period>
        <period>
          <period-start iso-date="2024-04-01" />
          <period-end iso-date="2025-03-31" />
          <target value="5016" />
          <actual value="4199" />
        </period>
        <period>
          <period-start iso-date="2024-04-01" />
          <period-end iso-date="2024-09-30" />
          <target value="2508" />
        </period>
        <period>
          <period-start iso-date="2024-10-01" />
          <period-end iso-date="2025-03-31" />
          <target value="2508" />
          <actual value="2036" />
        </period>
        <period>
          <period-start iso-date="2025-04-01" />
          <period-end iso-date="2025-09-30" />
          <target value="2363" />
          <actual value="1918" />
        </period>
      </indicator>
    </result>
    <result type="1" aggregation-status="0">
      <title>
        <narrative>Number of cases with RR-TB and/or MDR-TB that began second-line treatment</narrative>
      </title>
      <description>
        <narrative>Module: MDR-TB.</narrative>
      </description>
      <indicator measure="5" aggregation-status="0">
        <title>
          <narrative>Number of cases with RR-TB and/or MDR-TB that began second-line treatment</narrative>
        </title>
        <description>
          <narrative>Geographic coverage: Subnational, less than 100% national program target. Aggregation: Non cumulative.</narrative>
        </description>
        <baseline year="2020" iso-date="2020-12-31">
          <comment>
            <narrative>Numerator: 3457.</narrative>
          </comment>
        </baseline>
        <baseline year="2020" iso-date="2020-12-31">
          <dimension name="Age" value="15+" />
          <comment>
            <narrative>Numerator: 3518; Denominator: 3635; Percentage: 96.78%.</narrative>
          </comment>
        </baseline>
        <baseline year="2020" iso-date="2020-12-31">
          <dimension name="Age" value="15+" />
          <comment>
            <narrative>Numerator: 3518; Denominator: 3635; Percentage: 96.78%.</narrative>
          </comment>
        </baseline>
        <baseline year="2020" iso-date="2020-12-31">
          <dimension name="Age" value="15+" />
          <comment>
            <narrative>Numerator: 3518; Denominator: 3635; Percentage: 96.78%.</narrative>
          </comment>
        </baseline>
        <baseline year="2020" iso-date="2020-12-31">
          <dimension name="Age" value="15+" />
          <comment>
            <narrative>Numerator: 3518; Denominator: 3635; Percentage: 96.78%.</narrative>
          </comment>
        </baseline>
        <baseline year="2020" iso-date="2020-12-31">
          <dimension name="Age" value="15+" />
          <comment>
            <narrative>Numerator: 3518; Denominator: 3635; Percentage: 96.78%.</narrative>
          </comment>
        </baseline>
        <baseline year="2020" iso-date="2020-12-31">
          <dimension name="Age" value="15+" />
          <comment>
            <narrative>Numerator: 3518; Denominator: 3635; Percentage: 96.78%.</narrative>
          </comment>
        </baseline>
        <baseline year="2020" iso-date="2020-12-31">
          <dimension name="Age" value="&lt;15" />
          <comment>
            <narrative>Numerator: 117; Denominator: 3635; Percentage: 3.22%.</narrative>
          </comment>
        </baseline>
        <baseline year="2020" iso-date="2020-12-31">
          <dimension name="Age" value="&lt;15" />
          <comment>
            <narrative>Numerator: 117; Denominator: 3635; Percentage: 3.22%.</narrative>
          </comment>
        </baseline>
        <baseline year="2020" iso-date="2020-12-31">
          <dimension name="Age" value="&lt;15" />
          <comment>
            <narrative>Numerator: 117; Denominator: 3635; Percentage: 3.22%.</narrative>
          </comment>
        </baseline>
        <baseline year="2020" iso-date="2020-12-31">
          <dimension name="Age" value="&lt;15" />
          <comment>
            <narrative>Numerator: 117; Denominator: 3635; Percentage: 3.22%.</narrative>
          </comment>
        </baseline>
        <baseline year="2020" iso-date="2020-12-31">
          <dimension name="Age" value="&lt;15" />
          <comment>
            <narrative>Numerator: 117; Denominator: 3635; Percentage: 3.22%.</narrative>
          </comment>
        </baseline>
        <baseline year="2020" iso-date="2020-12-31">
          <dimension name="Age" value="&lt;15" />
          <comment>
            <narrative>Numerator: 117; Denominator: 3635; Percentage: 3.22%.</narrative>
          </comment>
        </baseline>
        <baseline year="2020" iso-date="2020-12-31">
          <dimension name="Gender" value="Female" />
          <comment>
            <narrative>Numerator: 1488; Denominator: 3635; Percentage: 40.94%.</narrative>
          </comment>
        </baseline>
        <baseline year="2020" iso-date="2020-12-31">
          <dimension name="Gender" value="Female" />
          <comment>
            <narrative>Numerator: 1488; Denominator: 3635; Percentage: 40.94%.</narrative>
          </comment>
        </baseline>
        <baseline year="2020" iso-date="2020-12-31">
          <dimension name="Gender" value="Female" />
          <comment>
            <narrative>Numerator: 1488; Denominator: 3635; Percentage: 40.94%.</narrative>
          </comment>
        </baseline>
        <baseline year="2020" iso-date="2020-12-31">
          <dimension name="Gender" value="Female" />
          <comment>
            <narrative>Numerator: 1488; Denominator: 3635; Percentage: 40.94%.</narrative>
          </comment>
        </baseline>
        <baseline year="2020" iso-date="2020-12-31">
          <dimension name="Gender" value="Female" />
          <comment>
            <narrative>Numerator: 1488; Denominator: 3635; Percentage: 40.94%.</narrative>
          </comment>
        </baseline>
        <baseline year="2020" iso-date="2020-12-31">
          <dimension name="Gender" value="Female" />
          <comment>
            <narrative>Numerator: 1488; Denominator: 3635; Percentage: 40.94%.</narrative>
          </comment>
        </baseline>
        <baseline year="2020" iso-date="2020-12-31">
          <dimension name="Gender" value="Male" />
          <comment>
            <narrative>Numerator: 2147; Denominator: 3635; Percentage: 59.06%.</narrative>
          </comment>
        </baseline>
        <baseline year="2020" iso-date="2020-12-31">
          <dimension name="Gender" value="Male" />
          <comment>
            <narrative>Numerator: 2147; Denominator: 3635; Percentage: 59.06%.</narrative>
          </comment>
        </baseline>
        <baseline year="2020" iso-date="2020-12-31">
          <dimension name="Gender" value="Male" />
          <comment>
            <narrative>Numerator: 2147; Denominator: 3635; Percentage: 59.06%.</narrative>
          </comment>
        </baseline>
        <baseline year="2020" iso-date="2020-12-31">
          <dimension name="Gender" value="Male" />
          <comment>
            <narrative>Numerator: 2147; Denominator: 3635; Percentage: 59.06%.</narrative>
          </comment>
        </baseline>
        <baseline year="2020" iso-date="2020-12-31">
          <dimension name="Gender" value="Male" />
          <comment>
            <narrative>Numerator: 2147; Denominator: 3635; Percentage: 59.06%.</narrative>
          </comment>
        </baseline>
        <baseline year="2020" iso-date="2020-12-31">
          <dimension name="Gender" value="Male" />
          <comment>
            <narrative>Numerator: 2147; Denominator: 3635; Percentage: 59.06%.</narrative>
          </comment>
        </baseline>
        <baseline year="2020" iso-date="2020-12-31">
          <dimension name="TB regimen" value="New TB drugs" />
          <comment>
            <narrative>Numerator: 3486; Denominator: 3635; Percentage: 95.9%.</narrative>
          </comment>
        </baseline>
        <baseline year="2020" iso-date="2020-12-31">
          <dimension name="TB regimen" value="New TB drugs" />
          <comment>
            <narrative>Numerator: 3486; Denominator: 3635; Percentage: 95.9%.</narrative>
          </comment>
        </baseline>
        <baseline year="2020" iso-date="2020-12-31">
          <dimension name="TB regimen" value="New TB drugs" />
          <comment>
            <narrative>Numerator: 3486; Denominator: 3635; Percentage: 95.9%.</narrative>
          </comment>
        </baseline>
        <baseline year="2020" iso-date="2020-12-31">
          <dimension name="TB regimen" value="New TB drugs" />
          <comment>
            <narrative>Numerator: 3486; Denominator: 3635; Percentage: 95.9%.</narrative>
          </comment>
        </baseline>
        <baseline year="2020" iso-date="2020-12-31">
          <dimension name="TB regimen" value="New TB drugs" />
          <comment>
            <narrative>Numerator: 3486; Denominator: 3635; Percentage: 95.9%.</narrative>
          </comment>
        </baseline>
        <baseline year="2020" iso-date="2020-12-31">
          <dimension name="TB regimen" value="Short regimens" />
          <comment>
            <narrative>Numerator: 2235; Denominator: 3635; Percentage: 61.49%.</narrative>
          </comment>
        </baseline>
        <baseline year="2020" iso-date="2020-12-31">
          <dimension name="TB regimen" value="Short regimens" />
          <comment>
            <narrative>Numerator: 2235; Denominator: 3635; Percentage: 61.49%.</narrative>
          </comment>
        </baseline>
        <baseline year="2020" iso-date="2020-12-31">
          <dimension name="TB regimen" value="Short regimens" />
          <comment>
            <narrative>Numerator: 2235; Denominator: 3635; Percentage: 61.49%.</narrative>
          </comment>
        </baseline>
        <baseline year="2020" iso-date="2020-12-31">
          <dimension name="TB regimen" value="Short regimens" />
          <comment>
            <narrative>Numerator: 2235; Denominator: 3635; Percentage: 61.49%.</narrative>
          </comment>
        </baseline>
        <baseline year="2020" iso-date="2020-12-31">
          <dimension name="TB regimen" value="Short regimens" />
          <comment>
            <narrative>Numerator: 2235; Denominator: 3635; Percentage: 61.49%.</narrative>
          </comment>
        </baseline>
        <baseline year="2020" iso-date="2020-12-31">
          <dimension name="TB regimen" value="Short regimens" />
          <comment>
            <narrative>Numerator: 2235; Denominator: 3635; Percentage: 61.49%.</narrative>
          </comment>
        </baseline>
        <period>
          <period-start iso-date="2022-04-01" />
          <period-end iso-date="2022-09-30" />
          <target>
            <comment>
              <narrative>Numerator: 2101.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 1798.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Age" value="15+" />
            <comment>
              <narrative>Numerator: 1748; Denominator: 1798; Percentage: 97.22%.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Age" value="&lt;15" />
            <comment>
              <narrative>Numerator: 50; Denominator: 1799; Percentage: 2.78%.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Gender" value="Female" />
            <comment>
              <narrative>Numerator: 752; Denominator: 1798; Percentage: 41.82%.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Gender" value="Male" />
            <comment>
              <narrative>Numerator: 1046; Denominator: 1798; Percentage: 58.18%.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="TB regimen" value="Short regimens" />
            <comment>
              <narrative>Numerator: 1193; Denominator: 1799; Percentage: 66.31%.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2022-04-01" />
          <period-end iso-date="2023-03-31" />
          <target>
            <comment>
              <narrative>Numerator: 4203.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 3230.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2022-10-01" />
          <period-end iso-date="2023-03-31" />
          <target>
            <comment>
              <narrative>Numerator: 2102.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 1432.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Age" value="15+" />
            <comment>
              <narrative>Numerator: 1388.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Age" value="&lt;15" />
            <comment>
              <narrative>Numerator: 44.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Gender" value="Female" />
            <comment>
              <narrative>Numerator: 587.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Gender" value="Male" />
            <comment>
              <narrative>Numerator: 845.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="TB regimen" value="New TB drugs" />
            <comment>
              <narrative>Numerator: 1296.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="TB regimen" value="Short regimens" />
            <comment>
              <narrative>Numerator: 811.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2023-04-01" />
          <period-end iso-date="2023-09-30" />
          <target>
            <comment>
              <narrative>Numerator: 2160.9.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 1423.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Age" value="15+" />
            <comment>
              <narrative>Numerator: 1378.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Age" value="&lt;15" />
            <comment>
              <narrative>Numerator: 43.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Gender" value="Female" />
            <comment>
              <narrative>Numerator: 578.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Gender" value="Male" />
            <comment>
              <narrative>Numerator: 843.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="TB regimen" value="Short regimens" />
            <comment>
              <narrative>Numerator: 803.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2023-04-01" />
          <period-end iso-date="2024-03-31" />
          <target>
            <comment>
              <narrative>Numerator: 4321.8.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 3281.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2023-10-01" />
          <period-end iso-date="2024-03-31" />
          <target>
            <comment>
              <narrative>Numerator: 2160.9.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 1858.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Age" value="15+" />
            <comment>
              <narrative>Numerator: 1778; Denominator: 1858; Percentage: 95.69%.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Age" value="&lt;15" />
            <comment>
              <narrative>Numerator: 80; Denominator: 1858; Percentage: 4.31%.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Gender" value="Female" />
            <comment>
              <narrative>Numerator: 727; Denominator: 1858; Percentage: 39.13%.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Gender" value="Male" />
            <comment>
              <narrative>Numerator: 1131; Denominator: 1858; Percentage: 60.87%.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="TB regimen" value="Short regimens" />
            <comment>
              <narrative>Numerator: 1366; Denominator: 1858; Percentage: 73.52%.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2024-04-01" />
          <period-end iso-date="2024-09-30" />
          <target>
            <comment>
              <narrative>Numerator: 2082.</narrative>
            </comment>
          </target>
        </period>
        <period>
          <period-start iso-date="2024-04-01" />
          <period-end iso-date="2025-03-31" />
          <target>
            <comment>
              <narrative>Numerator: 4164.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 3662.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2024-10-01" />
          <period-end iso-date="2025-03-31" />
          <target>
            <comment>
              <narrative>Numerator: 2082.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 1740.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Age" value="15+" />
            <comment>
              <narrative>Numerator: 1650.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Age" value="&lt;15" />
            <comment>
              <narrative>Numerator: 90.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Gender" value="Female" />
            <comment>
              <narrative>Numerator: 676.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Gender" value="Male" />
            <comment>
              <narrative>Numerator: 1064.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="TB regimen" value="New TB drugs" />
            <comment>
              <narrative>Numerator: 1355.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="TB regimen" value="Short regimens" />
            <comment>
              <narrative>Numerator: 1462.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2025-04-01" />
          <period-end iso-date="2025-09-30" />
          <target>
            <comment>
              <narrative>Numerator: 2032.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 1721.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Age" value="15+" />
            <comment>
              <narrative>Numerator: 1646.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Age" value="&lt;15" />
            <comment>
              <narrative>Numerator: 75.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Gender" value="Female" />
            <comment>
              <narrative>Numerator: 687.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Gender" value="Male" />
            <comment>
              <narrative>Numerator: 1034.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="TB regimen" value="New TB drugs" />
            <comment>
              <narrative>Numerator: 1416.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="TB regimen" value="Short regimens" />
            <comment>
              <narrative>Numerator: 1478.</narrative>
            </comment>
          </actual>
        </period>
      </indicator>
    </result>
    <result type="1" aggregation-status="0">
      <title>
        <narrative>Treatment success rate of RR TB and/or MDR-TB: Percentage of cases with RR and/or MDR-TB successfully treated</narrative>
      </title>
      <description>
        <narrative>Module: MDR-TB.</narrative>
      </description>
      <indicator measure="5" aggregation-status="0">
        <title>
          <narrative>Treatment success rate of RR TB and/or MDR-TB: Percentage of cases with RR and/or MDR-TB successfully treated</narrative>
        </title>
        <description>
          <narrative>Geographic coverage: Subnational, less than 100% national program target. Aggregation: Non cumulative.</narrative>
        </description>
        <baseline year="2019" iso-date="2019-12-31">
          <comment>
            <narrative>Numerator: 2059; Denominator: 3093; Percentage: 66.57%.</narrative>
          </comment>
        </baseline>
        <baseline year="2019" iso-date="2019-12-31">
          <dimension name="Age" value="15+" />
          <comment>
            <narrative>Numerator: 1947; Denominator: 3093; Percentage: 62.95%.</narrative>
          </comment>
        </baseline>
        <baseline year="2019" iso-date="2019-12-31">
          <dimension name="Age" value="15+" />
          <comment>
            <narrative>Numerator: 1947; Denominator: 3093; Percentage: 62.95%.</narrative>
          </comment>
        </baseline>
        <baseline year="2019" iso-date="2019-12-31">
          <dimension name="Age" value="15+" />
          <comment>
            <narrative>Numerator: 1947; Denominator: 3093; Percentage: 62.95%.</narrative>
          </comment>
        </baseline>
        <baseline year="2019" iso-date="2019-12-31">
          <dimension name="Age" value="15+" />
          <comment>
            <narrative>Numerator: 1947; Denominator: 3093; Percentage: 62.95%.</narrative>
          </comment>
        </baseline>
        <baseline year="2019" iso-date="2019-12-31">
          <dimension name="Age" value="&lt;15" />
          <comment>
            <narrative>Numerator: 112; Denominator: 3093; Percentage: 3.62%.</narrative>
          </comment>
        </baseline>
        <baseline year="2019" iso-date="2019-12-31">
          <dimension name="Age" value="&lt;15" />
          <comment>
            <narrative>Numerator: 112; Denominator: 3093; Percentage: 3.62%.</narrative>
          </comment>
        </baseline>
        <baseline year="2019" iso-date="2019-12-31">
          <dimension name="Age" value="&lt;15" />
          <comment>
            <narrative>Numerator: 112; Denominator: 3093; Percentage: 3.62%.</narrative>
          </comment>
        </baseline>
        <baseline year="2019" iso-date="2019-12-31">
          <dimension name="Age" value="&lt;15" />
          <comment>
            <narrative>Numerator: 112; Denominator: 3093; Percentage: 3.62%.</narrative>
          </comment>
        </baseline>
        <baseline year="2019" iso-date="2019-12-31">
          <dimension name="Gender" value="Female" />
          <comment>
            <narrative>Numerator: 865; Denominator: 3093; Percentage: 27.97%.</narrative>
          </comment>
        </baseline>
        <baseline year="2019" iso-date="2019-12-31">
          <dimension name="Gender" value="Female" />
          <comment>
            <narrative>Numerator: 865; Denominator: 3093; Percentage: 27.97%.</narrative>
          </comment>
        </baseline>
        <baseline year="2019" iso-date="2019-12-31">
          <dimension name="Gender" value="Female" />
          <comment>
            <narrative>Numerator: 865; Denominator: 3093; Percentage: 27.97%.</narrative>
          </comment>
        </baseline>
        <baseline year="2019" iso-date="2019-12-31">
          <dimension name="Gender" value="Female" />
          <comment>
            <narrative>Numerator: 865; Denominator: 3093; Percentage: 27.97%.</narrative>
          </comment>
        </baseline>
        <baseline year="2019" iso-date="2019-12-31">
          <dimension name="Gender" value="Male" />
          <comment>
            <narrative>Numerator: 1194; Denominator: 3093; Percentage: 38.6%.</narrative>
          </comment>
        </baseline>
        <baseline year="2019" iso-date="2019-12-31">
          <dimension name="Gender" value="Male" />
          <comment>
            <narrative>Numerator: 1194; Denominator: 3093; Percentage: 38.6%.</narrative>
          </comment>
        </baseline>
        <baseline year="2019" iso-date="2019-12-31">
          <dimension name="Gender" value="Male" />
          <comment>
            <narrative>Numerator: 1194; Denominator: 3093; Percentage: 38.6%.</narrative>
          </comment>
        </baseline>
        <baseline year="2019" iso-date="2019-12-31">
          <dimension name="Gender" value="Male" />
          <comment>
            <narrative>Numerator: 1194; Denominator: 3093; Percentage: 38.6%.</narrative>
          </comment>
        </baseline>
        <baseline year="2019" iso-date="2019-12-31">
          <dimension name="HIV test status" value="Positive" />
          <comment>
            <narrative>Numerator: 1340; Denominator: 3093; Percentage: 43.32%.</narrative>
          </comment>
        </baseline>
        <baseline year="2019" iso-date="2019-12-31">
          <dimension name="HIV test status" value="Positive" />
          <comment>
            <narrative>Numerator: 1340; Denominator: 3093; Percentage: 43.32%.</narrative>
          </comment>
        </baseline>
        <baseline year="2019" iso-date="2019-12-31">
          <dimension name="HIV test status" value="Positive" />
          <comment>
            <narrative>Numerator: 1340; Denominator: 3093; Percentage: 43.32%.</narrative>
          </comment>
        </baseline>
        <baseline year="2019" iso-date="2019-12-31">
          <dimension name="HIV test status" value="Positive" />
          <comment>
            <narrative>Numerator: 1340; Denominator: 3093; Percentage: 43.32%.</narrative>
          </comment>
        </baseline>
        <baseline year="2019" iso-date="2019-12-31">
          <dimension name="Type of TB" value="XDR TB" />
          <comment>
            <narrative>Numerator: 142; Denominator: 237; Percentage: 59.92%.</narrative>
          </comment>
        </baseline>
        <baseline year="2019" iso-date="2019-12-31">
          <dimension name="Type of TB" value="XDR TB" />
          <comment>
            <narrative>Numerator: 142; Denominator: 237; Percentage: 59.92%.</narrative>
          </comment>
        </baseline>
        <baseline year="2019" iso-date="2019-12-31">
          <dimension name="Type of TB" value="XDR TB" />
          <comment>
            <narrative>Numerator: 142; Denominator: 237; Percentage: 59.92%.</narrative>
          </comment>
        </baseline>
        <baseline year="2019" iso-date="2019-12-31">
          <dimension name="Type of TB" value="XDR TB" />
          <comment>
            <narrative>Numerator: 142; Denominator: 237; Percentage: 59.92%.</narrative>
          </comment>
        </baseline>
        <period>
          <period-start iso-date="2022-04-01" />
          <period-end iso-date="2023-03-31" />
          <target>
            <comment>
              <narrative>Numerator: 1535; Denominator: 2235; Percentage: 68.7%.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 1065; Denominator: 1595; Percentage: 66.8%.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2022-10-01" />
          <period-end iso-date="2023-03-31" />
          <target>
            <comment>
              <narrative>Numerator: 1535; Denominator: 2235; Percentage: 69%.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 1065; Denominator: 1595; Percentage: 66.8%.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Age" value="15+" />
            <comment>
              <narrative>Numerator: 1035.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Age" value="&lt;15" />
            <comment>
              <narrative>Numerator: 30.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Gender" value="Female" />
            <comment>
              <narrative>Numerator: 440.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Gender" value="Male" />
            <comment>
              <narrative>Numerator: 625.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="HIV test status" value="Positive" />
            <comment>
              <narrative>Numerator: 729.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2023-04-01" />
          <period-end iso-date="2024-03-31" />
          <target>
            <comment>
              <narrative>Numerator: 1743; Denominator: 2461; Percentage: 70.8%.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 1019; Denominator: 1546; Percentage: 65.9%.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2023-10-01" />
          <period-end iso-date="2024-03-31" />
          <target>
            <comment>
              <narrative>Numerator: 1743; Denominator: 2461; Percentage: 71%.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 1019; Denominator: 1546; Percentage: 65.9%.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Age" value="15+" />
            <comment>
              <narrative>Numerator: 980; Denominator: 1019; Percentage: 96.17%.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Age" value="&lt;15" />
            <comment>
              <narrative>Numerator: 39; Denominator: 1019; Percentage: 3.83%.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Gender" value="Female" />
            <comment>
              <narrative>Numerator: 431; Denominator: 1019; Percentage: 42.3%.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Gender" value="Male" />
            <comment>
              <narrative>Numerator: 588; Denominator: 1019; Percentage: 57.7%.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="HIV test status" value="Positive" />
            <comment>
              <narrative>Numerator: 691; Denominator: 1019; Percentage: 67.81%.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2024-04-01" />
          <period-end iso-date="2025-03-31" />
          <target>
            <comment>
              <narrative>Numerator: 1796; Denominator: 2566; Percentage: 70%.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 1751; Denominator: 2517; Percentage: 69.57%.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2024-10-01" />
          <period-end iso-date="2025-03-31" />
          <target>
            <comment>
              <narrative>Numerator: 1796; Denominator: 2566; Percentage: 69.99%.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 1751; Denominator: 2517; Percentage: 69.57%.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Age" value="15+" />
            <comment>
              <narrative>Numerator: 1637; Denominator: 1751; Percentage: 93.49%.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Age" value="&lt;15" />
            <comment>
              <narrative>Numerator: 114; Denominator: 1751; Percentage: 6.51%.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Gender" value="Female" />
            <comment>
              <narrative>Numerator: 712; Denominator: 1751; Percentage: 40.66%.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Gender" value="Male" />
            <comment>
              <narrative>Numerator: 1039; Denominator: 1751; Percentage: 59.34%.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="HIV test status" value="Positive" />
            <comment>
              <narrative>Numerator: 1031; Denominator: 1751; Percentage: 58.88%.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Type of TB" value="XDR TB" />
            <comment>
              <narrative>Numerator: 0; Denominator: 1751; Percentage: 0%.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2025-04-01" />
          <period-end iso-date="2025-09-30" />
          <target>
            <comment>
              <narrative>Numerator: 1384; Denominator: 1922; Percentage: 72.01%.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 1235; Denominator: 1568; Percentage: 78.76%.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Age" value="15+" />
            <comment>
              <narrative>Numerator: 1174; Denominator: 1235; Percentage: 95.06%.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Age" value="&lt;15" />
            <comment>
              <narrative>Numerator: 61; Denominator: 1235; Percentage: 4.94%.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Gender" value="Female" />
            <comment>
              <narrative>Numerator: 492; Denominator: 1235; Percentage: 39.84%.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Gender" value="Male" />
            <comment>
              <narrative>Numerator: 743; Denominator: 1235; Percentage: 60.16%.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="HIV test status" value="Positive" />
            <comment>
              <narrative>Numerator: 720; Denominator: 1235; Percentage: 58.3%.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Type of TB" value="XDR TB" />
            <comment>
              <narrative>Numerator: 0; Denominator: 1235; Percentage: 0%.</narrative>
            </comment>
          </actual>
        </period>
      </indicator>
    </result>
    <result type="1" aggregation-status="0">
      <title>
        <narrative>Completeness of facility reporting: Percentage of expected facility monthly reports (for the reporting period) that are actually received</narrative>
      </title>
      <description>
        <narrative>Module: RSSH: Health management information systems and M&amp;E.</narrative>
      </description>
      <indicator measure="5" aggregation-status="0">
        <title>
          <narrative>Completeness of facility reporting: Percentage of expected facility monthly reports (for the reporting period) that are actually received</narrative>
        </title>
        <description>
          <narrative>Geographic coverage: National, 100% of national program target. Aggregation: Non cumulative.</narrative>
        </description>
        <baseline year="2021" iso-date="2021-12-31">
          <comment>
            <narrative>Numerator: 4724; Denominator: 4765; Percentage: 99.14%.</narrative>
          </comment>
        </baseline>
        <baseline year="2021" iso-date="2021-12-31">
          <dimension name="Report type" value="HIV reports" />
          <comment>
            <narrative>Numerator: 4115; Denominator: 4135; Percentage: 99.52%.</narrative>
          </comment>
        </baseline>
        <baseline year="2021" iso-date="2021-12-31">
          <dimension name="Report type" value="HIV reports" />
          <comment>
            <narrative>Numerator: 4115; Denominator: 4135; Percentage: 99.52%.</narrative>
          </comment>
        </baseline>
        <baseline year="2021" iso-date="2021-12-31">
          <dimension name="Report type" value="HIV reports" />
          <comment>
            <narrative>Numerator: 4115; Denominator: 4135; Percentage: 99.52%.</narrative>
          </comment>
        </baseline>
        <baseline year="2021" iso-date="2021-12-31">
          <dimension name="Report type" value="HIV reports" />
          <comment>
            <narrative>Numerator: 4115; Denominator: 4135; Percentage: 99.52%.</narrative>
          </comment>
        </baseline>
        <baseline year="2021" iso-date="2021-12-31">
          <dimension name="Report type" value="HIV reports" />
          <comment>
            <narrative>Numerator: 4115; Denominator: 4135; Percentage: 99.52%.</narrative>
          </comment>
        </baseline>
        <baseline year="2021" iso-date="2021-12-31">
          <dimension name="Report type" value="HIV reports" />
          <comment>
            <narrative>Numerator: 4115; Denominator: 4135; Percentage: 99.52%.</narrative>
          </comment>
        </baseline>
        <baseline year="2021" iso-date="2021-12-31">
          <dimension name="Report type" value="TB reports" />
          <comment>
            <narrative>Numerator: 4724; Denominator: 4765; Percentage: 99.14%.</narrative>
          </comment>
        </baseline>
        <baseline year="2021" iso-date="2021-12-31">
          <dimension name="Report type" value="TB reports" />
          <comment>
            <narrative>Numerator: 4724; Denominator: 4765; Percentage: 99.14%.</narrative>
          </comment>
        </baseline>
        <baseline year="2021" iso-date="2021-12-31">
          <dimension name="Report type" value="TB reports" />
          <comment>
            <narrative>Numerator: 4724; Denominator: 4765; Percentage: 99.14%.</narrative>
          </comment>
        </baseline>
        <baseline year="2021" iso-date="2021-12-31">
          <dimension name="Report type" value="TB reports" />
          <comment>
            <narrative>Numerator: 4724; Denominator: 4765; Percentage: 99.14%.</narrative>
          </comment>
        </baseline>
        <baseline year="2021" iso-date="2021-12-31">
          <dimension name="Report type" value="TB reports" />
          <comment>
            <narrative>Numerator: 4724; Denominator: 4765; Percentage: 99.14%.</narrative>
          </comment>
        </baseline>
        <baseline year="2021" iso-date="2021-12-31">
          <dimension name="Report type" value="TB reports" />
          <comment>
            <narrative>Numerator: 4724; Denominator: 4765; Percentage: 99.14%.</narrative>
          </comment>
        </baseline>
        <period>
          <period-start iso-date="2022-04-01" />
          <period-end iso-date="2022-09-30" />
          <target>
            <comment>
              <narrative>Numerator: 4724; Denominator: 4765; Percentage: 99%.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 4789; Denominator: 4827; Percentage: 99.2%.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Report type" value="HIV reports" />
            <comment>
              <narrative>Numerator: 4842; Denominator: 4873; Percentage: 99.36%.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Report type" value="TB reports" />
            <comment>
              <narrative>Numerator: 4789; Denominator: 4827; Percentage: 99.21%.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2022-04-01" />
          <period-end iso-date="2023-03-31" />
          <target>
            <comment>
              <narrative>Numerator: 9448; Denominator: 9530; Percentage: 99.1%.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 9584; Denominator: 9677; Percentage: 99%.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2022-10-01" />
          <period-end iso-date="2023-03-31" />
          <target>
            <comment>
              <narrative>Numerator: 4724; Denominator: 4765; Percentage: 99%.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 4795; Denominator: 4850; Percentage: 98.9%.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Report type" value="HIV reports" />
            <comment>
              <narrative>Numerator: 4854.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Report type" value="TB reports" />
            <comment>
              <narrative>Numerator: 4785.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2023-04-01" />
          <period-end iso-date="2024-03-31" />
          <target>
            <comment>
              <narrative>Numerator: 9448; Denominator: 9530; Percentage: 99.1%.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 9802; Denominator: 9915; Percentage: 98.9%.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2023-04-01" />
          <period-end iso-date="2023-09-30" />
          <target>
            <comment>
              <narrative>Numerator: 4724; Denominator: 4765; Percentage: 99%.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 4865; Denominator: 4944; Percentage: 98.4%.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Report type" value="HIV reports" />
            <comment>
              <narrative>Numerator: 4069.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Report type" value="TB reports" />
            <comment>
              <narrative>Numerator: 4865.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2023-10-01" />
          <period-end iso-date="2024-03-31" />
          <target>
            <comment>
              <narrative>Numerator: 4724; Denominator: 4765; Percentage: 99%.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 4937; Denominator: 4971; Percentage: 99.3%.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Report type" value="HIV reports" />
            <comment>
              <narrative>Numerator: 4113; Denominator: 4122; Percentage: 99.78%.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Report type" value="TB reports" />
            <comment>
              <narrative>Numerator: 4937; Denominator: 4971; Percentage: 99.32%.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2024-04-01" />
          <period-end iso-date="2024-09-30" />
          <target>
            <comment>
              <narrative>Numerator: 4724; Denominator: 4765; Percentage: 99.14%.</narrative>
            </comment>
          </target>
        </period>
        <period>
          <period-start iso-date="2024-04-01" />
          <period-end iso-date="2025-03-31" />
          <target>
            <comment>
              <narrative>Numerator: 9448; Denominator: 9530; Percentage: 99.1%.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 9891; Denominator: 9956; Percentage: 99.35%.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2024-10-01" />
          <period-end iso-date="2025-03-31" />
          <target>
            <comment>
              <narrative>Numerator: 4724; Denominator: 4765; Percentage: 99.14%.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 4938; Denominator: 4967; Percentage: 99.42%.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Report type" value="HIV reports" />
            <comment>
              <narrative>Numerator: 4892; Denominator: 4923; Percentage: 99.37%.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Report type" value="TB reports" />
            <comment>
              <narrative>Numerator: 4938; Denominator: 4967; Percentage: 99.42%.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2025-04-01" />
          <period-end iso-date="2025-09-30" />
          <target>
            <comment>
              <narrative>Numerator: 4869; Denominator: 4901; Percentage: 99.35%.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 4903; Denominator: 4958; Percentage: 98.89%.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Report type" value="HIV reports" />
            <comment>
              <narrative>Numerator: 4862; Denominator: 4904; Percentage: 99.14%.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Report type" value="TB reports" />
            <comment>
              <narrative>Numerator: 4903; Denominator: 4956; Percentage: 98.93%.</narrative>
            </comment>
          </actual>
        </period>
      </indicator>
    </result>
    <result type="1" aggregation-status="0">
      <title>
        <narrative>HR-Other 1: Number of health care providers trained on medical ethics and Human rights</narrative>
      </title>
      <description>
        <narrative>Module: Reducing human rights-related barriers to HIV/TB services.</narrative>
      </description>
      <indicator measure="5" aggregation-status="0">
        <title>
          <narrative>HR-Other 1: Number of health care providers trained on medical ethics and Human rights</narrative>
        </title>
        <description>
          <narrative>Geographic coverage: Subnational, less than 100% national program target. Aggregation: Non cumulative.</narrative>
        </description>
        <baseline year="2021" iso-date="2021-12-31">
          <comment>
            <narrative>Numerator: 5472.</narrative>
          </comment>
        </baseline>
        <period>
          <period-start iso-date="2022-04-01" />
          <period-end iso-date="2023-03-31" />
          <target>
            <comment>
              <narrative>Numerator: 3250.</narrative>
            </comment>
          </target>
        </period>
        <period>
          <period-start iso-date="2022-10-01" />
          <period-end iso-date="2023-03-31" />
          <target>
            <comment>
              <narrative>Numerator: 3250.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 0.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2023-04-01" />
          <period-end iso-date="2024-03-31" />
          <target>
            <comment>
              <narrative>Numerator: 8126.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 586.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2023-04-01" />
          <period-end iso-date="2023-09-30" />
          <target>
            <comment>
              <narrative>Numerator: 4063.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 0.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2023-10-01" />
          <period-end iso-date="2024-03-31" />
          <target>
            <comment>
              <narrative>Numerator: 4063.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 586.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2024-04-01" />
          <period-end iso-date="2024-09-30" />
          <target>
            <comment>
              <narrative>Numerator: 4063.</narrative>
            </comment>
          </target>
        </period>
        <period>
          <period-start iso-date="2024-04-01" />
          <period-end iso-date="2025-03-31" />
          <target>
            <comment>
              <narrative>Numerator: 8126.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 9434; Denominator: 8126; Percentage: 116.1%.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2024-10-01" />
          <period-end iso-date="2025-03-31" />
          <target>
            <comment>
              <narrative>Numerator: 4063.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 4084; Denominator: 8126; Percentage: 50.26%.</narrative>
            </comment>
          </actual>
        </period>
      </indicator>
    </result>
    <result type="1" aggregation-status="0">
      <title>
        <narrative>Number of notified cases of all forms of TB (i.e. bacteriologically confirmed + clinically diagnosed), new and relapse cases</narrative>
      </title>
      <description>
        <narrative>Module: TB care and prevention.</narrative>
      </description>
      <indicator measure="5" aggregation-status="0">
        <title>
          <narrative>Number of notified cases of all forms of TB (i.e. bacteriologically confirmed + clinically diagnosed), new and relapse cases</narrative>
        </title>
        <description>
          <narrative>Geographic coverage: Subnational, less than 100% national program target. Aggregation: Non cumulative.</narrative>
        </description>
        <baseline year="2020" iso-date="2020-12-31">
          <comment>
            <narrative>Numerator: 80795.</narrative>
          </comment>
        </baseline>
        <baseline year="2020" iso-date="2020-12-31">
          <dimension name="HIV test status" value="Positive" />
          <comment>
            <narrative>Numerator: 39464; Denominator: 80795; Percentage: 48.84%.</narrative>
          </comment>
        </baseline>
        <baseline year="2020" iso-date="2020-12-31">
          <dimension name="HIV test status" value="Positive" />
          <comment>
            <narrative>Numerator: 39464; Denominator: 80795; Percentage: 48.84%.</narrative>
          </comment>
        </baseline>
        <baseline year="2020" iso-date="2020-12-31">
          <dimension name="HIV test status" value="Positive" />
          <comment>
            <narrative>Numerator: 39464; Denominator: 80795; Percentage: 48.84%.</narrative>
          </comment>
        </baseline>
        <baseline year="2020" iso-date="2020-12-31">
          <dimension name="HIV test status" value="Positive" />
          <comment>
            <narrative>Numerator: 39464; Denominator: 80795; Percentage: 48.84%.</narrative>
          </comment>
        </baseline>
        <baseline year="2020" iso-date="2020-12-31">
          <dimension name="HIV test status" value="Positive" />
          <comment>
            <narrative>Numerator: 39464; Denominator: 80795; Percentage: 48.84%.</narrative>
          </comment>
        </baseline>
        <baseline year="2020" iso-date="2020-12-31">
          <dimension name="HIV test status" value="Positive" />
          <comment>
            <narrative>Numerator: 39464; Denominator: 80795; Percentage: 48.84%.</narrative>
          </comment>
        </baseline>
        <period>
          <period-start iso-date="2022-04-01" />
          <period-end iso-date="2022-09-30" />
          <target>
            <comment>
              <narrative>Numerator: 55860.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 43137.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="HIV test status" value="Positive" />
            <comment>
              <narrative>Numerator: 21593; Denominator: 43137; Percentage: 50.06%.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2022-04-01" />
          <period-end iso-date="2023-03-31" />
          <target>
            <comment>
              <narrative>Numerator: 111720.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 76772.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2022-10-01" />
          <period-end iso-date="2023-03-31" />
          <target>
            <comment>
              <narrative>Numerator: 55860.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 33635.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="HIV test status" value="Positive" />
            <comment>
              <narrative>Numerator: 18644.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2023-04-01" />
          <period-end iso-date="2024-03-31" />
          <target>
            <comment>
              <narrative>Numerator: 114887.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 80707.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2023-04-01" />
          <period-end iso-date="2023-09-30" />
          <target>
            <comment>
              <narrative>Numerator: 57443.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 33439.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="HIV test status" value="Positive" />
            <comment>
              <narrative>Numerator: 18241.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2023-10-01" />
          <period-end iso-date="2024-03-31" />
          <target>
            <comment>
              <narrative>Numerator: 57444.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 47268.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="HIV test status" value="Positive" />
            <comment>
              <narrative>Numerator: 24133; Denominator: 47268; Percentage: 51.06%.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2024-04-01" />
          <period-end iso-date="2025-03-31" />
          <target>
            <comment>
              <narrative>Numerator: 106112.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 101166.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2024-04-01" />
          <period-end iso-date="2024-09-30" />
          <target>
            <comment>
              <narrative>Numerator: 53056.</narrative>
            </comment>
          </target>
        </period>
        <period>
          <period-start iso-date="2024-10-01" />
          <period-end iso-date="2025-03-31" />
          <target>
            <comment>
              <narrative>Numerator: 53056.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 52144.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="HIV test status" value="Positive" />
            <comment>
              <narrative>Numerator: 24698.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2025-04-01" />
          <period-end iso-date="2025-09-30" />
          <target>
            <comment>
              <narrative>Numerator: 49887.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 49487.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="HIV test status" value="Positive" />
            <comment>
              <narrative>Numerator: 23418.</narrative>
            </comment>
          </actual>
        </period>
      </indicator>
    </result>
    <result type="1" aggregation-status="0">
      <title>
        <narrative>Number of people in contact with TB patients who began preventive therapy</narrative>
      </title>
      <description>
        <narrative>Module: TB care and prevention.</narrative>
      </description>
      <indicator measure="1" aggregation-status="0">
        <title>
          <narrative>Number of people in contact with TB patients who began preventive therapy</narrative>
        </title>
        <description>
          <narrative>Geographic coverage: Subnational, less than 100% national program target. Aggregation: Non cumulative.</narrative>
        </description>
        <baseline year="2020" iso-date="2020-12-31" value="7044" />
        <baseline year="2020" iso-date="2020-12-31" value="7044">
          <dimension name="Age" value="&lt;5" />
        </baseline>
        <baseline year="2020" iso-date="2020-12-31" value="7044">
          <dimension name="Age" value="&lt;5" />
        </baseline>
        <baseline year="2020" iso-date="2020-12-31" value="7044">
          <dimension name="Age" value="&lt;5" />
        </baseline>
        <baseline year="2020" iso-date="2020-12-31" value="7044">
          <dimension name="Age" value="&lt;5" />
        </baseline>
        <baseline year="2020" iso-date="2020-12-31" value="7044">
          <dimension name="Age" value="&lt;5" />
        </baseline>
        <baseline year="2020" iso-date="2020-12-31" value="7044">
          <dimension name="Age" value="&lt;5" />
        </baseline>
        <period>
          <period-start iso-date="2022-04-01" />
          <period-end iso-date="2023-03-31" />
          <target value="7748" />
          <actual value="5711" />
        </period>
        <period>
          <period-start iso-date="2022-04-01" />
          <period-end iso-date="2022-09-30" />
          <target value="3874" />
          <actual value="4255" />
          <actual value="4255">
            <dimension name="Age" value="&lt;5" />
          </actual>
        </period>
        <period>
          <period-start iso-date="2022-10-01" />
          <period-end iso-date="2023-03-31" />
          <target value="3874" />
          <actual value="1456" />
          <actual value="1456">
            <dimension name="Age" value="&lt;5" />
          </actual>
        </period>
        <period>
          <period-start iso-date="2023-04-01" />
          <period-end iso-date="2023-09-30" />
          <target value="4226" />
          <actual value="2479" />
          <actual value="2479">
            <dimension name="Age" value="&lt;5" />
          </actual>
        </period>
        <period>
          <period-start iso-date="2023-04-01" />
          <period-end iso-date="2024-03-31" />
          <target value="8453" />
          <actual value="5829" />
        </period>
        <period>
          <period-start iso-date="2023-10-01" />
          <period-end iso-date="2024-03-31" />
          <target value="4227" />
          <actual value="3350" />
          <actual value="3350">
            <dimension name="Age" value="&lt;5" />
          </actual>
        </period>
        <period>
          <period-start iso-date="2024-04-01" />
          <period-end iso-date="2025-03-31" />
          <target value="9157" />
          <actual value="9946" />
        </period>
        <period>
          <period-start iso-date="2024-04-01" />
          <period-end iso-date="2024-09-30" />
          <target value="4578" />
        </period>
        <period>
          <period-start iso-date="2024-10-01" />
          <period-end iso-date="2025-03-31" />
          <target value="4579" />
          <actual value="5205" />
          <actual value="5205">
            <dimension name="Age" value="&lt;5" />
          </actual>
        </period>
        <period>
          <period-start iso-date="2025-04-01" />
          <period-end iso-date="2025-09-30" />
          <target value="24875" />
          <actual value="22471" />
          <actual value="4650">
            <dimension name="Age" value="&lt;5" />
          </actual>
        </period>
      </indicator>
    </result>
    <result type="1" aggregation-status="0">
      <title>
        <narrative>Treatment success rate- all forms: Percentage of TB cases, all forms, bacteriologically confirmed plus clinically diagnosed, successfully treated (cured plus treatment completed) among all TB cases registered for treatment during a specified period, new and relapse cases</narrative>
      </title>
      <description>
        <narrative>Module: TB care and prevention.</narrative>
      </description>
      <indicator measure="2" aggregation-status="0">
        <title>
          <narrative>Treatment success rate- all forms: Percentage of TB cases, all forms, bacteriologically confirmed plus clinically diagnosed, successfully treated (cured plus treatment completed) among all TB cases registered for treatment during a specified period, new and relapse cases</narrative>
        </title>
        <description>
          <narrative>Geographic coverage: Subnational, less than 100% national program target. Aggregation: Non cumulative.</narrative>
        </description>
        <baseline year="2020" iso-date="2020-12-31" value="84.41">
          <comment>
            <narrative>Numerator: 68199; Denominator: 80795.</narrative>
          </comment>
        </baseline>
        <period>
          <period-start iso-date="2022-04-01" />
          <period-end iso-date="2023-03-31" />
          <target value="87" />
          <actual value="81">
            <comment>
              <narrative>Numerator: 50789; Denominator: 62727.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2022-04-01" />
          <period-end iso-date="2022-09-30" />
          <target value="87" />
          <actual value="80.2">
            <comment>
              <narrative>Numerator: 27657; Denominator: 34482.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2022-10-01" />
          <period-end iso-date="2023-03-31" />
          <target value="87" />
          <actual value="81.9">
            <comment>
              <narrative>Numerator: 23132; Denominator: 28245.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2023-04-01" />
          <period-end iso-date="2023-09-30" />
          <target value="90">
            <comment>
              <narrative>Numerator: 50274; Denominator: 55860.</narrative>
            </comment>
          </target>
          <actual value="82.2">
            <comment>
              <narrative>Numerator: 25164; Denominator: 30607.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2023-04-01" />
          <period-end iso-date="2024-03-31" />
          <target value="90">
            <comment>
              <narrative>Numerator: 100548; Denominator: 111720.</narrative>
            </comment>
          </target>
          <actual value="76.6">
            <comment>
              <narrative>Numerator: 57260; Denominator: 74725.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2023-10-01" />
          <period-end iso-date="2024-03-31" />
          <target value="90">
            <comment>
              <narrative>Numerator: 50274; Denominator: 55860.</narrative>
            </comment>
          </target>
          <actual value="72.8">
            <comment>
              <narrative>Numerator: 32096; Denominator: 44118.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2024-04-01" />
          <period-end iso-date="2025-03-31" />
          <target value="83">
            <comment>
              <narrative>Numerator: 78048; Denominator: 94033.</narrative>
            </comment>
          </target>
          <actual value="76.38">
            <comment>
              <narrative>Numerator: 76912; Denominator: 100691.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2024-04-01" />
          <period-end iso-date="2024-09-30" />
          <target value="83">
            <comment>
              <narrative>Numerator: 42375; Denominator: 51054.</narrative>
            </comment>
          </target>
        </period>
        <period>
          <period-start iso-date="2024-10-01" />
          <period-end iso-date="2025-03-31" />
          <target value="83">
            <comment>
              <narrative>Numerator: 35673; Denominator: 42979.</narrative>
            </comment>
          </target>
          <actual value="76.74">
            <comment>
              <narrative>Numerator: 40907; Denominator: 53307.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2025-04-01" />
          <period-end iso-date="2025-09-30" />
          <target value="86">
            <comment>
              <narrative>Numerator: 42387; Denominator: 49287.</narrative>
            </comment>
          </target>
          <actual value="76.67">
            <comment>
              <narrative>Numerator: 38196; Denominator: 49817.</narrative>
            </comment>
          </actual>
        </period>
      </indicator>
    </result>
    <result type="1" aggregation-status="0">
      <title>
        <narrative>Percentage of HIV-positive new and relapse TB patients on ART during TB treatment</narrative>
      </title>
      <description>
        <narrative>Module: TB/HIV.</narrative>
      </description>
      <indicator measure="2" aggregation-status="0">
        <title>
          <narrative>Percentage of HIV-positive new and relapse TB patients on ART during TB treatment</narrative>
        </title>
        <description>
          <narrative>Geographic coverage: Subnational, less than 100% national program target. Aggregation: Non cumulative.</narrative>
        </description>
        <baseline year="2020" iso-date="2020-12-31" value="87.16">
          <comment>
            <narrative>Numerator: 34395; Denominator: 39464.</narrative>
          </comment>
        </baseline>
        <period>
          <period-start iso-date="2022-04-01" />
          <period-end iso-date="2022-09-30" />
          <target value="90">
            <comment>
              <narrative>Numerator: 24396; Denominator: 27239.</narrative>
            </comment>
          </target>
          <actual value="88">
            <comment>
              <narrative>Numerator: 19003; Denominator: 21593.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2022-04-01" />
          <period-end iso-date="2023-03-31" />
          <target value="89.6">
            <comment>
              <narrative>Numerator: 48793; Denominator: 54479.</narrative>
            </comment>
          </target>
          <actual value="89.3">
            <comment>
              <narrative>Numerator: 35944; Denominator: 40237.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2022-10-01" />
          <period-end iso-date="2023-03-31" />
          <target value="90">
            <comment>
              <narrative>Numerator: 24397; Denominator: 27240.</narrative>
            </comment>
          </target>
          <actual value="90.9">
            <comment>
              <narrative>Numerator: 16941; Denominator: 18644.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2023-04-01" />
          <period-end iso-date="2023-09-30" />
          <target value="91">
            <comment>
              <narrative>Numerator: 25306; Denominator: 27921.</narrative>
            </comment>
          </target>
          <actual value="91.3">
            <comment>
              <narrative>Numerator: 16655; Denominator: 18241.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2023-04-01" />
          <period-end iso-date="2024-03-31" />
          <target value="90.6">
            <comment>
              <narrative>Numerator: 50613; Denominator: 55843.</narrative>
            </comment>
          </target>
          <actual value="92">
            <comment>
              <narrative>Numerator: 38979; Denominator: 42372.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2023-10-01" />
          <period-end iso-date="2024-03-31" />
          <target value="91">
            <comment>
              <narrative>Numerator: 25307; Denominator: 27922.</narrative>
            </comment>
          </target>
          <actual value="92.5">
            <comment>
              <narrative>Numerator: 22324; Denominator: 24131.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2024-04-01" />
          <period-end iso-date="2024-09-30" />
          <target value="92">
            <comment>
              <narrative>Numerator: 23917; Denominator: 25997.</narrative>
            </comment>
          </target>
        </period>
        <period>
          <period-start iso-date="2024-04-01" />
          <period-end iso-date="2025-03-31" />
          <target value="92">
            <comment>
              <narrative>Numerator: 47834; Denominator: 51994.</narrative>
            </comment>
          </target>
          <actual value="94.24">
            <comment>
              <narrative>Numerator: 45427; Denominator: 48201.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2024-10-01" />
          <period-end iso-date="2025-03-31" />
          <target value="92">
            <comment>
              <narrative>Numerator: 23917; Denominator: 25997.</narrative>
            </comment>
          </target>
          <actual value="94.57">
            <comment>
              <narrative>Numerator: 23358; Denominator: 24698.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2025-04-01" />
          <period-end iso-date="2025-09-30" />
          <target value="95.31">
            <comment>
              <narrative>Numerator: 23074; Denominator: 24209.</narrative>
            </comment>
          </target>
          <actual value="94.85">
            <comment>
              <narrative>Numerator: 22213; Denominator: 23418.</narrative>
            </comment>
          </actual>
        </period>
      </indicator>
    </result>
    <result type="1" aggregation-status="0">
      <title>
        <narrative>Percentage of PLHIV on ART who initiated TB preventive therapy among those eligible during the reporting period</narrative>
      </title>
      <description>
        <narrative>Module: TB/HIV.</narrative>
      </description>
      <indicator measure="2" aggregation-status="0">
        <title>
          <narrative>Percentage of PLHIV on ART who initiated TB preventive therapy among those eligible during the reporting period</narrative>
        </title>
        <description>
          <narrative>Geographic coverage: Subnational, less than 100% national program target. Aggregation: Non cumulative.</narrative>
        </description>
        <baseline year="2020" iso-date="2020-12-31" value="92.22">
          <comment>
            <narrative>Numerator: 188967; Denominator: 204903.</narrative>
          </comment>
        </baseline>
        <period>
          <period-start iso-date="2022-04-01" />
          <period-end iso-date="2022-09-30" />
          <target value="93">
            <comment>
              <narrative>Numerator: 96233; Denominator: 103476.</narrative>
            </comment>
          </target>
          <actual value="87.1">
            <comment>
              <narrative>Numerator: 59344; Denominator: 68153.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2022-04-01" />
          <period-end iso-date="2023-03-31" />
          <target value="93">
            <comment>
              <narrative>Numerator: 192466; Denominator: 206952.</narrative>
            </comment>
          </target>
          <actual value="87.8">
            <comment>
              <narrative>Numerator: 110744; Denominator: 126176.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2022-10-01" />
          <period-end iso-date="2023-03-31" />
          <target value="93">
            <comment>
              <narrative>Numerator: 96233; Denominator: 103476.</narrative>
            </comment>
          </target>
          <actual value="88.6">
            <comment>
              <narrative>Numerator: 51400; Denominator: 58023.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2023-04-01" />
          <period-end iso-date="2024-03-31" />
          <target value="94">
            <comment>
              <narrative>Numerator: 196480; Denominator: 209022.</narrative>
            </comment>
          </target>
          <actual value="92.8">
            <comment>
              <narrative>Numerator: 89385; Denominator: 96371.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2023-04-01" />
          <period-end iso-date="2023-09-30" />
          <target value="94">
            <comment>
              <narrative>Numerator: 98240; Denominator: 104511.</narrative>
            </comment>
          </target>
          <actual value="93">
            <comment>
              <narrative>Numerator: 31055; Denominator: 33399.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2023-10-01" />
          <period-end iso-date="2024-03-31" />
          <target value="94">
            <comment>
              <narrative>Numerator: 98240; Denominator: 104511.</narrative>
            </comment>
          </target>
          <actual value="92.6">
            <comment>
              <narrative>Numerator: 58330; Denominator: 62972.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2024-04-01" />
          <period-end iso-date="2024-09-30" />
          <target value="95">
            <comment>
              <narrative>Numerator: 100278; Denominator: 105556.</narrative>
            </comment>
          </target>
        </period>
        <period>
          <period-start iso-date="2024-04-01" />
          <period-end iso-date="2025-03-31" />
          <target value="95">
            <comment>
              <narrative>Numerator: 200556; Denominator: 211112.</narrative>
            </comment>
          </target>
          <actual value="95.25">
            <comment>
              <narrative>Numerator: 123656; Denominator: 129822.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2024-10-01" />
          <period-end iso-date="2025-03-31" />
          <target value="95">
            <comment>
              <narrative>Numerator: 100278; Denominator: 105556.</narrative>
            </comment>
          </target>
          <actual value="90.3">
            <comment>
              <narrative>Numerator: 54890; Denominator: 60789.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2025-04-01" />
          <period-end iso-date="2025-09-30" />
          <target value="95.24">
            <comment>
              <narrative>Numerator: 74600; Denominator: 78330.</narrative>
            </comment>
          </target>
          <actual value="78.02">
            <comment>
              <narrative>Numerator: 44088; Denominator: 56511.</narrative>
            </comment>
          </actual>
        </period>
      </indicator>
    </result>
    <result type="1" aggregation-status="0">
      <title>
        <narrative>Percentage of people on ART among all people living with HIV at the end of the reporting period</narrative>
      </title>
      <description>
        <narrative>Module: Treatment, care and support.</narrative>
      </description>
      <indicator measure="5" aggregation-status="0">
        <title>
          <narrative>Percentage of people on ART among all people living with HIV at the end of the reporting period</narrative>
        </title>
        <description>
          <narrative>Geographic coverage: National, 100% of national program target. Aggregation: Non cumulative - other.</narrative>
        </description>
        <baseline year="2020" iso-date="2020-12-31">
          <comment>
            <narrative>Numerator: 5117541; Denominator: 8008080; Percentage: 63.9%.</narrative>
          </comment>
        </baseline>
        <baseline year="2020" iso-date="2020-12-31">
          <dimension name="Age" value="15+" />
          <comment>
            <narrative>Numerator: 4906094; Denominator: 7892070; Percentage: 62.16%.</narrative>
          </comment>
        </baseline>
        <baseline year="2020" iso-date="2020-12-31">
          <dimension name="Age" value="15+" />
          <comment>
            <narrative>Numerator: 4906094; Denominator: 7892070; Percentage: 62.16%.</narrative>
          </comment>
        </baseline>
        <baseline year="2020" iso-date="2020-12-31">
          <dimension name="Age" value="15+" />
          <comment>
            <narrative>Numerator: 4906094; Denominator: 7892070; Percentage: 62.16%.</narrative>
          </comment>
        </baseline>
        <baseline year="2020" iso-date="2020-12-31">
          <dimension name="Age" value="15+" />
          <comment>
            <narrative>Numerator: 4906094; Denominator: 7892070; Percentage: 62.16%.</narrative>
          </comment>
        </baseline>
        <baseline year="2020" iso-date="2020-12-31">
          <dimension name="Age" value="&lt;15" />
          <comment>
            <narrative>Numerator: 139828; Denominator: 7892070; Percentage: 1.77%.</narrative>
          </comment>
        </baseline>
        <baseline year="2020" iso-date="2020-12-31">
          <dimension name="Age" value="&lt;15" />
          <comment>
            <narrative>Numerator: 139828; Denominator: 7892070; Percentage: 1.77%.</narrative>
          </comment>
        </baseline>
        <baseline year="2020" iso-date="2020-12-31">
          <dimension name="Age" value="&lt;15" />
          <comment>
            <narrative>Numerator: 139828; Denominator: 7892070; Percentage: 1.77%.</narrative>
          </comment>
        </baseline>
        <baseline year="2020" iso-date="2020-12-31">
          <dimension name="Age" value="&lt;15" />
          <comment>
            <narrative>Numerator: 139828; Denominator: 7892070; Percentage: 1.77%.</narrative>
          </comment>
        </baseline>
        <baseline year="2020" iso-date="2020-12-31">
          <dimension name="Duration of treatment" value="Newly initiating ART" />
          <comment>
            <narrative>Numerator: 541465; Denominator: 7892070; Percentage: 6.86%.</narrative>
          </comment>
        </baseline>
        <baseline year="2020" iso-date="2020-12-31">
          <dimension name="Duration of treatment" value="Newly initiating ART" />
          <comment>
            <narrative>Numerator: 541465; Denominator: 7892070; Percentage: 6.86%.</narrative>
          </comment>
        </baseline>
        <baseline year="2020" iso-date="2020-12-31">
          <dimension name="Duration of treatment" value="Newly initiating ART" />
          <comment>
            <narrative>Numerator: 541465; Denominator: 7892070; Percentage: 6.86%.</narrative>
          </comment>
        </baseline>
        <baseline year="2020" iso-date="2020-12-31">
          <dimension name="Duration of treatment" value="Newly initiating ART" />
          <comment>
            <narrative>Numerator: 541465; Denominator: 7892070; Percentage: 6.86%.</narrative>
          </comment>
        </baseline>
        <period>
          <period-start iso-date="2022-04-01" />
          <period-end iso-date="2023-03-31" />
          <target>
            <comment>
              <narrative>Numerator: 5707564; Denominator: 8110600; Percentage: 70%.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 5437913; Denominator: 8110600; Percentage: 67%.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2022-10-01" />
          <period-end iso-date="2023-03-31" />
          <target>
            <comment>
              <narrative>Numerator: 5707564; Denominator: 8110600; Percentage: 70%.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 5437913; Denominator: 8110600; Percentage: 67%.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Age" value="15+" />
            <comment>
              <narrative>Numerator: 5326130.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Age" value="&lt;15" />
            <comment>
              <narrative>Numerator: 111783.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Duration of treatment" value="Newly initiating ART" />
            <comment>
              <narrative>Numerator: 211012.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2023-04-01" />
          <period-end iso-date="2024-03-31" />
          <actual>
            <comment>
              <narrative>Numerator: 5549084; Denominator: 7809260; Percentage: 71.1%.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2023-10-01" />
          <period-end iso-date="2024-03-31" />
          <actual>
            <comment>
              <narrative>Numerator: 5549084; Denominator: 7809260; Percentage: 71.1%.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Age" value="15+" />
            <comment>
              <narrative>Numerator: 5446406; Denominator: 7809260; Percentage: 69.74%.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Age" value="&lt;15" />
            <comment>
              <narrative>Numerator: 102678; Denominator: 7809260; Percentage: 1.31%.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Duration of treatment" value="Newly initiating ART" />
            <comment>
              <narrative>Numerator: 192331; Denominator: 7809260; Percentage: 2.46%.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2024-04-01" />
          <period-end iso-date="2025-03-31" />
          <target>
            <comment>
              <narrative>Numerator: 6542035; Denominator: 7881970; Percentage: 83%.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 5614691; Denominator: 7881970; Percentage: 71.23%.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2024-04-01" />
          <period-end iso-date="2024-09-30" />
          <target>
            <comment>
              <narrative>Numerator: 6037450; Denominator: 7881970; Percentage: 76.6%.</narrative>
            </comment>
          </target>
        </period>
        <period>
          <period-start iso-date="2024-10-01" />
          <period-end iso-date="2025-03-31" />
          <target>
            <comment>
              <narrative>Numerator: 6542035; Denominator: 7881970; Percentage: 83%.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 5614691; Denominator: 7881970; Percentage: 71.23%.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Age" value="15+" />
            <comment>
              <narrative>Numerator: 5521843; Denominator: 7881970; Percentage: 70.06%.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Age" value="&lt;15" />
            <comment>
              <narrative>Numerator: 92848; Denominator: 7881970; Percentage: 1.18%.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Duration of treatment" value="Newly initiating ART" />
            <comment>
              <narrative>Numerator: 214173; Denominator: 7881970; Percentage: 2.72%.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2025-04-01" />
          <period-end iso-date="2025-09-30" />
          <target>
            <comment>
              <narrative>Numerator: 6594815; Denominator: 7945560; Percentage: 83%.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 6391130; Denominator: 8124260; Percentage: 78.67%.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Age" value="15+" />
            <comment>
              <narrative>Numerator: 6297620; Denominator: 7980580; Percentage: 78.91%.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Age" value="&lt;15" />
            <comment>
              <narrative>Numerator: 93508; Denominator: 143680; Percentage: 65.08%.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Duration of treatment" value="Newly initiating ART" />
            <comment>
              <narrative>Numerator: 214473; Denominator: 8124260; Percentage: 2.64%.</narrative>
            </comment>
          </actual>
        </period>
      </indicator>
    </result>
  </iati-activity>
  <iati-activity last-updated-datetime="2026-11-11T11:05:58+00:00" xml:lang="en" default-currency="USD" humanitarian="0" hierarchy="1">
    <iati-identifier>47045-ZAF-C-NDOH-4</iati-identifier>
    <reporting-org ref="47045" type="30">
      <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
    </reporting-org>
    <title>
      <narrative>Investing for impact against Tuberculosis and HIV - South Africa (01-Oct-2025-31-Mar-2028)</narrative>
    </title>
    <description type="1">
      <narrative>South Africa, TB/HIV, National Department of Health of the Republic of South Africa</narrative>
    </description>
    <description type="2">
      <narrative>Goals: Break down barriers to achieving solutions for HIV, TB and STIs; Maximise equitable and equal access to services and solutions for HIV, TB and STIs; Build resilient systems for HIV, TB and STIs that are integrated into systems for health, social protection, and pandemic response. Objectives: Strengthen TB diagnosis and support for PWTB and accelerate scale up of innovative processes, diagnostic tools and regimens for the diagnosis, treatment and care for PWTB; Strengthen TB-prevention interventions for key and other priority populations and implement airborne infection-prevention and control in health facilities and high-risk indoor places; Ensure that 95% of PLHIV, especially key and other priority populations, know their status and 95% of them are on treatment, and 95% of those on treatment are retained in care and achieve long-term viral suppression; Harness technology and innovation to fight the epidemics with the latest available tools; Build a stronger public health supply chain management and support the acceleration of the approval of new health products.</narrative>
    </description>
    <participating-org ref="47045" type="30" role="1" crs-channel-code="47045">
      <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
    </participating-org>
    <participating-org type="10" role="2" crs-channel-code="12001">
      <narrative>National Department of Health of the Republic of South Africa</narrative>
    </participating-org>
    <participating-org type="10" role="4" crs-channel-code="12001">
      <narrative>National Department of Health of the Republic of South Africa</narrative>
    </participating-org>
    <other-identifier ref="ZAF-C-NDOHP04" type="A1">
      <owner-org ref="47045">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </owner-org>
    </other-identifier>
    <activity-status code="2" />
    <activity-date type="1" iso-date="2025-10-01" />
    <activity-date type="2" iso-date="2025-10-01" />
    <activity-date type="3" iso-date="2028-03-31" />
    <contact-info type="1">
      <organisation>
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </organisation>
      <department>
        <narrative>Communications</narrative>
      </department>
      <telephone>+41 58 791 1700</telephone>
      <email>website@theglobalfund.org</email>
      <website>https://www.theglobalfund.org</website>
      <mailing-address>
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria, Global Health Campus, Chemin du Pommier 40, 1218 Grand-Saconnex, Geneva, Switzerland</narrative>
      </mailing-address>
    </contact-info>
    <contact-info type="2">
      <organisation>
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </organisation>
      <department>
        <narrative>Grant Management Division</narrative>
      </department>
      <person-name>
        <narrative>John Ochero</narrative>
      </person-name>
      <job-title>
        <narrative>Fund Portfolio Manager</narrative>
      </job-title>
      <telephone>+41 58 791 1700</telephone>
      <email>john.ochero@theglobalfund.org</email>
      <website>https://www.theglobalfund.org</website>
      <mailing-address>
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria, Global Health Campus, Chemin du Pommier 40, 1218 Grand-Saconnex, Geneva, Switzerland</narrative>
      </mailing-address>
    </contact-info>
    <activity-scope code="4" />
    <recipient-country code="ZA" percentage="100">
      <narrative>South Africa</narrative>
    </recipient-country>
    <sector vocabulary="1" code="12263" percentage="46.05">
      <narrative>Tuberculosis</narrative>
    </sector>
    <sector vocabulary="1" code="12110" percentage="27.69">
      <narrative>Multicomponent, RSSH</narrative>
    </sector>
    <sector vocabulary="1" code="13040" percentage="26.26">
      <narrative>HIV</narrative>
    </sector>
    <tag vocabulary="2" code="3">
      <narrative>Ensure healthy lives and promote well-being for all at all ages</narrative>
    </tag>
    <tag vocabulary="3" code="3.3">
      <narrative>End the epidemics of AIDS, tuberculosis, malaria and neglected tropical diseases, and combat hepatitis, water-borne diseases and other communicable diseases</narrative>
    </tag>
    <tag vocabulary="3" code="3.8">
      <narrative>Achieve universal health coverage</narrative>
    </tag>
    <country-budget-items vocabulary="4">
      <budget-item code="ae365c24-71a9-48d4-b3ee-c436f513a41a" percentage="0.02">
        <description>
          <narrative>HIV -&gt; Differentiated HIV Testing Services -&gt; Self-testing for AGYW and their male sexual partners programs</narrative>
        </description>
      </budget-item>
      <budget-item code="48867067-7709-4cef-94a9-7dcc66211686" percentage="0.01">
        <description>
          <narrative>HIV -&gt; Differentiated HIV Testing Services -&gt; Self-testing for KP programs</narrative>
        </description>
      </budget-item>
      <budget-item code="c7596dbc-702f-4654-8ff9-9bea34d5790c" percentage="0.03">
        <description>
          <narrative>HIV -&gt; Differentiated HIV Testing Services -&gt; Self-testing outside of KP and AGYW programs</narrative>
        </description>
      </budget-item>
      <budget-item code="54f285ef-8db0-40b2-8052-f00a00522b8d" percentage="0.01">
        <description>
          <narrative>HIV -&gt; Elimination of vertical transmission of HIV, syphilis and hepatitis B -&gt; Integrated testing of pregnant women for HIV, syphilis and hepatitis B</narrative>
        </description>
      </budget-item>
      <budget-item code="3eb32c17-6380-4aa6-8a3b-73b4cb922dee" percentage="0.07">
        <description>
          <narrative>HIV -&gt; Elimination of vertical transmission of HIV, syphilis and hepatitis B -&gt; Post-natal infant prophylaxis</narrative>
        </description>
      </budget-item>
      <budget-item code="698ea3f4-346f-4df8-ab2e-c01a47bbccd9" percentage="0.22">
        <description>
          <narrative>HIV -&gt; Elimination of vertical transmission of HIV, syphilis and hepatitis B -&gt; Prevention of incident HIV among pregnant and breastfeeding women</narrative>
        </description>
      </budget-item>
      <budget-item code="1ef60004-7321-4f53-93cf-6bdfa56924ef" percentage="0.29">
        <description>
          <narrative>HIV -&gt; Elimination of vertical transmission of HIV, syphilis and hepatitis B -&gt; Retention support for pregnant and breastfeeding women (facility and community)</narrative>
        </description>
      </budget-item>
      <budget-item code="9d329dd4-6e6b-430c-80f6-afb56fbbbacd" percentage="0.21">
        <description>
          <narrative>HIV -&gt; Prevention package for adolescent girls and young women (AGYW) and male sexual partners in high HIV incidence settings -&gt; Condom and lubricant programming for AGYW in high HIV incidence settings</narrative>
        </description>
      </budget-item>
      <budget-item code="1240f978-9714-4e2a-9e31-d18773f6e595" percentage="10.98">
        <description>
          <narrative>HIV -&gt; Prevention package for adolescent girls and young women (AGYW) and male sexual partners in high HIV incidence settings -&gt; Pre-exposure prophylaxis (PrEP) programming for AGYW in high HIV incidence settings</narrative>
        </description>
      </budget-item>
      <budget-item code="47ac0494-6213-481b-a81d-d00d7dca8f99" percentage="0.25">
        <description>
          <narrative>HIV -&gt; Prevention package for adolescent girls and young women (AGYW) and male sexual partners in high HIV incidence settings -&gt; Pre-exposure prophylaxis (PrEP) programming for male sexual partners of AGYW in high HIV incidence settings</narrative>
        </description>
      </budget-item>
      <budget-item code="7a803e07-8560-47f6-9b59-72193d6812db" percentage="0.55">
        <description>
          <narrative>HIV -&gt; Prevention package for men who have sex with men (MSM) and their sexual partners -&gt; Condom and lubricant programming for MSM</narrative>
        </description>
      </budget-item>
      <budget-item code="7300b0bf-fc7f-49ac-b933-534346c226a5" percentage="0.5">
        <description>
          <narrative>HIV -&gt; Prevention package for men who have sex with men (MSM) and their sexual partners -&gt; Pre-exposure prophylaxis (PrEP) programming for MSM</narrative>
        </description>
      </budget-item>
      <budget-item code="1d7ecc3b-d5b9-48ca-a9e7-d8fa38cf3455" percentage="0.01">
        <description>
          <narrative>HIV -&gt; Prevention package for people who use drugs (PUD) and their sexual partners -&gt; Condom and lubricant programming for PUD</narrative>
        </description>
      </budget-item>
      <budget-item code="e2889950-b814-4736-95c3-6957c4461ebe" percentage="0.12">
        <description>
          <narrative>HIV -&gt; Prevention package for people who use drugs (PUD) and their sexual partners -&gt; Pre-exposure prophylaxis (PrEP) programming for PUD</narrative>
        </description>
      </budget-item>
      <budget-item code="94dbd87e-0cec-46fb-83f5-7c805de185cb" percentage="0.18">
        <description>
          <narrative>HIV -&gt; Prevention package for sex workers, their clients and other sexual partners -&gt; Condom and lubricant programming for sex workers</narrative>
        </description>
      </budget-item>
      <budget-item code="4ad468bf-4376-466e-944a-b25f3e1b00ee" percentage="0.37">
        <description>
          <narrative>HIV -&gt; Prevention package for sex workers, their clients and other sexual partners -&gt; Pre-exposure prophylaxis (PrEP) programming for sex workers</narrative>
        </description>
      </budget-item>
      <budget-item code="daac344e-ec8e-4193-9c8a-266fdd2e69ac" percentage="0.27">
        <description>
          <narrative>HIV -&gt; Prevention package for transgender people and their sexual partners -&gt; Condom and lubricant programming for transgender people</narrative>
        </description>
      </budget-item>
      <budget-item code="6853dd18-909c-4836-8981-2e434afc456c" percentage="0.25">
        <description>
          <narrative>HIV -&gt; Prevention package for transgender people and their sexual partners -&gt; Pre-exposure prophylaxis (PrEP) programming for transgender people</narrative>
        </description>
      </budget-item>
      <budget-item code="a4e4d0e7-9dfd-49d8-8030-0f9cc9b713fc" percentage="0.17">
        <description>
          <narrative>HIV -&gt; Prevention program stewardship -&gt; Prevention program stewardship</narrative>
        </description>
      </budget-item>
      <budget-item code="39d71dad-c8af-467d-9fcc-8ac534b86784" percentage="1.66">
        <description>
          <narrative>HIV -&gt; Reducing human rights-related barriers to HIV/TB services -&gt; Ensuring nondiscriminatory provision of health care</narrative>
        </description>
      </budget-item>
      <budget-item code="d49b353e-9087-48e0-9c3b-f8ed91d6fd53" percentage="9.77">
        <description>
          <narrative>HIV -&gt; Treatment, care and support -&gt; HIV treatment and differentiated service delivery - adults (15 and above)</narrative>
        </description>
      </budget-item>
      <budget-item code="6bb2376e-8c74-4cf1-98f0-f72ea58797fa" percentage="0.03">
        <description>
          <narrative>HIV -&gt; Treatment, care and support -&gt; HIV treatment and differentiated service delivery - children (under 15)</narrative>
        </description>
      </budget-item>
      <budget-item code="75665eb3-7cb7-4083-b197-c97fcbe30044" percentage="0.28">
        <description>
          <narrative>HIV -&gt; Treatment, care and support -&gt; Treatment monitoring - Viral load and antiretroviral (ARV) toxicity</narrative>
        </description>
      </budget-item>
      <budget-item code="cd09d6c8-13e6-412e-a54d-84c32d99a370" percentage="1.33">
        <description>
          <narrative>Multicomponent -&gt; Program management -&gt; Coordination and management of national disease control programs</narrative>
        </description>
      </budget-item>
      <budget-item code="43337786-bfab-487f-b388-9fbe8808948d" percentage="7.73">
        <description>
          <narrative>Multicomponent -&gt; Program management -&gt; Grant management</narrative>
        </description>
      </budget-item>
      <budget-item code="57ef74d8-840a-4792-b7d8-0c12163d7d91" percentage="0.58">
        <description>
          <narrative>RSSH -&gt; RSSH/PP: Laboratory systems (including national and peripheral) -&gt; RSSH/PP: Biosafety and biosecurity, infrastructure and equipment</narrative>
        </description>
      </budget-item>
      <budget-item code="376b4c32-f875-4663-ba6e-759f6042be74" percentage="0">
        <description>
          <narrative>RSSH -&gt; RSSH/PP: Laboratory systems (including national and peripheral) -&gt; RSSH/PP: Laboratory supply chain systems</narrative>
        </description>
      </budget-item>
      <budget-item code="0aa54232-09ea-488b-86df-48a82af99ed4" percentage="0.55">
        <description>
          <narrative>RSSH -&gt; RSSH/PP: Laboratory systems (including national and peripheral) -&gt; RSSH/PP: Quality management systems and accreditation</narrative>
        </description>
      </budget-item>
      <budget-item code="a964bfef-7776-4f8c-bf11-c2f904336a18" percentage="0.14">
        <description>
          <narrative>RSSH -&gt; RSSH/PP: Laboratory systems (including national and peripheral) -&gt; RSSH/PP: Specimen referral and transport system</narrative>
        </description>
      </budget-item>
      <budget-item code="9489918c-160e-4868-89f0-24a1320c8e8d" percentage="1.3">
        <description>
          <narrative>RSSH -&gt; RSSH/PP: Medical oxygen and respiratory care system -&gt; RSSH/PP: Bulk Oxygen supply</narrative>
        </description>
      </budget-item>
      <budget-item code="7dbf6454-4357-4937-89a1-9a1c7f0174fa" percentage="0.2">
        <description>
          <narrative>RSSH -&gt; RSSH: Community systems strengthening -&gt; Community engagement, linkages and coordination</narrative>
        </description>
      </budget-item>
      <budget-item code="20ec7d90-e6c6-4769-a81d-e6b1e7987227" percentage="0.02">
        <description>
          <narrative>RSSH -&gt; RSSH: Health financing systems -&gt; Blended financing arrangements</narrative>
        </description>
      </budget-item>
      <budget-item code="e7ae970e-44ac-44a1-b3e1-cbff96079a5d" percentage="0.03">
        <description>
          <narrative>RSSH -&gt; RSSH: Health financing systems -&gt; Health financing data and analytics</narrative>
        </description>
      </budget-item>
      <budget-item code="4f5c256c-b6d1-40ea-9bd7-f061f042bc98" percentage="0.14">
        <description>
          <narrative>RSSH -&gt; RSSH: Health financing systems -&gt; Health financing strategies and planning</narrative>
        </description>
      </budget-item>
      <budget-item code="9047155e-4a95-4897-b0bd-857d3f703670" percentage="0.17">
        <description>
          <narrative>RSSH -&gt; RSSH: Health financing systems -&gt; Routine financial management systems</narrative>
        </description>
      </budget-item>
      <budget-item code="49227074-d9ed-412b-b8b5-0fadf80db456" percentage="5.11">
        <description>
          <narrative>RSSH -&gt; RSSH: Health products management systems -&gt; Augmenting national supply chain system with outsourcing</narrative>
        </description>
      </budget-item>
      <budget-item code="48d7f7e3-61fc-4c8d-88f3-aefc44da79dc" percentage="0.69">
        <description>
          <narrative>RSSH -&gt; RSSH: Health products management systems -&gt; Planning and procurement capacity</narrative>
        </description>
      </budget-item>
      <budget-item code="78165abf-6e6d-46ad-b445-d380c1037123" percentage="0.27">
        <description>
          <narrative>RSSH -&gt; RSSH: Health products management systems -&gt; Policy, strategy, governance</narrative>
        </description>
      </budget-item>
      <budget-item code="1e7328c2-4fcd-47b0-8e3c-31a8a421d74c" percentage="3.13">
        <description>
          <narrative>RSSH -&gt; RSSH: Health products management systems -&gt; Regulatory/quality assurance support</narrative>
        </description>
      </budget-item>
      <budget-item code="31d3a0e8-e9f1-4c88-b1b7-ce75b4e952eb" percentage="0.63">
        <description>
          <narrative>RSSH -&gt; RSSH: Health products management systems -&gt; Storage and distribution capacity, design &amp; operations</narrative>
        </description>
      </budget-item>
      <budget-item code="0e90e07b-37cc-4294-9a44-c1afd707a824" percentage="0.21">
        <description>
          <narrative>RSSH -&gt; RSSH: Health sector planning and governance for integrated people-centered services -&gt; Integration/coordination across disease programs and at the service delivery level</narrative>
        </description>
      </budget-item>
      <budget-item code="2c341d5c-b46c-47a9-9aff-2700be47f75e" percentage="0.03">
        <description>
          <narrative>RSSH -&gt; RSSH: Monitoring and evaluation systems -&gt; Analyses, evaluations, reviews and data use</narrative>
        </description>
      </budget-item>
      <budget-item code="f94cd008-2af3-49cf-9149-7be7cf0228e7" percentage="0.18">
        <description>
          <narrative>RSSH -&gt; RSSH: Monitoring and evaluation systems -&gt; Data quality</narrative>
        </description>
      </budget-item>
      <budget-item code="42e7a4b3-fa75-4c16-8a4d-110492b156f4" percentage="5.25">
        <description>
          <narrative>RSSH -&gt; RSSH: Monitoring and evaluation systems -&gt; Routine reporting</narrative>
        </description>
      </budget-item>
      <budget-item code="1da38701-f878-40c8-aeaf-621a89991324" percentage="0.01">
        <description>
          <narrative>Tuberculosis -&gt; Collaboration with other providers and sectors -&gt; Private provider engagement in TB/DR-TB care</narrative>
        </description>
      </budget-item>
      <budget-item code="ea39b4f6-cd94-4310-b181-394f794f9144" percentage="21.4">
        <description>
          <narrative>Tuberculosis -&gt; Drug-resistant (DR)-TB diagnosis, treatment and care -&gt; DR-TB diagnosis/drug susceptibility testing (DST)</narrative>
        </description>
      </budget-item>
      <budget-item code="5b20da70-c625-405c-858b-6de52626ae46" percentage="0.1">
        <description>
          <narrative>Tuberculosis -&gt; Drug-resistant (DR)-TB diagnosis, treatment and care -&gt; DR-TB treatment, care and support</narrative>
        </description>
      </budget-item>
      <budget-item code="f50f08b4-b9d9-4b4a-a8b2-065858f9ce31" percentage="14.93">
        <description>
          <narrative>Tuberculosis -&gt; TB diagnosis, treatment and care -&gt; TB screening and diagnosis</narrative>
        </description>
      </budget-item>
      <budget-item code="003bd5ec-d813-43cd-9bae-ec060870a2c4" percentage="8.51">
        <description>
          <narrative>Tuberculosis -&gt; TB diagnosis, treatment and care -&gt; TB treatment, care and support</narrative>
        </description>
      </budget-item>
      <budget-item code="7332ed72-b538-4ab5-b90e-f820e56c0c5b" percentage="0.72">
        <description>
          <narrative>Tuberculosis -&gt; TB/DR-TB Prevention -&gt; Infection prevention and control (IPC)</narrative>
        </description>
      </budget-item>
      <budget-item code="68262ac7-05ab-4aec-9c9e-320d5883c55c" percentage="0.31">
        <description>
          <narrative>Tuberculosis -&gt; TB/DR-TB Prevention -&gt; Screening/testing for TB infection</narrative>
        </description>
      </budget-item>
      <budget-item code="7c7a7505-bdfe-4146-976c-78a03ca0d545" percentage="0.08">
        <description>
          <narrative>Tuberculosis -&gt; TB/HIV -&gt; TB/HIV - Screening, testing and diagnosis</narrative>
        </description>
      </budget-item>
    </country-budget-items>
    <collaboration-type code="1" />
    <default-flow-type code="10" />
    <default-finance-type code="110" />
    <default-aid-type code="C01" vocabulary="1" />
    <default-tied-status code="5" />
    <budget type="2" status="2">
      <period-start iso-date="2025-01-01" />
      <period-end iso-date="2025-12-31" />
      <value currency="USD" value-date="2025-01-01">38371894.06</value>
    </budget>
    <budget type="2" status="2">
      <period-start iso-date="2026-01-01" />
      <period-end iso-date="2026-12-31" />
      <value currency="USD" value-date="2026-01-01">109803880.66</value>
    </budget>
    <budget type="2" status="2">
      <period-start iso-date="2027-01-01" />
      <period-end iso-date="2027-12-31" />
      <value currency="USD" value-date="2027-01-01">86337171.44</value>
    </budget>
    <capital-spend percentage="7.2" />
    <transaction ref="57430412-3564-491e-a793-e112b9db4ca4">
      <transaction-type code="2" />
      <transaction-date iso-date="2025-10-23" />
      <value currency="USD" value-date="2025-10-23">10849800.00</value>
      <description>
        <narrative>Global Fund commitment to ZAF-C-NDOHP04.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="10">
        <narrative>National Department of Health of the Republic of South Africa</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="80947b61-143c-44c5-8704-269d7d4f13ac">
      <transaction-type code="2" />
      <transaction-date iso-date="2025-10-25" />
      <value currency="USD" value-date="2025-10-25">-10849800.00</value>
      <description>
        <narrative>Global Fund commitment to ZAF-C-NDOHP04.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="10">
        <narrative>National Department of Health of the Republic of South Africa</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="9d0645a0-b876-4164-8cc8-6c022dba3494">
      <transaction-type code="2" />
      <transaction-date iso-date="2025-10-25" />
      <value currency="USD" value-date="2025-10-25">10278000.00</value>
      <description>
        <narrative>Global Fund commitment to ZAF-C-NDOHP04.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="10">
        <narrative>National Department of Health of the Republic of South Africa</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="b804a27f-1f48-4be4-834e-fc75c9a859c0">
      <transaction-type code="2" />
      <transaction-date iso-date="2026-02-26" />
      <value currency="USD" value-date="2026-02-26">81285834.44</value>
      <description>
        <narrative>Global Fund commitment to ZAF-C-NDOHP04.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="10">
        <narrative>National Department of Health of the Republic of South Africa</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="da24a7b7-33c0-45cb-8135-f660818fdb3a">
      <transaction-type code="3" />
      <transaction-date iso-date="2026-03-03" />
      <value currency="USD" value-date="2026-03-03">14258849.39</value>
      <description>
        <narrative>Global Fund disbursement to ZAF-C-NDOHP04 (Government).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="10">
        <narrative>National Department of Health of the Republic of South Africa</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="e71c678b-cddc-4be8-91e0-6845b1f6a5dc">
      <transaction-type code="3" />
      <transaction-date iso-date="2026-04-15" />
      <value currency="USD" value-date="2026-04-15">1137600.00</value>
      <description>
        <narrative>Global Fund disbursement to ZAF-C-NDOHP04 (Pooled Procurement Mechanism).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="10">
        <narrative>National Department of Health of the Republic of South Africa</narrative>
      </receiver-org>
      <disbursement-channel code="3" />
    </transaction>
    <transaction ref="03a5591a-1804-4042-8b3d-6d9e8fba5e37">
      <transaction-type code="2" />
      <transaction-date iso-date="2026-04-15" />
      <value currency="USD" value-date="2026-04-15">241450.00</value>
      <description>
        <narrative>Global Fund commitment to ZAF-C-NDOHP04.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="10">
        <narrative>National Department of Health of the Republic of South Africa</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="c17171d3-bc76-47ce-ae28-9af2f289a4f9">
      <transaction-type code="3" />
      <transaction-date iso-date="2026-05-19" />
      <value currency="USD" value-date="2026-05-19">18302214.30</value>
      <description>
        <narrative>Global Fund disbursement to ZAF-C-NDOHP04 (Government).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="10">
        <narrative>National Department of Health of the Republic of South Africa</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="abae0b57-fb0f-4e00-b880-500d146293ee">
      <transaction-type code="3" />
      <transaction-date iso-date="2026-07-01" />
      <value currency="USD" value-date="2026-07-01">594000.00</value>
      <description>
        <narrative>Global Fund disbursement to ZAF-C-NDOHP04 (Pooled Procurement Mechanism).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="10">
        <narrative>National Department of Health of the Republic of South Africa</narrative>
      </receiver-org>
      <disbursement-channel code="3" />
    </transaction>
    <transaction ref="0830e83d-498c-49ec-8548-a500e4e284a7">
      <transaction-type code="3" />
      <transaction-date iso-date="2026-07-07" />
      <value currency="USD" value-date="2026-07-07">432000.00</value>
      <description>
        <narrative>Global Fund disbursement to ZAF-C-NDOHP04 (Pooled Procurement Mechanism).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="10">
        <narrative>National Department of Health of the Republic of South Africa</narrative>
      </receiver-org>
      <disbursement-channel code="3" />
    </transaction>
    <transaction ref="3e85a82d-3b23-405b-8613-80aa72b9a65c">
      <transaction-type code="3" />
      <transaction-date iso-date="2026-07-07" />
      <value currency="USD" value-date="2026-07-07">432000.00</value>
      <description>
        <narrative>Global Fund disbursement to ZAF-C-NDOHP04 (Pooled Procurement Mechanism).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="10">
        <narrative>National Department of Health of the Republic of South Africa</narrative>
      </receiver-org>
      <disbursement-channel code="3" />
    </transaction>
    <transaction ref="7980de3d-1cda-4e1c-ba31-964601d7766c">
      <transaction-type code="3" />
      <transaction-date iso-date="2026-07-07" />
      <value currency="USD" value-date="2026-07-07">432000.00</value>
      <description>
        <narrative>Global Fund disbursement to ZAF-C-NDOHP04 (Pooled Procurement Mechanism).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="10">
        <narrative>National Department of Health of the Republic of South Africa</narrative>
      </receiver-org>
      <disbursement-channel code="3" />
    </transaction>
    <transaction ref="c4c28fa0-3a98-44f7-9ad1-7db874ffe4ca">
      <transaction-type code="3" />
      <transaction-date iso-date="2026-07-07" />
      <value currency="USD" value-date="2026-07-07">432000.00</value>
      <description>
        <narrative>Global Fund disbursement to ZAF-C-NDOHP04 (Pooled Procurement Mechanism).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="10">
        <narrative>National Department of Health of the Republic of South Africa</narrative>
      </receiver-org>
      <disbursement-channel code="3" />
    </transaction>
    <transaction ref="0d213793-7106-435c-a5de-b2b752a74338">
      <transaction-type code="3" />
      <transaction-date iso-date="2026-08-11" />
      <value currency="USD" value-date="2026-08-11">20380889.26</value>
      <description>
        <narrative>Global Fund disbursement to ZAF-C-NDOHP04 (Government).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="10">
        <narrative>National Department of Health of the Republic of South Africa</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="1c4ee487-0e2c-475d-b39e-d29b56b0a433">
      <transaction-type code="3" />
      <transaction-date iso-date="2026-09-01" />
      <value currency="USD" value-date="2026-09-01">164450.00</value>
      <description>
        <narrative>Global Fund disbursement to ZAF-C-NDOHP04 (Pooled Procurement Mechanism).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="10">
        <narrative>National Department of Health of the Republic of South Africa</narrative>
      </receiver-org>
      <disbursement-channel code="3" />
    </transaction>
    <transaction ref="30914c02-f9ac-4f8d-8f76-12af1dc1de46">
      <transaction-type code="3" />
      <transaction-date iso-date="2026-09-29" />
      <value currency="USD" value-date="2026-09-29">15416249.81</value>
      <description>
        <narrative>Global Fund disbursement to ZAF-C-NDOHP04 (Government).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="10">
        <narrative>National Department of Health of the Republic of South Africa</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="c9b6a0c6-a652-4c5b-9f37-249606f89b96">
      <transaction-type code="3" />
      <transaction-date iso-date="2026-11-10" />
      <value currency="USD" value-date="2026-11-10">594000.00</value>
      <description>
        <narrative>Global Fund disbursement to ZAF-C-NDOHP04 (Pooled Procurement Mechanism).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="10">
        <narrative>National Department of Health of the Republic of South Africa</narrative>
      </receiver-org>
      <disbursement-channel code="3" />
    </transaction>
    <transaction ref="5cd1872c-1ff2-4de2-9e2b-2475eed2e27b">
      <transaction-type code="3" />
      <transaction-date iso-date="2026-11-10" />
      <value currency="USD" value-date="2026-11-10">288000.00</value>
      <description>
        <narrative>Global Fund disbursement to ZAF-C-NDOHP04 (Pooled Procurement Mechanism).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="10">
        <narrative>National Department of Health of the Republic of South Africa</narrative>
      </receiver-org>
      <disbursement-channel code="3" />
    </transaction>
    <transaction ref="2ea1e210-7ea9-4e55-bac9-9bd1f0915e0b">
      <transaction-type code="3" />
      <transaction-date iso-date="2026-11-10" />
      <value currency="USD" value-date="2026-11-10">468000.00</value>
      <description>
        <narrative>Global Fund disbursement to ZAF-C-NDOHP04 (Pooled Procurement Mechanism).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="10">
        <narrative>National Department of Health of the Republic of South Africa</narrative>
      </receiver-org>
      <disbursement-channel code="3" />
    </transaction>
    <document-link url="https://data.theglobalfund.org/grant/ZAF-C-NDOH" format="text/html">
      <title>
        <narrative>Grant page on the data explorer of the Global Fund.</narrative>
      </title>
      <description>
        <narrative>An overview of a grant over its lifetime.</narrative>
      </description>
      <category code="A12" />
      <category code="A01" />
      <category code="A02" />
      <category code="A05" />
      <category code="A07" />
      <category code="A08" />
      <language code="en" />
      <document-date iso-date="2026-11-11" />
    </document-link>
    <document-link url="https://www.theglobalfund.org/media/13342/core_grantregulationsversiontwo_regulations_en.pdf" format="application/pdf">
      <title>
        <narrative>Grant terms and conditions.</narrative>
      </title>
      <description>
        <narrative>General terms and conditions which apply to Global Fund grants.</narrative>
      </description>
      <category code="A04" />
      <language code="en" />
    </document-link>
    <document-link url="https://docs.theglobalfund.org/files/Applications/Funding Requests/ZAF/2024/HIV_TB/en/ZAF-C_FundingRequest_1_en.zip" format="application/zip">
      <title>
        <narrative>2024 - Funding Request - Window 6 - South Africa - English</narrative>
      </title>
      <description>
        <narrative>Funding Request of funding request FR1691-ZAF-C.</narrative>
      </description>
      <category code="A01" />
      <category code="A02" />
      <category code="A08" />
      <language code="en" />
      <document-date iso-date="2024-09-09" />
    </document-link>
    <conditions attached="1">
      <condition type="1">
        <narrative>1 - Personal Data (1) Principles. The Principal Recipient, acknowledges that Program Activities are expected to respect the following principles and rights (“Data Protection Principles”): (a) Information that could be used to identify a natural person (“Personal Data”) will be: (i) processed lawfully, fairly and transparently; (ii) collected for specified, explicit and legitimate purposes and not further processed in a manner not compatible with those purposes;  (iii) adequate, relevant and limited to what is necessary for the purposes for which they are processed; (iv) accurate and, where necessary, kept up to date; (v) kept in a form which permits identification of the individuals for no longer than is necessary for the purposes for which the Personal Data is processed; and (vi) processed in a manner that ensures appropriate security of the Personal Data; and (b) Natural persons are afforded, where relevant, the right to information about Personal Data that is processed; the right to access and rectify or erase Personal Data; the right to data portability; the right to confidentiality of electronic communications; and the right to object to processing. (2) Limitations. Where collection and processing of Personal Data is required in order to implement Program Activities, whether by the Principal Recipient, a Sub-recipient, or Supplier, the Principal Recipient should respect the Data Protection Principles: (a) to the extent that doing so does not violate or conflict with applicable law and/or policy; and (b) subject to the Principal Recipient balancing the Data Protection Principles with other fundamental rights in accordance with the principle of proportionality, taking into account the risks to the rights and freedoms of natural persons.</narrative>
      </condition>
      <condition type="1">
        <narrative>2 - Right of Access. With respect to Section 7.6 (Right of Access) of the Global Fund Grant Regulations (as amended from time to time), (1) the Global Fund may collect or seek to collect data, and it is possible that such data may contain Personal Data, and (2), prior to collection and at all times thereafter, the Principal Recipient shall take all necessary actions to ensure that the transfer of such information to the Global Fund does not violate any applicable law or regulation.</narrative>
      </condition>
      <condition type="1">
        <narrative>3 - (1) In accordance with the Global Fund’s Sustainability, Transition and Co-financing Policy (GF/B35/04) (the “STC Policy”), the commitment and disbursement of USD 80,490,069 (the “Co-Financing Incentive”), is subject to the Global Fund’s satisfaction of the Grantee’s compliance with the requirements listed at 6.3(1)(a) and 6.3(1)(b) below (“Co-Financing Requirements”). The Principal Recipient acknowledges and agrees that the Global Fund may reduce Grant Funds during the current or any subsequent Implementation Period in the event the Grantee fails to: (a) maintain government expenditure on health to meet national universal health coverage goals; and/or (b) maintain domestic funding of Global Fund-supported programs, with a focus on progressively absorbing the key costs of national disease plans, as identified in consultation with the Global Fund. (2) In order to satisfy the Co-Financing Requirements, the Grantee shall, as set out in the co-financing commitment letter to be signed by the Government of the Republic of South Africa and submitted in form and substance satisfactory to the Global Fund, by 01 March 2026: (a) fulfil a total minimum co-financing commitment; (b) fulfil the specific programmatic commitments linked to domestic investments in key and vulnerable populations, as stipulated in the co-financing commitment letter; and (c) provide to the Global Fund, by no later than the agreed date of each year of the Implementation Period and the year following the end of the Implementation Period, evidence supporting achievement of the Co-Financing Requirements, including but not limited to, expenditure reports on domestic HIV and TB spending; and evidence of procurement of HIV and TB health products.</narrative>
      </condition>
      <condition type="2">
        <narrative>4 - The Program budget may be funded in part by Grant Funds disbursed under a previous Grant Agreement, which the Global Fund has approved to be used for the Program under the current Grant Agreement (“Previously Disbursed Grant Funds”), as well as additional Grant Funds up to the amount set forth in Section 3.6. hereof. Accordingly, the Global Fund may reduce the amount of Grant Funds set forth in Section 3.6. hereof by the amount of any Previously Disbursed Grant Funds. Previously Disbursed Grant Funds shall be governed by the terms of this Grant Agreement.</narrative>
      </condition>
      <condition type="3">
        <narrative>5 - The Global Fund may disburse Grant Funds in a currency other than that specified in the Grant Confirmation. In such cases, the exchange rate used to calculate the amount of the disbursement into its equivalent in the currency specified in the Grant Confirmation shall be the relevant exchange rate reflected in the Program budget.</narrative>
      </condition>
    </conditions>
    <result type="1" aggregation-status="0">
      <title>
        <narrative>Number of people with confirmed RR-TB and/or MDR-TB notified</narrative>
      </title>
      <description>
        <narrative>Module: Drug-resistant (DR)-TB diagnosis, treatment and care.</narrative>
      </description>
      <indicator measure="5" aggregation-status="0">
        <title>
          <narrative>Number of people with confirmed RR-TB and/or MDR-TB notified</narrative>
        </title>
        <description>
          <narrative>Geographic coverage: Subnational, less than 100% national program target. Aggregation: Non cumulative.</narrative>
        </description>
        <baseline year="2024" iso-date="2024-12-31">
          <comment>
            <narrative>Numerator: 4201.</narrative>
          </comment>
        </baseline>
        <baseline year="2024" iso-date="2024-12-31">
          <dimension name="Age" value="15+" />
          <comment>
            <narrative>Numerator: 3989; Denominator: 4201; Percentage: 94.95%.</narrative>
          </comment>
        </baseline>
        <baseline year="2024" iso-date="2024-12-31">
          <dimension name="Age" value="&lt;15" />
          <comment>
            <narrative>Numerator: 114; Denominator: 4201; Percentage: 2.71%.</narrative>
          </comment>
        </baseline>
        <baseline year="2024" iso-date="2024-12-31">
          <dimension name="Gender" value="Female" />
          <comment>
            <narrative>Numerator: 1602; Denominator: 4201; Percentage: 38.13%.</narrative>
          </comment>
        </baseline>
        <baseline year="2024" iso-date="2024-12-31">
          <dimension name="Gender" value="Male" />
          <comment>
            <narrative>Numerator: 2502; Denominator: 4201; Percentage: 59.56%.</narrative>
          </comment>
        </baseline>
        <period>
          <period-start iso-date="2025-10-01" />
          <period-end iso-date="2026-03-31" />
          <target>
            <comment>
              <narrative>Numerator: 2852.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 0.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Age" value="15+" />
            <comment>
              <narrative>Numerator: 0.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Age" value="&lt;15" />
            <comment>
              <narrative>Numerator: 0.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Gender" value="Female" />
            <comment>
              <narrative>Numerator: 0.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Gender" value="Male" />
            <comment>
              <narrative>Numerator: 0.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2026-04-01" />
          <period-end iso-date="2026-09-30" />
          <target>
            <comment>
              <narrative>Numerator: 2407.</narrative>
            </comment>
          </target>
        </period>
        <period>
          <period-start iso-date="2026-10-01" />
          <period-end iso-date="2027-03-31" />
          <target>
            <comment>
              <narrative>Numerator: 2714.</narrative>
            </comment>
          </target>
        </period>
        <period>
          <period-start iso-date="2027-04-01" />
          <period-end iso-date="2027-09-30" />
          <target>
            <comment>
              <narrative>Numerator: 2276.</narrative>
            </comment>
          </target>
        </period>
        <period>
          <period-start iso-date="2027-10-01" />
          <period-end iso-date="2028-03-31" />
          <target>
            <comment>
              <narrative>Numerator: 2566.</narrative>
            </comment>
          </target>
        </period>
      </indicator>
    </result>
    <result type="1" aggregation-status="0">
      <title>
        <narrative>Percentage of people with confirmed RR-TB and/or MDR-TB that began second-line treatment</narrative>
      </title>
      <description>
        <narrative>Module: Drug-resistant (DR)-TB diagnosis, treatment and care.</narrative>
      </description>
      <indicator measure="5" aggregation-status="0">
        <title>
          <narrative>Percentage of people with confirmed RR-TB and/or MDR-TB that began second-line treatment</narrative>
        </title>
        <description>
          <narrative>Geographic coverage: Subnational, less than 100% national program target. Aggregation: Non cumulative.</narrative>
        </description>
        <baseline year="2024" iso-date="2024-12-31">
          <comment>
            <narrative>Numerator: 3692; Denominator: 4201; Percentage: 87.88%.</narrative>
          </comment>
        </baseline>
        <baseline year="2024" iso-date="2024-12-31">
          <dimension name="Age" value="15+" />
          <comment>
            <narrative>Numerator: 3507; Denominator: 3692; Percentage: 94.99%.</narrative>
          </comment>
        </baseline>
        <baseline year="2024" iso-date="2024-12-31">
          <dimension name="Age" value="&lt;15" />
          <comment>
            <narrative>Numerator: 184; Denominator: 3692; Percentage: 4.98%.</narrative>
          </comment>
        </baseline>
        <baseline year="2024" iso-date="2024-12-31">
          <dimension name="Gender" value="Female" />
          <comment>
            <narrative>Numerator: 1475; Denominator: 3692; Percentage: 39.95%.</narrative>
          </comment>
        </baseline>
        <baseline year="2024" iso-date="2024-12-31">
          <dimension name="Treatment regimen" value="Longer individualized" />
          <comment>
            <narrative>Numerator: 632; Denominator: 3692; Percentage: 17.12%.</narrative>
          </comment>
        </baseline>
        <baseline year="2024" iso-date="2024-12-31">
          <dimension name="Gender" value="Male" />
          <comment>
            <narrative>Numerator: 2217; Denominator: 3692; Percentage: 60.05%.</narrative>
          </comment>
        </baseline>
        <baseline year="2024" iso-date="2024-12-31">
          <dimension name="Treatment regimen" value="Shorter 6-9 month" />
          <comment>
            <narrative>Numerator: 2681; Denominator: 3692; Percentage: 72.62%.</narrative>
          </comment>
        </baseline>
        <period>
          <period-start iso-date="2025-10-01" />
          <period-end iso-date="2026-03-31" />
          <target>
            <comment>
              <narrative>Numerator: 2510; Denominator: 2852; Percentage: 88.01%.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 0; Denominator: 0.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Age" value="15+" />
            <comment>
              <narrative>Numerator: 0; Denominator: 0.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Age" value="&lt;15" />
            <comment>
              <narrative>Numerator: 0; Denominator: 0.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Gender" value="Female" />
            <comment>
              <narrative>Numerator: 0; Denominator: 0.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Treatment regimen" value="Longer individualized" />
            <comment>
              <narrative>Numerator: 0.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Gender" value="Male" />
            <comment>
              <narrative>Numerator: 0; Denominator: 0.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Treatment regimen" value="Shorter 6-9 month" />
            <comment>
              <narrative>Numerator: 0.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2026-04-01" />
          <period-end iso-date="2026-09-30" />
          <target>
            <comment>
              <narrative>Numerator: 2142; Denominator: 2407; Percentage: 88.99%.</narrative>
            </comment>
          </target>
        </period>
        <period>
          <period-start iso-date="2026-10-01" />
          <period-end iso-date="2027-03-31" />
          <target>
            <comment>
              <narrative>Numerator: 2415; Denominator: 2714; Percentage: 88.98%.</narrative>
            </comment>
          </target>
        </period>
        <period>
          <period-start iso-date="2027-04-01" />
          <period-end iso-date="2027-09-30" />
          <target>
            <comment>
              <narrative>Numerator: 2072; Denominator: 2276; Percentage: 91.04%.</narrative>
            </comment>
          </target>
        </period>
        <period>
          <period-start iso-date="2027-10-01" />
          <period-end iso-date="2028-03-31" />
          <target>
            <comment>
              <narrative>Numerator: 2335; Denominator: 2566; Percentage: 91%.</narrative>
            </comment>
          </target>
        </period>
      </indicator>
    </result>
    <result type="1" aggregation-status="0">
      <title>
        <narrative>Treatment success rate of RR-TB and/or MDR-TB: Percentage of patients with RR and/or MDR-TB successfully treated</narrative>
      </title>
      <description>
        <narrative>Module: Drug-resistant (DR)-TB diagnosis, treatment and care.</narrative>
      </description>
      <indicator measure="5" aggregation-status="0">
        <title>
          <narrative>Treatment success rate of RR-TB and/or MDR-TB: Percentage of patients with RR and/or MDR-TB successfully treated</narrative>
        </title>
        <description>
          <narrative>Geographic coverage: Subnational, less than 100% national program target. Aggregation: Non cumulative.</narrative>
        </description>
        <baseline year="2022" iso-date="2022-12-31">
          <comment>
            <narrative>Numerator: 2473; Denominator: 4110; Percentage: 60.17%.</narrative>
          </comment>
        </baseline>
        <baseline year="2023" iso-date="2023-12-31">
          <dimension name="Age" value="15+" />
          <comment>
            <narrative>Numerator: 1609; Denominator: 1722; Percentage: 93.44%.</narrative>
          </comment>
        </baseline>
        <baseline year="2023" iso-date="2023-12-31">
          <dimension name="Age" value="&lt;15" />
          <comment>
            <narrative>Numerator: 113; Denominator: 1722; Percentage: 6.56%.</narrative>
          </comment>
        </baseline>
        <baseline year="2023" iso-date="2023-12-31">
          <dimension name="Gender" value="Female" />
          <comment>
            <narrative>Numerator: 702; Denominator: 1722; Percentage: 40.77%.</narrative>
          </comment>
        </baseline>
        <baseline year="2023" iso-date="2023-12-31">
          <dimension name="Gender" value="Male" />
          <comment>
            <narrative>Numerator: 1020; Denominator: 1722; Percentage: 59.23%.</narrative>
          </comment>
        </baseline>
        <baseline year="2023" iso-date="2023-12-31">
          <dimension name="HIV status" value="Negative" />
          <comment>
            <narrative>Numerator: 704; Denominator: 1722; Percentage: 40.88%.</narrative>
          </comment>
        </baseline>
        <baseline year="2023" iso-date="2023-12-31">
          <dimension name="HIV status" value="Positive" />
          <comment>
            <narrative>Numerator: 1014; Denominator: 1722; Percentage: 58.89%.</narrative>
          </comment>
        </baseline>
        <baseline year="2023" iso-date="2023-12-31">
          <dimension name="Provider type" value="Public" />
          <comment>
            <narrative>Numerator: 1722; Denominator: 1722; Percentage: 100%.</narrative>
          </comment>
        </baseline>
        <baseline year="2023" iso-date="2023-12-31">
          <dimension name="Treatment regimen" value="Shorter 6-9 month" />
          <comment>
            <narrative>Numerator: 506; Denominator: 1722; Percentage: 29.38%.</narrative>
          </comment>
        </baseline>
        <baseline year="2023" iso-date="2023-12-31">
          <dimension name="HIV status" value="Unknown" />
          <comment>
            <narrative>Numerator: 4; Denominator: 1722; Percentage: 0.23%.</narrative>
          </comment>
        </baseline>
        <period>
          <period-start iso-date="2025-10-01" />
          <period-end iso-date="2026-03-31" />
          <target>
            <comment>
              <narrative>Numerator: 1515; Denominator: 2104; Percentage: 72.01%.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 0; Denominator: 1568; Percentage: 0%.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Age" value="15+" />
            <comment>
              <narrative>Numerator: 1174; Denominator: 1568; Percentage: 74.87%.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Age" value="&lt;15" />
            <comment>
              <narrative>Numerator: 61; Denominator: 1568; Percentage: 3.89%.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Gender" value="Female" />
            <comment>
              <narrative>Numerator: 492; Denominator: 1568; Percentage: 31.38%.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Gender" value="Male" />
            <comment>
              <narrative>Numerator: 743; Denominator: 1568; Percentage: 47.39%.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="HIV status" value="Negative" />
            <comment>
              <narrative>Numerator: 514; Denominator: 1568; Percentage: 32.78%.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="HIV status" value="Positive" />
            <comment>
              <narrative>Numerator: 720; Denominator: 1568; Percentage: 45.92%.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Provider type" value="Public" />
            <comment>
              <narrative>Numerator: 1235; Denominator: 1235; Percentage: 100%.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Treatment regimen" value="Shorter 6-9 month" />
            <comment>
              <narrative>Numerator: 1235.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="HIV status" value="Unknown" />
            <comment>
              <narrative>Numerator: 1; Denominator: 1568; Percentage: 0.06%.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2026-04-01" />
          <period-end iso-date="2026-09-30" />
          <target>
            <comment>
              <narrative>Numerator: 1291; Denominator: 1745; Percentage: 73.98%.</narrative>
            </comment>
          </target>
        </period>
        <period>
          <period-start iso-date="2026-10-01" />
          <period-end iso-date="2027-03-31" />
          <target>
            <comment>
              <narrative>Numerator: 1450; Denominator: 1959; Percentage: 74.02%.</narrative>
            </comment>
          </target>
        </period>
        <period>
          <period-start iso-date="2027-04-01" />
          <period-end iso-date="2027-09-30" />
          <target>
            <comment>
              <narrative>Percentage: 75%.</narrative>
            </comment>
          </target>
        </period>
        <period>
          <period-start iso-date="2027-10-01" />
          <period-end iso-date="2028-03-31" />
          <target>
            <comment>
              <narrative>Percentage: 75%.</narrative>
            </comment>
          </target>
        </period>
      </indicator>
    </result>
    <result type="1" aggregation-status="0">
      <title>
        <narrative>Percentage of laboratories successfully participating in external quality assurance (EQA) or proficiency testing (PT) schemes</narrative>
      </title>
      <description>
        <narrative>Module: RSSH/PP: Laboratory systems (including national and peripheral).</narrative>
      </description>
      <indicator measure="2" aggregation-status="0">
        <title>
          <narrative>Percentage of laboratories successfully participating in external quality assurance (EQA) or proficiency testing (PT) schemes</narrative>
        </title>
        <description>
          <narrative>Geographic coverage: National, 100% of national program target. Aggregation: Non cumulative - other.</narrative>
        </description>
        <baseline year="2024" iso-date="2024-12-31" value="91.43">
          <comment>
            <narrative>Numerator: 32; Denominator: 35.</narrative>
          </comment>
        </baseline>
        <period>
          <period-start iso-date="2025-10-01" />
          <period-end iso-date="2026-03-31" />
          <target value="97.14">
            <comment>
              <narrative>Numerator: 34; Denominator: 35.</narrative>
            </comment>
          </target>
          <actual value="0">
            <comment>
              <narrative>Numerator: 0; Denominator: 35.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2026-04-01" />
          <period-end iso-date="2026-09-30" />
          <target value="97.14">
            <comment>
              <narrative>Numerator: 34; Denominator: 35.</narrative>
            </comment>
          </target>
        </period>
        <period>
          <period-start iso-date="2026-10-01" />
          <period-end iso-date="2027-03-31" />
          <target value="97.14">
            <comment>
              <narrative>Numerator: 34; Denominator: 35.</narrative>
            </comment>
          </target>
        </period>
        <period>
          <period-start iso-date="2027-04-01" />
          <period-end iso-date="2027-09-30" />
          <target value="97.14">
            <comment>
              <narrative>Numerator: 34; Denominator: 35.</narrative>
            </comment>
          </target>
        </period>
        <period>
          <period-start iso-date="2027-10-01" />
          <period-end iso-date="2028-03-31" />
          <target value="97.14">
            <comment>
              <narrative>Numerator: 34; Denominator: 35.</narrative>
            </comment>
          </target>
        </period>
      </indicator>
    </result>
    <result type="1" aggregation-status="0">
      <title>
        <narrative>Percentage of reporting units which digitally enter and submit data at the reporting unit level using the electronic information system</narrative>
      </title>
      <description>
        <narrative>Module: RSSH: Monitoring and evaluation systems.</narrative>
      </description>
      <indicator measure="2" aggregation-status="0">
        <title>
          <narrative>Percentage of reporting units which digitally enter and submit data at the reporting unit level using the electronic information system</narrative>
        </title>
        <description>
          <narrative>Geographic coverage: Subnational, less than 100% national program target. Aggregation: Non cumulative - other.</narrative>
        </description>
        <baseline year="2025" iso-date="2025-12-31" value="1.18">
          <comment>
            <narrative>Numerator: 39; Denominator: 3300.</narrative>
          </comment>
        </baseline>
        <period>
          <period-start iso-date="2025-10-01" />
          <period-end iso-date="2026-03-31" />
          <target value="10.61">
            <comment>
              <narrative>Numerator: 350; Denominator: 3300.</narrative>
            </comment>
          </target>
          <actual value="2.18">
            <comment>
              <narrative>Numerator: 72; Denominator: 3300.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2026-04-01" />
          <period-end iso-date="2026-09-30" />
          <target value="56.06">
            <comment>
              <narrative>Numerator: 1850; Denominator: 3300.</narrative>
            </comment>
          </target>
        </period>
        <period>
          <period-start iso-date="2026-10-01" />
          <period-end iso-date="2027-03-31" />
          <target value="92.42">
            <comment>
              <narrative>Numerator: 3050; Denominator: 3300.</narrative>
            </comment>
          </target>
        </period>
        <period>
          <period-start iso-date="2027-04-01" />
          <period-end iso-date="2027-09-30" />
          <target value="100">
            <comment>
              <narrative>Numerator: 3300; Denominator: 3300.</narrative>
            </comment>
          </target>
        </period>
        <period>
          <period-start iso-date="2027-10-01" />
          <period-end iso-date="2028-03-31" />
          <target value="100">
            <comment>
              <narrative>Numerator: 3300; Denominator: 3300.</narrative>
            </comment>
          </target>
        </period>
      </indicator>
    </result>
    <result type="1" aggregation-status="0">
      <title>
        <narrative>HR-Other 1 Number of healthcare workers trained on Human Rights and Medical Ethics</narrative>
      </title>
      <description>
        <narrative>Module: Reducing human rights-related barriers to HIV/TB services.</narrative>
      </description>
      <indicator measure="1" aggregation-status="0">
        <title>
          <narrative>HR-Other 1 Number of healthcare workers trained on Human Rights and Medical Ethics</narrative>
        </title>
        <description>
          <narrative>Geographic coverage: Subnational, less than 100% national program target. Aggregation: Non cumulative.</narrative>
        </description>
        <baseline year="2025" iso-date="2025-12-31" value="10067" />
        <period>
          <period-start iso-date="2025-10-01" />
          <period-end iso-date="2026-03-31" />
          <target value="1668" />
          <actual value="0">
            <comment>
              <narrative>Denominator: 0.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2026-04-01" />
          <period-end iso-date="2026-09-30" />
          <target value="2083" />
        </period>
        <period>
          <period-start iso-date="2026-10-01" />
          <period-end iso-date="2027-03-31" />
          <target value="2083" />
        </period>
        <period>
          <period-start iso-date="2027-04-01" />
          <period-end iso-date="2027-09-30" />
          <target value="2083" />
        </period>
        <period>
          <period-start iso-date="2027-10-01" />
          <period-end iso-date="2028-03-31" />
          <target value="2083" />
        </period>
      </indicator>
    </result>
    <result type="1" aggregation-status="0">
      <title>
        <narrative>Number of patients with of all forms of TB notified (i.e., bacteriologically confirmed + clinically diagnosed); *includes only those with new and relapse TB</narrative>
      </title>
      <description>
        <narrative>Module: TB diagnosis, treatment and care.</narrative>
      </description>
      <indicator measure="5" aggregation-status="0">
        <title>
          <narrative>Number of patients with of all forms of TB notified (i.e., bacteriologically confirmed + clinically diagnosed); *includes only those with new and relapse TB</narrative>
        </title>
        <description>
          <narrative>Geographic coverage: Subnational, less than 100% national program target. Aggregation: Non cumulative.</narrative>
        </description>
        <baseline year="2024" iso-date="2024-12-31">
          <comment>
            <narrative>Numerator: 100761.</narrative>
          </comment>
        </baseline>
        <baseline year="2024" iso-date="2024-12-31">
          <dimension name="Type of TB" value="Bacteriologically confirmed" />
          <comment>
            <narrative>Numerator: 64332; Denominator: 100761; Percentage: 63.85%.</narrative>
          </comment>
        </baseline>
        <baseline year="2024" iso-date="2024-12-31">
          <dimension name="HIV status" value="Positive" />
          <comment>
            <narrative>Numerator: 48362; Denominator: 100761; Percentage: 48%.</narrative>
          </comment>
        </baseline>
        <period>
          <period-start iso-date="2025-10-01" />
          <period-end iso-date="2026-03-31" />
          <target>
            <comment>
              <narrative>Numerator: 56842.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 0.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Type of TB" value="Bacteriologically confirmed" />
            <comment>
              <narrative>Numerator: 0.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="HIV status" value="Positive" />
            <comment>
              <narrative>Numerator: 0.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2026-04-01" />
          <period-end iso-date="2026-09-30" />
          <target>
            <comment>
              <narrative>Numerator: 48065.</narrative>
            </comment>
          </target>
        </period>
        <period>
          <period-start iso-date="2026-10-01" />
          <period-end iso-date="2027-03-31" />
          <target>
            <comment>
              <narrative>Numerator: 54201.</narrative>
            </comment>
          </target>
        </period>
        <period>
          <period-start iso-date="2027-04-01" />
          <period-end iso-date="2027-09-30" />
          <target>
            <comment>
              <narrative>Numerator: 45448.</narrative>
            </comment>
          </target>
        </period>
        <period>
          <period-start iso-date="2027-10-01" />
          <period-end iso-date="2028-03-31" />
          <target>
            <comment>
              <narrative>Numerator: 51250.</narrative>
            </comment>
          </target>
        </period>
      </indicator>
    </result>
    <result type="1" aggregation-status="0">
      <title>
        <narrative>Percentage of new and relapse TB patients tested using WHO recommended rapid diagnostic tests at the time of diagnosis</narrative>
      </title>
      <description>
        <narrative>Module: TB diagnosis, treatment and care.</narrative>
      </description>
      <indicator measure="5" aggregation-status="0">
        <title>
          <narrative>Percentage of new and relapse TB patients tested using WHO recommended rapid diagnostic tests at the time of diagnosis</narrative>
        </title>
        <description>
          <narrative>Geographic coverage: Subnational, less than 100% national program target. Aggregation: Non cumulative.</narrative>
        </description>
        <baseline year="2024" iso-date="2024-12-31">
          <comment>
            <narrative>Numerator: 88056; Denominator: 100761; Percentage: 87.39%.</narrative>
          </comment>
        </baseline>
        <period>
          <period-start iso-date="2025-10-01" />
          <period-end iso-date="2026-03-31" />
          <target>
            <comment>
              <narrative>Numerator: 50589; Denominator: 56842; Percentage: 89%.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 0; Denominator: 0.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2026-04-01" />
          <period-end iso-date="2026-09-30" />
          <target>
            <comment>
              <narrative>Numerator: 43259; Denominator: 48065; Percentage: 90%.</narrative>
            </comment>
          </target>
        </period>
        <period>
          <period-start iso-date="2026-10-01" />
          <period-end iso-date="2027-03-31" />
          <target>
            <comment>
              <narrative>Numerator: 48781; Denominator: 54201; Percentage: 90%.</narrative>
            </comment>
          </target>
        </period>
        <period>
          <period-start iso-date="2027-04-01" />
          <period-end iso-date="2027-09-30" />
          <target>
            <comment>
              <narrative>Numerator: 41358; Denominator: 45448; Percentage: 91%.</narrative>
            </comment>
          </target>
        </period>
        <period>
          <period-start iso-date="2027-10-01" />
          <period-end iso-date="2028-03-31" />
          <target>
            <comment>
              <narrative>Numerator: 46638; Denominator: 51250; Percentage: 91%.</narrative>
            </comment>
          </target>
        </period>
      </indicator>
    </result>
    <result type="1" aggregation-status="0">
      <title>
        <narrative>Treatment success rate- all forms: Percentage of patients with all forms of TB, bacteriologically confirmed plus clinically diagnosed, successfully treated (cured plus treatment completed) among all TB patients notified during a specified period; *includes only those with new and relapse TB</narrative>
      </title>
      <description>
        <narrative>Module: TB diagnosis, treatment and care.</narrative>
      </description>
      <indicator measure="2" aggregation-status="0">
        <title>
          <narrative>Treatment success rate- all forms: Percentage of patients with all forms of TB, bacteriologically confirmed plus clinically diagnosed, successfully treated (cured plus treatment completed) among all TB patients notified during a specified period; *includes only those with new and relapse TB</narrative>
        </title>
        <description>
          <narrative>Geographic coverage: Subnational, less than 100% national program target. Aggregation: Non cumulative.</narrative>
        </description>
        <baseline year="2023" iso-date="2023-12-31" value="76.55">
          <comment>
            <narrative>Numerator: 76780; Denominator: 100299.</narrative>
          </comment>
        </baseline>
        <period>
          <period-start iso-date="2025-10-01" />
          <period-end iso-date="2026-03-31" />
          <target value="86">
            <comment>
              <narrative>Numerator: 45927; Denominator: 53403.</narrative>
            </comment>
          </target>
          <actual value="0">
            <comment>
              <narrative>Numerator: 0; Denominator: 49817.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2026-04-01" />
          <period-end iso-date="2026-09-30" />
          <target value="88">
            <comment>
              <narrative>Numerator: 44358; Denominator: 50407.</narrative>
            </comment>
          </target>
        </period>
        <period>
          <period-start iso-date="2026-10-01" />
          <period-end iso-date="2027-03-31" />
          <target value="88.01">
            <comment>
              <narrative>Numerator: 50024; Denominator: 56842.</narrative>
            </comment>
          </target>
        </period>
        <period>
          <period-start iso-date="2027-04-01" />
          <period-end iso-date="2027-09-30" />
          <target value="90">
            <comment>
              <narrative>Numerator: 43258; Denominator: 48065.</narrative>
            </comment>
          </target>
        </period>
        <period>
          <period-start iso-date="2027-10-01" />
          <period-end iso-date="2028-03-31" />
          <target value="90">
            <comment>
              <narrative>Numerator: 48780; Denominator: 54201.</narrative>
            </comment>
          </target>
        </period>
      </indicator>
    </result>
    <result type="1" aggregation-status="0">
      <title>
        <narrative>Number of people in contact with TB patients who began preventive therapy</narrative>
      </title>
      <description>
        <narrative>Module: TB/DR-TB Prevention.</narrative>
      </description>
      <indicator measure="5" aggregation-status="0">
        <title>
          <narrative>Number of people in contact with TB patients who began preventive therapy</narrative>
        </title>
        <description>
          <narrative>Geographic coverage: Subnational, less than 100% national program target. Aggregation: Non cumulative.</narrative>
        </description>
        <baseline year="2024" iso-date="2024-12-31">
          <comment>
            <narrative>Numerator: 34974.</narrative>
          </comment>
        </baseline>
        <baseline year="2024" iso-date="2024-12-31">
          <dimension name="Age" value="&lt;5" />
          <comment>
            <narrative>Numerator: 9883; Denominator: 34974; Percentage: 28.26%.</narrative>
          </comment>
        </baseline>
        <baseline year="2024" iso-date="2024-12-31">
          <dimension name="Provider type" value="Public" />
          <comment>
            <narrative>Numerator: 34974; Denominator: 34974; Percentage: 100%.</narrative>
          </comment>
        </baseline>
        <period>
          <period-start iso-date="2025-10-01" />
          <period-end iso-date="2026-03-31" />
          <target>
            <comment>
              <narrative>Numerator: 28713.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 0.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Age" value="&lt;5" />
            <comment>
              <narrative>Numerator: 0.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Provider type" value="Public" />
            <comment>
              <narrative>Numerator: 0.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2026-04-01" />
          <period-end iso-date="2026-09-30" />
          <target>
            <comment>
              <narrative>Numerator: 37433.</narrative>
            </comment>
          </target>
        </period>
        <period>
          <period-start iso-date="2026-10-01" />
          <period-end iso-date="2027-03-31" />
          <target>
            <comment>
              <narrative>Numerator: 40552.</narrative>
            </comment>
          </target>
        </period>
        <period>
          <period-start iso-date="2027-04-01" />
          <period-end iso-date="2027-09-30" />
          <target>
            <comment>
              <narrative>Numerator: 46819.</narrative>
            </comment>
          </target>
        </period>
        <period>
          <period-start iso-date="2027-10-01" />
          <period-end iso-date="2028-03-31" />
          <target>
            <comment>
              <narrative>Numerator: 50721.</narrative>
            </comment>
          </target>
        </period>
      </indicator>
    </result>
    <result type="1" aggregation-status="0">
      <title>
        <narrative>Percentage of HIV-positive new and relapse TB patients on ART during TB treatment</narrative>
      </title>
      <description>
        <narrative>Module: TB/HIV.</narrative>
      </description>
      <indicator measure="5" aggregation-status="0">
        <title>
          <narrative>Percentage of HIV-positive new and relapse TB patients on ART during TB treatment</narrative>
        </title>
        <description>
          <narrative>Geographic coverage: Subnational, less than 100% national program target. Aggregation: Non cumulative.</narrative>
        </description>
        <baseline year="2024" iso-date="2024-12-31">
          <comment>
            <narrative>Numerator: 45615; Denominator: 48362; Percentage: 94.32%.</narrative>
          </comment>
        </baseline>
        <period>
          <period-start iso-date="2025-10-01" />
          <period-end iso-date="2026-03-31" />
          <target>
            <comment>
              <narrative>Numerator: 25908; Denominator: 27271; Percentage: 95%.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 0; Denominator: 0.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2026-04-01" />
          <period-end iso-date="2026-09-30" />
          <target>
            <comment>
              <narrative>Numerator: 19738; Denominator: 20776; Percentage: 95%.</narrative>
            </comment>
          </target>
        </period>
        <period>
          <period-start iso-date="2026-10-01" />
          <period-end iso-date="2027-03-31" />
          <target>
            <comment>
              <narrative>Numerator: 22257; Denominator: 23429; Percentage: 95%.</narrative>
            </comment>
          </target>
        </period>
        <period>
          <period-start iso-date="2027-04-01" />
          <period-end iso-date="2027-09-30" />
          <target>
            <comment>
              <narrative>Numerator: 18861; Denominator: 19854; Percentage: 95%.</narrative>
            </comment>
          </target>
        </period>
        <period>
          <period-start iso-date="2027-10-01" />
          <period-end iso-date="2028-03-31" />
          <target>
            <comment>
              <narrative>Numerator: 21269; Denominator: 22389; Percentage: 95%.</narrative>
            </comment>
          </target>
        </period>
      </indicator>
    </result>
    <result type="1" aggregation-status="0">
      <title>
        <narrative>Percentage of people living with HIV currently enrolled on antiretroviral therapy who started TB preventive treatment (TPT) during the reporting period</narrative>
      </title>
      <description>
        <narrative>Module: TB/HIV.</narrative>
      </description>
      <indicator measure="5" aggregation-status="0">
        <title>
          <narrative>Percentage of people living with HIV currently enrolled on antiretroviral therapy who started TB preventive treatment (TPT) during the reporting period</narrative>
        </title>
        <description>
          <narrative>Geographic coverage: National, 100% of national program target. Aggregation: Non cumulative - special.</narrative>
        </description>
        <baseline year="2024" iso-date="2024-12-31">
          <comment>
            <narrative>Numerator: 130888; Denominator: 6230200; Percentage: 2.1%.</narrative>
          </comment>
        </baseline>
        <baseline year="2024" iso-date="2024-12-31">
          <dimension name="Age" value="&lt;5" />
          <comment>
            <narrative>Numerator: 9883.</narrative>
          </comment>
        </baseline>
        <period>
          <period-start iso-date="2025-10-01" />
          <period-end iso-date="2026-03-31" />
          <target>
            <comment>
              <narrative>Numerator: 196332; Denominator: 7068106; Percentage: 2.78%.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 0; Denominator: 6268541; Percentage: 0%.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Age" value="&lt;5" />
            <comment>
              <narrative>Numerator: 0.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2026-10-01" />
          <period-end iso-date="2027-03-31" />
          <target>
            <comment>
              <narrative>Numerator: 294498; Denominator: 7473675; Percentage: 3.94%.</narrative>
            </comment>
          </target>
        </period>
        <period>
          <period-start iso-date="2027-10-01" />
          <period-end iso-date="2028-03-31" />
          <target>
            <comment>
              <narrative>Numerator: 441747; Denominator: 7880155; Percentage: 5.61%.</narrative>
            </comment>
          </target>
        </period>
      </indicator>
    </result>
    <result type="1" aggregation-status="0">
      <title>
        <narrative>Percentage of people living with HIV and currently on antiretroviral therapy who are receiving multi month dispensing of antiretroviral medicine</narrative>
      </title>
      <description>
        <narrative>Module: Treatment, care and support.</narrative>
      </description>
      <indicator measure="2" aggregation-status="0">
        <title>
          <narrative>Percentage of people living with HIV and currently on antiretroviral therapy who are receiving multi month dispensing of antiretroviral medicine</narrative>
        </title>
        <description>
          <narrative>Geographic coverage: Subnational, less than 100% national program target. Aggregation: Non cumulative - other.</narrative>
        </description>
        <baseline year="2024" iso-date="2024-12-31" value="41.11">
          <comment>
            <narrative>Numerator: 2405441; Denominator: 5851473.</narrative>
          </comment>
        </baseline>
        <period>
          <period-start iso-date="2025-10-01" />
          <period-end iso-date="2026-03-31" />
          <target value="42.46">
            <comment>
              <narrative>Numerator: 2817360; Denominator: 6635142.</narrative>
            </comment>
          </target>
          <actual value="41.68">
            <comment>
              <narrative>Numerator: 2612489; Denominator: 6268541.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2026-04-01" />
          <period-end iso-date="2026-09-30" />
          <target value="42.19">
            <comment>
              <narrative>Numerator: 2958228; Denominator: 7011311.</narrative>
            </comment>
          </target>
        </period>
        <period>
          <period-start iso-date="2026-10-01" />
          <period-end iso-date="2027-03-31" />
          <target value="44.2">
            <comment>
              <narrative>Numerator: 3099096; Denominator: 7011311.</narrative>
            </comment>
          </target>
        </period>
        <period>
          <period-start iso-date="2027-04-01" />
          <period-end iso-date="2027-09-30" />
          <target value="44.05">
            <comment>
              <narrative>Numerator: 3254051; Denominator: 7387862.</narrative>
            </comment>
          </target>
        </period>
        <period>
          <period-start iso-date="2027-10-01" />
          <period-end iso-date="2028-03-31" />
          <target value="46.14">
            <comment>
              <narrative>Numerator: 3409006; Denominator: 7387862.</narrative>
            </comment>
          </target>
        </period>
      </indicator>
    </result>
    <result type="1" aggregation-status="0">
      <title>
        <narrative>Percentage of people on ART among all people living with HIV at the end of the reporting period</narrative>
      </title>
      <description>
        <narrative>Module: Treatment, care and support.</narrative>
      </description>
      <indicator measure="2" aggregation-status="0">
        <title>
          <narrative>Percentage of people on ART among all people living with HIV at the end of the reporting period</narrative>
        </title>
        <description>
          <narrative>Geographic coverage: National, 100% of national program target. Aggregation: Non cumulative - other.</narrative>
        </description>
        <baseline year="2024" iso-date="2024-12-31" value="77.59">
          <comment>
            <narrative>Numerator: 6230200; Denominator: 8029480.</narrative>
          </comment>
        </baseline>
        <baseline year="2024" iso-date="2024-12-31" value="65.11">
          <dimension name="Gender" value="Female" />
          <comment>
            <narrative>Numerator: 5228360; Denominator: 8029480.</narrative>
          </comment>
        </baseline>
        <baseline year="2024" iso-date="2024-12-31" value="32.93">
          <dimension name="Gender" value="Male" />
          <comment>
            <narrative>Numerator: 2643710; Denominator: 8029480.</narrative>
          </comment>
        </baseline>
        <period>
          <period-start iso-date="2025-10-01" />
          <period-end iso-date="2026-03-31" />
          <target value="87">
            <comment>
              <narrative>Numerator: 7068106; Denominator: 8124260.</narrative>
            </comment>
          </target>
          <actual value="79.19">
            <comment>
              <narrative>Numerator: 6268541; Denominator: 7916310.</narrative>
            </comment>
          </actual>
          <actual value="82.81">
            <dimension name="Gender" value="Female" />
            <comment>
              <narrative>Numerator: 4221180; Denominator: 5097180.</narrative>
            </comment>
          </actual>
          <actual value="71.09">
            <dimension name="Gender" value="Male" />
            <comment>
              <narrative>Numerator: 1861320; Denominator: 2618400.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2026-04-01" />
          <period-end iso-date="2026-09-30" />
          <target value="88.53">
            <comment>
              <narrative>Numerator: 7270890; Denominator: 8212830.</narrative>
            </comment>
          </target>
        </period>
        <period>
          <period-start iso-date="2026-10-01" />
          <period-end iso-date="2027-03-31" />
          <target value="91">
            <comment>
              <narrative>Numerator: 7473675; Denominator: 8212830.</narrative>
            </comment>
          </target>
        </period>
        <period>
          <period-start iso-date="2027-04-01" />
          <period-end iso-date="2027-09-30" />
          <target value="92.55">
            <comment>
              <narrative>Numerator: 7676915; Denominator: 8294900.</narrative>
            </comment>
          </target>
        </period>
        <period>
          <period-start iso-date="2027-10-01" />
          <period-end iso-date="2028-03-31" />
          <target value="95">
            <comment>
              <narrative>Numerator: 7880155; Denominator: 8294900.</narrative>
            </comment>
          </target>
        </period>
      </indicator>
    </result>
  </iati-activity>
</iati-activities>